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SUMMARY
Gene expression profiling using DNA microarrays has the potential to illuminate the 
molecular processes that govern the phenotypic characteristics of porcine skeletal muscles, 
such as hypertrophy or atrophy, and the expression of specific fibre types. This infonnation 
is not only important for understanding basic muscle biology but also provides underpinning 
knowledge for enhancing the efficiency of livestock production. This thesis describes the de 
novo development of a composite skeletal muscle cDNA microanay, comprising 5,500 
clones from two developmentally distinct cDNA libraries {longissimus dorsi of a 50-day 
porcine foetus and the gastrocnemius of a 3-day-old pig). The cDNA clones selected for the 
micro array assembly were of low to moderate abundance, as indicated by colony blot 
hybridisation. Once constructed, the porcine cDNA microaiTay was used to profile the 
differential expression of genes between the psoas (red muscle) and the longissimus dorsi 
(white muscle) of a pig, by co-hybridisation of Cy3 and Cy5 labelled cDNA derived from 
these two muscles. Clones that were preferentially more highly expressed in one muscle type 
were chosen for identification by sequencing. A number of novel candidate regulatory genes 
and candidate genes that could be involved in muscle phenotype determination were 
identified. Gene expression results from seven microaiTay slides (replicates) correctly 
identified genes (e.g., genes of mitochondrial origin, genes for myosin heavy chain fast 
isoforms) that were expected to be differentially expressed, as well as a number of candidate 
regulatory genes (e.g., genes for bin 1, heat shock cognate protein, casein kinase 2 al 
subunit). A novel gene kc2725 was also identified as being differentially expressed. These 
candidate genes could be involved in muscle phenotype deteiinination, and include several 
members of the casein kinase 2 signalling pathways (e.g., casein kinase 2 a l subunit, small 
muscle protein, tyi'osine kinase 9-like A6-related protein). Quantitative real-time RT-PCR 
perfonned on the selected genes (e.g., bin 1, novel gene kc2725, myosin heavy chain lib) 
was used to confirm the results fiom the microanay. The red-white muscle micro array 
expression analysis demonstrated the effectiveness of the porcine cDNA microarray for high 
throughput differential gene expression. Differential gene expression using the porcine 
skeletal muscle cDNA microaiTay was also studied in the ionomycin-treated and the control 
vehicle-treated porcine skeletal muscle myocytes by co-hybridisation of Cy3 and Cy5 
labelled cDNA targets derived from both cell groups. Results from eight replicated 
microarray hybridisations profiled high throughput gene expression and identified a number
XXI
of ionomycin-regulated genes (e.g., genes for protein tyrosine phosphatase non-receptor type 
13, dystrophia myotonica-protein kinase) in porcine skeletal muscle. This study further 
confirmed effectiveness of the porcine cDNA microaiTay for profiling differential gene 
expression.
xxii
CHAPTER ONE
INTRODUCTION
INTRODUCTION
Complementary DNA (cDNA) micro arrays are technological approaches that have the potential 
to accurately measure changes in global mRNA expression levels in various biological contexts 
(DeRisi and Iyer, 1999;Epstein and Butow, 2000). This project was designed to develop a 
porcine skeletal muscle cDNA micro array, and utilise the microarray in different biological 
contexts for investigating the molecular basis of skeletal muscle physiological processes.
To date, rapid progress has been made in delineating signalling pathways that influence skeletal 
muscle remodelling in response to enviromnental or pathological stresses (Chin et al., 
1998;Duim et al., 1999;Wu et a l, 2000). While the causes and consequences of myocyte 
differentiation, proliferation, hypertrophy, atrophy and fibre phenotype switch are well loiown, 
the underlying transcriptional mediators of these processes and the molecular details of complex 
interactions among different signalling pathways which evoke these processes are less clear 
(Olson and Williams, 2000a;01son and Williams, 2000b). To investigate molecular pathways 
involved in skeletal muscle, significant and pressing progress has been anticipated in obtaining 
vast amount of information on gene expression patterns in skeletal muscle in various biological 
contexts. With the advent of microanay technology, skeletal muscle research has seen increasing 
application of DNA micro array to simultaneous evaluation of expression levels of thousands of 
mRNA species (Stewart, 2000;Hughes and Shoemaker, 2001). Such studies have previously 
been limited to human and rodent systems. The pig is both an invaluable large animal 
experimental model for human health, and an important target farm animal species that serves as 
one of the major sources of protein for human consumption. For many decades, commercial 
swine industries have been pursuing higher giowth rate and better meat quality in pigs as two of 
their highest priority goals for profitability. The study of complex genomic interactions has been 
the focus of research in recent years to identify pigs with better genetic potential for the 
improvement of pig production. In addition to its applicability to agriculture, the pig’s role in 
biomedical research makes the study of the porcine genome important for the investigation of 
human skeletal muscle development, regeneration, function and diseases. To better understand 
the physiological complexity of the pig skeletal muscle transcriptomes for both agiicultural 
purpose and for its importance to human biomedical concerns, high thioughput gene expression 
profiling needs to be undertaken. Request and desire have, therefore, arisen for the development 
of a porcine skeletal muscle cDNA micro array, which has previously not been reported.
1.1. SKELETAL MUSCLE STRUCTURE AND FIBRE TYPES
1.1.1. GENERAL DESCRIPTION OF SKELETAL MUSCLE STRUCTURE
Skeletal muscles consist of bundles of multinucleated, differentiated and cylindrical cells, called 
muscle fibres, which lie side by side and run roughly parallel to the line of muscle action. Along 
the centre of each muscle fibre, occupying most of the intracellular space, are protein filaments 
called myofibrils. Consequently, nuclei and mitochondria are forced to peripheral locations in 
the cytoplasm (or sarcoplasm). Each myofibril comprises a continuous chain of contractile 
elements called sarcomeres. These are the hasic units of muscle function, each capable of 
generating a vectoral force when activated. Sarcomeres are composed mostly of actin thin 
filaments and myosin thick filaments. Sarcomeres are directionally aligned and work co­
operatively, so that when muscle contracts, tension develops along the axis of the myofibrils and, 
hence, along the muscle fibre itself. When it is observed with a light microscope, the skeletal 
muscle cells are characterised by a series of light and dark bands perpendicular to the long axis 
of the muscle fibre. This striated banding pattern in skeletal muscle results from the precise 
aiTangement of numerous thick and thin filaments in the cytoplasm into myofibrils. Because the 
striations on adjacent myofibrils are usually aligned, the entire muscle fibre appears uniformly 
striated (McGavin et al., 2001;Russell et al., 2000).
1.1.2. MYOFILAMENT SUBSTRUCTURE
1.1.2.1. Thin filaments
The thin filaments consist largely of the contractile protein actin, as well as two other proteins - 
tropomyosin and troponin. Actin is a globular protein. An actin molecule is composed of a single 
polypeptide that polymerises with other actins to foim two intertwined helical chains that make 
up the primary structure of a thin filament. Each actin molecule contains a binding site for 
myosin heavy chain. Tropomyosin molecules, which stretch along each strand of the thin 
filament, exist as homodimers or heterodimers of two identical or similar a-helical polypeptide 
chains arranged in parallel. Tropomyosin is wedged into the grooves formed by the actin helix, 
and attached, at intervals, complexes of globular protein molecules, collectively called troponin.
Troponin is a complex of three subunits: troponin C, troponin I, and troponin T. In skeletal 
muscles, tropomyosin, together with the troponin complex, comprises the Ca^’^ -dependent 
regulatory machinery by which the interaction of F-actin and myosin are controlled by the level 
of calcium ions (Vander et ah, 2001;Randall et ah, 2002;Pollard et ah, 1999;Squire and Morris, 
1998).
1.1.2.2. Thick filaments
The thick filaments are composed almost entirely of a large contractile protein myosin. The 
skeletal muscle myosin molecule consists of two heavy chains (MyHCs), two essential light 
chains and two regulatory light chains. The N-terminal region of each heavy chain, along with 
the regulatory light chains and the essential light chains, fonns the globular head region of the 
skeletal muscle myosin. The C-temiinal portions of the two heavy chains coil together to foiin a 
rod of 150 nm long. Thus, each skeletal muscle myosin has two globular heads and a long 
coiled-coil a-helical rod. The head portions of the skeletal myosin reach out from the thick 
filament and interact with adjacent actin filaments, forming the cross bridges. Each cross-bridge 
consists of two identical globular myosin heads. Cross-bridges extend outward from myosin 
thick filaments and contact actin in the thin filaments during muscle contraction. Muscles 
contract when the cross-bridges on myosin molecules bind transiently to sites on actin 
molecules, causing molecules to change their physical confonnation. These changes in the shape 
of the myosin molecules generate force, which drags the actin filaments past the myosin 
filaments and causes the sarcomere to shorten. The bond between actin and myosin is then 
broken. The cross-bridges bind and unbind over and over again, generating force each time they 
bind. Therefore, the principal determinant of skeletal muscle movement and performance is 
controlled by actin-myosin interaction in the sarcomere (Vander et ah, 2001;Randall et ah, 
2002;Pollard et ah, 1999).
1.1.3. SKELETAL MUSCLE FIBRE TYPES
1.1.3.1. Slow muscle and fast muscle
Based on speeds of shortening, whole skeletal muscle can be classified as being slow muscle or 
fast muscle. Slow muscle fibres, also termed slow-twitch oxidative fibres, have long twitch
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times, slow contraction velocity and high resistance to fatigue. Slow muscle fibres fatigue very 
slowly for two reasons. First, slow muscle fibres have a large number of mitochondria and 
oxidative enzymes, a rich blood supply supporting sustained oxidative phosphorylation, and a 
high capacity to generate ATP by oxidative metabolic processes. Slow muscle fibres contain 
very little glycogen and creatine phosphate. Second, slow muscle fibres use/split ATP at a 
relatively slow rate (Brooke and Kaiser, 1970; Chang et al., 1993). Skeletal muscles that contain 
a high proportion of slow muscle fibres are often called red muscles. The dark, reddish colour of 
slow muscles is caused by the high concentration of the oxygen-storage protein myoglobin in the 
sarcoplasm (cytoplasm) of slow muscle fibres. Hemoglobin, the pigment of red blood cells, 
brings oxygen fiom lungs to capillaries on the muscle fibre surface. From here, the transport of 
oxygen to the interior of the skeletal muscle fibre is facilitated by myoglobin. Slow muscle fibres 
contain an abundance of compomids that make them efficient at aerobic (complete oxidation of 
substrates with need for blood-bome oxygen) respiration. These compounds are high in both fat 
and sugar, which act as fuel for aerobic metabolism. Slow muscles produce less power for longer 
periods and are better suited for sustaining prolonged, low intensity contractile activity (e.g. 
postural maintenance; marathon rumaing) (Brooke and Kaiser, 1970; Chang et al., 1993). Slow 
muscles are found in large numbers in the postural muscles of the neck and in the soleus muscle 
in the leg.
Fibres of fast muscles can be categorised into two subtypes: fast-twitch glycolytic fibres and 
fast-twitch oxidative-glycolytic fibres. Fast-twitch glycolytic fibres, also called white muscles, 
usually appear white in colour. The white colour of fast-twitch glycolytic fibres is due to 
anaerobic (incomplete oxidation of carbohydrates without need for oxygen) energy metabolism. 
The majority of mammalian muscles contain a mixture of both red and white muscle fibres, with 
white muscle fibres normally larger than red muscle fibres. Fast-twitch glycolytic fibres display 
a fast contraction velocity but fatigue quickly/easily. Fast-twitch glycolytic fibres fatigue very 
quickly for two reasons. First, fast-twitch glycolytic fibres generate most of their ATP by 
anaerobic metabolic processes, and produce high levels of power for short periods. These 
properties correlate with high glycolytic activities, high ATPase activity and low oxidative 
capacity of fast-twitch glycolytic fibres. Fast-twitch glycolytic fibres store high levels of 
glycogen and creatine phosphate, but contain relatively few mitochondria, relatively few blood 
capillaries, and a low content of myoglobin. Second, fast-twitch glycolytic muscle fibres 
use/split ATP at a fast rate. Fast-twitch glycolytic muscle fibres are suited to high power output 
and are usually recmited only where very rapid or very intense effort is required. Fast-twitch
oxidative-glycolytic fibres appear to occupy an intermediate position between slow-twitch 
oxidative fibres and fast-twitch glycolytic fibres (Brooke and Kaiser, 1970;Chang and 
Fernandes, 1997;Pierobon et aL,1981;Schiaffmo and Reggiani, 1996). Fast-twitch oxidative- 
glycolytic fibres, which are high in oxidative enzymes, glycolytic enzymes, and ATPase activity, 
have both aerobic and anaerobic energy metabolism capabilities. Fast-twitch oxidative-glycolytic 
fibres have faster contraction speed when compared with slow muscle fibres, and are resistant to 
fatigue (Brooke and Kaiser, 1970;Chang and Fernandes, 1997;Pierobon et al.,1981;Schiaffino 
and Reggiani, 1996).
1.1.3.2. Myosin heavy chain isoforms and skeletal muscle fibre types
The MyHC of skeletal muscle is both a structural protein and an enzyme that hydrolyses ATP 
(Pollard et ah, 1999;Sun et al., 2001). Currently, the definitive classification of skeletal muscle 
fibre types is based on the MyHC isofoi*m identification. In mammalian skeletal muscle, nine 
MyHC isofirms have been identified. They are 1/(1, a, extra-ocular, neonatal, embryonic, 11a, 11b, 
IIx, and llm (Sciote and Morris, 2000;Weiss and Leinwand, 1996). Each of these proteins is 
encoded by a distinct gene and each has its own ATPase activity located in the head region of the 
molecule (Schiaffmo and Reggiani, 1994;Schiaffino and Reggiani, 1996), MyHC is the major 
structural protein of the myofibrillar thick filaments that are associated with power generation 
necessary for muscle contraction. Skeletal muscle fibres can be classified into types, since 
typically in any given muscle cell, the majority of the sarcomeric thick filaments contain the 
same isoform of MyHC, although co-expression of MyHCs within a single fibre is possible. 
MyHC a is a fast contracting MyHC isoform expressed in cardiac muscle. MyHC a also has rare 
tissue-specific expression in skeletal muscle and has been identified in both human and rabbit 
jaw-closing muscle. Extraocular MyHC is the main MyHC isoform in the posterior 
cricoarytenoid muscle. Embryonic and neonatal MyHC isoforms are typically expressed during 
muscle development. MyHC Ilm has tissue-specific expression in the jaw-closing muscles of 
carnivores and primates (Sciote and Moms, 2000).
In mammals, the main MyHC isoforms in adult skeletal muscle are 1/(3, Ila, Ilb and IIx. The 
expression of these four MyHC isoforms has been identified in postnatal porcine skeletal 
muscles (Chang et ah, I993;Chang et al., 1995;Chang, 2000;Chang and Fernandes, 1997;da 
Costa et ah, 2002;da Costa et ah, 2003). MyHC lib fibres are absent in human, horse and cow
skeletal muscles (Smerdu et al., 1994; Eizema et al., 2003; Chikuni et al., 2004). MyHC I/p is 
the same slow contracting MyHC with |3 designating its presence in heart muscle and 1 in 
skeletal muscle (Sciote and Morris, 2000). MyHC I fibres are slow-twitch oxidative fibres. 
MyHC Ila, lib and IIx are fast contracting isoforms with average fibre diameter and shortening 
speed relative to each other as IIb>IIx>IIa. Of the three fast fibres, MyHC IIx fibres appear to 
occupy an intennediate position between MyHC Ila and MyHC lib fibres, with respect to 
oxidative capacity, fatigue resistance and velocity of contraction, resulting in the description of 
MyHC Ila and MyHC IIx fibres as fast-twitch oxidative-glycolytic fibres and MyHC lib fibres 
as fast-twitch glycolytic fibres (Schiaffmo and Reggiani, 1994). Metaboiically, MyHC IIx fibres 
are more similar to MyHC lib fibres, whilst MyHC Ila fibres are more closely related to MyHC I 
fibres. If only a weak contraction is needed to perfoim a task, only MyHC I fibres are activated 
by their motor units. If a stronger contraction is needed, the motor units of MyHC Ila fibres are 
activated. If a maximal contraction is required, motor units of MyHC lib fibres are activated as 
well. Activation of various motor units is determined in the brain and spinal cord. Although fibre 
composition is strongly determined by genetic factors, these differences may also be strongly 
influenced by the type, intensity and duration of training, as well as the pre-training status of an 
individual. Remarkably, myofibres have the ability to transform between the different fibre types 
in response to environmental stimuli, changing the physiological properties of the skeletal 
muscle and facilitating adaptation of the skeletal muscle to enviromnental needs.
1.2. MOLECULAR PATHWAYS IN SKELETAL MUSCLE
1.2.1. MYOGENIC REGULATORY FACTORS AND SKELETAL MUSCLE
Embryonic skeletal myogenic cells arise from somitic progenitors in response to signalling 
molecules fiom surrounding tissues that specify myogenic cell fate. Adult myogenic cells, which 
are active during the post-natal growth and regeneration of skeletal muscle, are derived mainly 
from skeletal muscle satellite cells (Parker et al., 2003). Bone-marrow cells has been shown to 
participate in regenerative myogenesis (Ferrari et al., 1998;LaBarge and Blau, 2002). The 
signalling pathways and regulatory genes, which activate myogenesis in embryonic cells and 
adult stem cells, are largely unknown at this time (Buckingham, 2001). The myogenic regulatory
factors (MRFs) subfamily consists of MyoD (also termed Myf-3), Myf-5, myogenin (also termed 
Myf-1), and MRF4 (also termed Myf-6/Herculin) (Arnold and Braun, 1996). In all cases, 
overexpression of these factors converts non-muscle cells to the myogenic lineage, 
demonstrating their role in myogenic lineage determination and differentiation. Furthermore, the 
ability of each factor to initiate the expression of one or more of the other three suggests they 
form a cross-regulatory loop. The MRFs belong to the basic helix-loop-helix (bHLH) 
superfamily of transcription factors. The MRF proteins contain a conserved basic DNA-binding 
domain essential for sequence-specific DNA-binding and a helix-loop-helix domain that is 
responsible for heterodimerisation of the MRFs with the ubiquitously expressed E-protein family 
of transcription factors. Each of the MRFs has been shown to heterodimerise with E proteins. 
The heterodimers bind in a sequence-specific manner to E-box DNA sequences (CANNTG), 
which is present in the promoters of many skeletal muscle-specific genes and mediates gene 
activation in an MRF-dependent manner. Although the MRFs share a highly homologous bHLH 
domain, they have limited functional redundancy, owing to sequence divergence in their amino 
and carboxyl tenninals.
During development, the MRFs are expressed in a highly regulated spatial and temporal fashion. 
Either directly or indirectly, the signalling pathways that influence the onset of myogenesis lead 
to activation of the myogenic deteiinination genes Myf5 and MyoD, At least one of the two 
factors (MyoD and Myf5) is required for determining the myogenic/myoblast lineage during 
embryonic development (Rudnicki et al., 1993). Once myogenic cells have been specified, 
skeletal-muscle development requires the differentiation and fusion of progenitors to form 
multinucleated myo tubes and myofibres. Expression of myogenin and MRF4 is dependent on 
both the Myocyte Enhancer Factor-2 (MEF2) family and the MRFs (Naidu et ah, 
1995;Ridgeway et al., 2000). Myogenin has an important role in differentiation rather than 
specification (Hasty et ah, 1993;Nabeshima et al., 1993). MRF4 is important for terminal 
differentiation, fusion and myo fibre maintenance (Braun and Arnold, 1995;Patapoutian et al., 
1995;Zhang et al., 1995). Activation of myogenin and MRF4, is dependent upon the preceding 
expression of MyoD and/or Myf5, which are expressed prior to muscle cell differentiation. The 
paired-domain transcription factors Pax3 and Pax7, which are expressed by myogenic 
precursors, act upstream of MyoD and Myf5 (Parker et a l, 2003). The temporal expression of 
Sonic hedgehog (Shh), Wnts that encode protein giowth factors, bone morphogenic proteins 
(BMPs) and homeohox gene Msxl (Bendall et a l, 1999;Houzelstein et al, 1999;Odelberg et al, 
2000;Woloshin et a l, 1995) in embryonic skeletal myogenic cells ensures the appropriate
proliferation of myogenic precursors before myogenic differentiation. For example, Shli 
activates Myf5 (Borycki et al., 1999), Wntl activates expression of Myf5 indirectly (Cossu et al, 
1996), Wnt7a activates expression of MyoD indirectly, and Wnt3a activates expression of MyoD 
either directly or indirectly (Tajbakhsh et a l, 1998). BMPs, which inhibit expression of MyoD, 
might function to establish a sufficient number of myogenic progenitors before tenninal 
differentiation (Amthor et al, 1998;Dietrich et al, 1998). BMP inhibitor noggin induces 
premature differentiation and prevents myogenic proliferation (Hirsinger et al, 1997;McMahon 
et al, 1998;Reshef et a l, 1998). Wnt-mediated activation of |3-catenin signalling might activate 
the paired-domain transcription factor Pax3, leading to the expression of myogenin and, 
ultimately, myogenic differentiation. Notch ligand DELTA-1 (Delfini et al, 2000;Hirsinger et 
al, 2001) might negatively regulate differentiation of myogenic cells. Therefore, the competing 
action of Msxl, Shh, Wnts, BMPs, noggin, DELTA-1, and p-catenin could function to regulate 
expression of the MRFs.
Satellite cells arise during the late stages of embryogenesis and are highly active during the 
postnatal growth and regeneration of skeletal muscle tissue, so they provide most of the 
myonuclei to adult muscles (Zammit and Beauchamp, 2001). In adult muscles, satellite cells, 
which lie between the basal lamina and the muscle fibre, constitute a reservoir of 
undifferentiated, quiescent muscle precursor cells that are activated in response to muscle 
damage or weight bearing, leading to regeneration of adult skeletal muscle (Seale and Rudnicki,
2000). Recently, multipotent capacity of satellite cells to differentiate into osteogenic or 
adipogénie cell types has also been reported (Seale et al, 2001;Goldring et al, 2002;Hawke and 
Gany., 2001;Asakura et al, 2003). Some studies indicated that satellite cells are derived from the 
somite, whilst other studies showed that satellite cells are derived from cells that are associated 
with the embryonic vasculature (Aimand et al, 1983;De Angelis et al, 1999). The heterogeneity 
in satellite-cell populations described by recent studies might reflect several developmental 
origins for this lineage. Satellite cells were traditionally thought to give rise to all postnatal 
myogenic progenitors. Recently, bone-maiTow derived stem cells have been shown to be able to 
first differentiate as satellite cells in injured or diseased skeletal muscle, thereby providing a 
renewable source of myogenic progenitors (Fenari et al, 1998;Bittner et a l, 1999;Gussoni et al, 
1999). Independent adult stem-cell populations that are resident in skeletal muscle have also 
been defined and considered to function as satellite-cell myogenic progenitors (Seale et al,
2001). Quiescent satellite cells do not express detectable levels of MRF protein or transcripts.
However, in response to muscle damage, activated satellite cells commit to the myogenic lineage 
and express either MyoD or Myf5 prior to differentiation and fusion onto the existing damaged 
fibre. The co-expression of MyoD and Myf5 in satellite-cell-derived progenitors defines the 
myogenic precursor cells that proliferate in response to several growth factors and cytokines. 
Activation of myogenin and Mrf4 is associated with tenninal differentiation and fusion of 
myogenic precursor cells to new or existing fibres. The MRF expression profile in the satellite­
cell lineage indicates that satellite cells might share a common developmental programme for the 
acquisition of myogenic identity and subsequent muscle regeneration with embryonic muscle 
lineages. Although it is clear that similar transcriptional pathways control myogenic 
differentiation in embryonic and adult progenitors, there are notable differences. During 
regenerative responses, activated satellite cells, committed myoblasts or adult stem cells must 
give rise to new satellite cells. Such a mechanism involves a specific transcriptional programme 
that is probably not active in embryonic or foetal myoblasts. The development of the satellite­
cell lineage is dependent on the activity of the paired-box transcription factor, Pax7, which might 
function in the specification of satellite cells upstream of the MRFs. However, the downstream 
genetic pathways that are regulated by the Pax proteins (Pax7 and Pax3) in both embryonic and 
adult muscle development remain largely unknown. At present, little is known about the 
signalling pathways and transcriptional factors that regulate the myogenic differentiation, or 
activation and specification of adult stem cells. In vertebrates, it is considered that the 
fundamental transcriptional programme which regulates embryonic myogenesis and builds foetal 
muscles, is reactivated in adult stem cells to produce myogenic progenitors for tissue repair. 
However, it remains to be determined whether myogenic induction in somitic and adult stem 
cells is under the influence of the same signalling molecules. It is not yet clear which 
environmental signalling molecules elicit their expression (Seale and Rudnicki, 2000), nor to 
what extent the myogenic strategy is strictly equivalent. As in the embryo, the important 
regulatory question of proliferative versus myogenic responses remains open, both at the stem 
cell and the satellite cell level (Goldring et al., 2002).
1.2.2. SKELETAL MUSCLE ATROPHY AND HYPERTROPHY
In the adult mammal, skeletal muscle hypertrophy is characterised by an increase in size (as 
opposed to the number) of individual myofibres, with or without the addition of new myonuclei.
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Skeletal muscle myofibre size can be regulated by two distinct mechanisms. First, the 
cytoplasmic volume associated with individual myonuclei is regulated. This pathway appears to 
involve regulation of protein synthesis, through insulin-like giowth factor-1 (IGF-1) mediated 
phosphatidylinositol 3-kinase (PI3K) signalling, and of protein degradation, through muscle- 
specific ubiquitin ligases (Glass, 2003a;Glass, 2003b). Second, the number of myonuclei within 
a myofibre also determines myofibre size. For example, the myonucleis are lost during atrophy 
whereas during postnatal growth and hypertrophy, the myonucleated muscle cells - myoblasts 
proliferate and fuse to existing myofibres (Schiaffmo and Serrano, 2002). However, the 
mechanisms controlling myoblast fusion have remained elusive. Skeletal muscle hypertrophy 
results primarily from the giowth of each muscle cell, rather than an increase in the number of 
cells. Hypertrophy occurs as an adaptive response to load-bearing exercise, and as a result of an 
enlianced rate of protein synthesis. This increase in protein synthesis enables new contractile 
filaments to be incorporated into the pre-existing muscle fibre, which in turn enables the muscle 
to generate gioater force. Skeletal muscle hypertrophy can be induced by a number of stimuli, 
the most familiar of which is exercise. Whereas an increase in protein synthesis has been shown 
to occur during hypertrophy, atrophy has been associated with increases in protein breakdown. 
However, skeletal muscle atrophy is not necessarily the converse of skeletal muscle hypertrophy 
(Haddad et al., 2003a;Haddad et al., 2003b). Cancer and AIDS are disease conditions that cause 
skeletal muscle atrophy (Jagoe and Goldberg, 2001). A variety of circulating proteins have been 
shown to induce atrophy, including the cachexie cytokine interleukin-1 (IL-1), tumor necrosis 
factor (TNF) (Jagoe and Goldberg, 2001), and transfonning growth factor |3 (TGF-|3) family 
member myostatin (Kocamis and Killefer, 2002;Zimmers et al., 2002). Conditions that lead to 
skeletal muscle atrophy cause a decrease in the size of pre-existing muscle fibres, resulting from 
increases in the rate of ATF-dependent ubiquitin-mediated proteolysis (Mitch and Goldberg, 
1996).
1.2.2.1. Skeletal muscle atrophy via induction of ubiquitin ligase pathway
During skeletal muscle atrophy, a dramatic increase in protein degi'adation and turnover is 
stimulated. This stimulation of proteolysis is shown to occur at least in part because of an 
activation of the ubiquitin ligase pathways (Jagoe et al, 2002). Ubiquitin is a short peptide that 
can be conjugated to specific protein substrates. A chain of polyubiquitin, built onto the substrate 
through ligation, targets the substrate, which is then proteolysed into small peptides. This process
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requires tluee distinct enzymatic components, an El ubiquitin-activating enzyme, an E2 
ubiquitin-conjligating enzyme, and E3 ubiquitin-ligating enzyme. The ubiquitin ligase pathways, 
which regulate ubiquitination, might be activated by the enlianced proteolysis of a key inhibitor 
protein, or be inactivated via the degradation of an activating enzyme. The involvement of the 
ubiquitin ligase pathways in skeletal muscle atrophy, during which rates of protein breakdown 
increase, has been well-established (Lecker et ah, 1999;Lecker, 2003;Tawa, Jr. et al., 1997). 
Expression of two muscle-specific ubiquitin ligases - MuRFl (muscle ring finger) and MAFbx 
(muscle atrophy F-box; also known as Atrogin-1) - is significantly increased in multiple settings 
of skeletal muscle atrophy (Bodine et al., 2001 a;Gomes et ah, 2001). MuREl and MAFbx do not 
seem to be required for normal muscle growth or function. Both of MuRFl and MAFbx encode 
E3 ubiquitin ligases. Expression of MuRFl and MAFbx is stimulated when the nei*ve innervating 
a muscle is cut, during sepsis, by treatment with a glucocorticoid that causes muscle cachexia, or 
by immobilisation of muscle (Bodine et ah, 2001b;Wray et ah, 2003).
1.2.2.2. The IGF-l/PI3K/AKTl/mTOR/p70S6K pathway and skeletal muscle hypertrophy
The downstream signalling mechanisms induced by insulin-like giowth factor-1 (IGF-1) that are 
required for skeletal muscle hypertrophy has been a matter of some controversy. It was initially 
reported that calcineurin was critical for IGF-1-mediated hypertrophy and also required for load- 
induced hypertrophy (Dunn et ah, 1999;01son and Williams, 2000a; Olson and Williams, 
2000b;Semsarian et ah, 1999). However, recent work has shown that calcineurin signalling is not 
required for muscle fibre growth (Bodine et ah, 2001a;Bodine et ah, 2001b) and activated 
calcineurin shows no evidence for skeletal muscle hypertrophy (Naya et ah, 2000;Serrano et ah, 
2001). Moreover, recent work has demonstrated that IGF-1 induces hypertrophy by stimulating 
the phosphatidylinositol 3-kinase (PI3K) and the subsequent direct target protein kinase, Akt, 
resulting in the downstream activation of proteins that are required for protein synthesis. IGF-1, 
as one of the major downstream targets of growth hormone, is essential for regulating growth 
and body size at both prenatal and postnatal stages. Increases in muscle load stimulate the 
expression of IGF-1 (DeVoI et ah, 1990). Overexpression of IGF-1 in vitro using a muscle- 
specific promoter have resulted in significant increase in muscle mass (Coleman et ah, 
1995;Musaro et ah, 2001). IGF-1 stimulation is sufficient to induce hypertrophy of skeletal 
muscle in adult mammals (Vandenburgh et ah, 1991). The IGF-1 receptor (IGF-IR) is a receptor 
tyiosine kinase that becomes activated upon IGF-1 binding. The binding of IGF-1 to IGF-IR on 
the outside surface of muscle cells induces IGF-IR to phosphorylate itself at several tyrosine
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residues located inside the cell. This results in the recruitment of a lipid kinase termed 
phosphatidylinositol 3-kinase (PI3K) to the plasma membrane of cells. Therefore, PI3K activity 
is necessary for IGF-1 to induce skeletal muscle hypertrophy, and its activation is sufficient to 
induce hypertrophy (Murgia et al., 2000). Furthennore, skeletal myotube hypertrophy induced by 
IGF-1 could be inliibited by a phaimacological inliibitor of PI3K (Rommel et al., 1999).
Activated PI3K phosphorylates phosphatidylinositol-4,5-biphosphate, producing
phosphatidylinositol-3,4,5-trisphosphate [PtdIns(3,4,5)P3] (Matsui et al., 2003;Vivanco and 
Sawyers, 2002). Ptdlns(3,4,5)p3 is a membrane-binding site for two kinases: PDKl (for 3’- 
phosphoinositide-dependent protein kinase 1) and Akt, which is also known as protein kinase B 
(PKB). Akt is a serine/threonine kinase and a major participant in growth factor-mediated cell 
survival (Kandel and Hay, 1999). Three major isoforms of Akt (Aktl, Akt2 and Akt3) encoded 
by tlii'ee distinct genes have been found in mammalian cells (Altomare et ah, 1995;Jones et ah, 
1991;Nakatani et al., 1999). All thiee Akt isoforms are ubiquitously expressed in mammals; and 
Aktl is the predominant isoform in most tissues (Vivanco and Sawyers, 2002). Aktl activity is 
required for IGF-1-mediated hypertrophy (Pallafacchina et ah, 2002), and expression of a 
constitutively active foim of Aktl in skeletal muscle cells, either in vitro or m vivo, is sufficient 
to induce muscle hypertrophy (Bodine et ah, 2001a;Bodine et ah, 2001h;Chen et ah, 
2001;Rommel et ah, 2001;Shioi et ah, 2002;Takahashi et ah, 2002). A pleckstrin homology 
domain of Akt binds to Ptdhis(3,4,5)P3, resulting in translocation of Akt from the cytosol to the 
plasma membrane where Ptdhis(3,4,5)P3 is located. Akt is phosphorylated and activated by 
PDKl after tr ans location to the plasma membrane. Once activated, Akt dissociates from the 
plasma membrane and phosphorylates numerous substrates in both the cytoplasm and the 
nucleus, including proteins that mediate protein synthesis, gene transcription, cell proliferation 
and suiwival (Matsui et ah, 2003;Vivanco and Sawyers, 2002). Aktl activity can be regulated 
either by directly controlling its phosphorylation state or by altering the levels of PtdIns(3,4,5)P3 
that it binds at the cell membrane (Alessi et ah, 1997). The Aktl lipid-binding site 
Ptdhis(3,4,5)P3 is dephosphorylated by two lipid phosphatases —  PTEN (for phosphatase and 
tensin homologous on chromosome 10) and SHIP (for SH2-domain-containing inositol 5'- 
phosphatase), which has two foims (SHIPl and SHIP2) (Damen et ah, 1996). Overexpression of 
PTEN (Bodine et ah, 2001a;Bodine et ah, 2001b;Rommel et ah, 2001) or SHIP2 inhibits Aktl, 
causes subsequent decrease in cell size, and therefore blocks hypertrophy in muscle (Goberdhan 
et ah, 1999;Huang et ah, 1999;Stambolic et ah, 1998;Xu et ah, 2002). Aktl phosphorylates and
13
activates mTOR (for mammalian target of rapamycin), which is also known as FRAP or RAFT- 
1, resulting in skeletal muscle hypertrophy. During muscle hypertrophy, phosphorylation of both 
Aktl and mTOR are increased. Rapamycin, which is an inhibitor of mTOR, initially binds 
FK506-binding protein (FKBP12), and the complex of rapamycin and FKBP12 inhihits mTOR 
function. Tuberous sclerosis complex 1 (Tscl) and Tsc2 proteins can also inhibit niTOR- 
mediated signalling (McManus and Alessi, 2002).
Activation of mTOR results in an increase in protein translation by two mechanisms. The first 
mechanism is that mTOR activates p70 S6 kinase (p70S6K), a positive regulator of protein 
translation. The second mechanism is that mTOR inliibits the activity of a eIF-4E binding 
protein, PHAS-1 (also known as 4E-BP1), which is a repressor of translation and a negative 
regulator of the protein elongation/initiation factor eIF-4E (Gingras et al., 1999a;Gingras et al., 
1999b;Gingras et al., 2004;Hara et al., 1997;Sonenberg and Gingras, 1998). hi unstimulated 
cells, eIF-4E and PHAS-1 exist as an inactive heterodimer. Upon growth factor stimulation, 
PHAS-1 is directly phosphorylated and inactivated by mTOR and dissociates from eIF4E. 
Therefore, eIF4E is free to bind eIF4G and activate mRNA translation (Brunn et al., 
1997;Gingras et al., 1999a;Gingras et al., 1999b;Scott et al., 1998).
I.2.2.3. The IGF-I/PI3K/AKT/GSK3p pathway and skeletal muscle hypertrophy
Glycogen synthase kinase 3(3 (GSK3(3) is a physiological substrate of activated Aktl that has 
been shown to mediate muscle hypertrophy (Cross et al., 1995). Aktl phosphorylates and 
inactivates GSK3(3 (Cross et al., 1995). Expression of a dominant-negative, kinase-inactive form 
of GSK3p induces di'amatic hypertrophy in both skeletal myo tub es (Rommel et al., 2001) and 
cardiac muscle (Hardt and Sadoshima, 2002) via the IGF-1-mediated, PI3K-dependent signalling 
process, linking GSK3P to the IGF-1/PI3K/Akt pathway. In hypertrophic muscles, GSK3p 
phosphorylation/inactivation is also evident. Glycogen synthase, which is a key substrate of 
GSK3P, catalyses the final step in glycogen synthesis. GSK3p is a serine/threonine kinase and an 
inhibitor of glycogen synthase. Activated GSK3P phosphorylates and inactivates glycogen 
synthase; and thereafter blocked the downstream glycogen synthesis. In contrast, inactivation of 
GSK3p by Aktl results in dephosphorylation of glycogen synthase, and hence the activation of 
glycogen synthesis. GSK3P also phosphorylates and inhibits a guanine nucleotide exchange 
factor, eIF2B, which is required for initiation of protein translation. Therefore, inactivation of
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GSK3p by Aktl results in dephosphorylation of eIF2B. Dephosphorylated eIF2B stimulates the 
synthesis of protein from amino acids. Thus, IGF-1-dependent inactivation of GSK3p by Akt 
increases mRNA translation thiough activation of eIF2B (Welsh et al., 1998), and results in 
muscle hypertrophy by stimulating protein synthesis independent of the IGF- 
l/PI3K/Aktl/mTOR/p70S6K signalling pathway.
L2.3. CALCINEURIN SIGNALLING PATHWAY AND SKELETAL MUSCLE
hi skeletal muscle, the input received by motor neurons via acetylcholine receptors generates a 
motor neuron surface membrane depolarisation, which reaches the sarcolemma transverse 
tubular membrane (T-tubules). The skeletal muscle-specific isofoim of the voltage-operated 
calcium chamiel or L-type calcium channel in the T-tubules interacts with, and thereafter, 
activates a skeletal muscle-specific sarcoplasmic reticulum calcium release channel, ryanodine 
receptor 1 (RyRl). This physical interaction causes the RyRl to open and release calcium from 
the sarcoplasmic reticulum (SR). Thus cytosolic Ca^  ^ is elevated locally to higher levels. After 
its release from the SR, Ca^  ^binds to troponin C (TnC) on the thin filament. Upon Ca^ "^  binding 
to TnC, skeletal muscle contraction is activated. The energy-dependent Ca^  ^uptake into the SR 
is mediated by the SR ATPase, an enzyme that itself is regulated by both Ca^ "*"- and calmodulin- 
dependent phosphorylation (Berchtold et al., 2000). Elevations in intracellular calcium 
concentration serve as a second messenger to activate calcineurin, resulting in activation of gene 
transcription and muscle remodelling (Berridge et al., 2000;Bemdge et al., 2003;Tomida et al., 
2003). Activated calcineurin dephosphorylates molecules of the Nuclear Factor of Activated T- 
cells (NFAT). Calcineurin also activates Myocyte Enhancer Factor-2 (MEF2) and in 
combination with other signalling pathways activates gene transcription (Bassel-Duby and 
Olson, 2003).
1.2.3.1. Calciueurin and calcineurin inhibitors
Calcineurin, also called protein phosphatase 2B (PP2B), is a serine-tlu'eonine, calcium-dependent 
protein phosphatase localised to the cytoplasm. Calcineurin is a critical transducer of calcium 
signals that influence development, adaptation, and disease of cardiac and skeletal muscle. 
Calcineurin is ubiquitous, but is particularly abundant in both nerve and muscle cells.
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Calcineurin exists as a heterodimer, composed of calcineurin A (CnA) and calcineurin B (CnB). 
CnA is a catalytic subunit containing a calmodulin-binding domain and an auto-inhibitory 
region. CnB is a Ca^'^-binding regulatory subunit (Oison and Williams, 2000a;01son and 
Williams, 2000b;Ryder et al., 2003). Both CnA and CnB are essential for catalytic activity of the 
holoenzyme. Calcineurin, which is activated upon binding of calcium/calmodulin in response to 
low-amplitude, sustained elevation in intracellular Ca^ ,^ is tightly regulated by intracellular Ca^”*" 
concentration. Activated calcineurin affects gene expression by dephosphorylating specific 
substrates. The most potent, specific, and well-known inhibitors of calcineurin are the immuno­
suppressant drugs, cyclosporin A (CsA) and tacrolimus (also called FK506). They inliibit 
calcineurin when complexed with their respective cytoplasmic receptors, cyclophilin A and 
FKBP12 (for FK506 binding protein 12). The complexes bind to inhibit calcineurin, and thereby 
prevent activation of calcineurin-dependent genes. Pimecrolimus (also called ASM981) is an 
ascomycin macrolactone derivative, closely related in structure to tacrolimus, and blocks 
calcineurin activity. Responsiveness to calcineurin activity can also be inhibited by cytoplasmic 
calcineurin-binding proteins, such as AKAP79, Cabin-1 (also called Cain), and MCIPl (for 
Myocyte-enriched modulatory Calcineurin-Interacting Protein 1), which is also known as 
DSCRl (for Down Syndrome Critical Region 1). The AKAP79 protein, which is a scaffolding 
protein, was the first calcineurin inhibitor to be found. AKAP79 binds calcineurin in conjunction 
with protein kinase A and C (Lai et al., 1998; Sun et al., 1998; Kashishian et al., 1998). Cabin- 
1/Cain binds both calcineurin and the transcription factor, MEF2 (for Myocyte Enliancer Factor- 
2). Overexpression of Cabin-1/Cain leads to calcineurin and MEF2 inliibition. The A238L 
protein encoded by African swine fever virus can bind tightly to calcineurin and blocks NFAT 
translocation and function (Miskin et a l, 1998). MCIP2 (for Myocyte-enriched modulatory 
Calcineurin-Interacting Protein 2), also known as ZAKI-4 (assigned as DSCRILI by Human 
Nomenclature Committee), is a thyroid homione-responsive protein, which bind to CnA and 
inhibit calcineurin activity (Rothennel et al., 2003).
1.2.3.2. Nuclear Factor of Activated T cells (NFATs)
NFAT was first identified in T cells as a rapidly inducible nuclear factor binding to the distal 
antigen receptor response element, ARRE-2, of the human interleukin-2 (IL-2) promoter. The 
induction of NFAT in T cells required calcium-activated signalling pathways and was blocked 
by CsA and FK506. The NFAT complex that fonned on this site contained a cytoplasmic 
component and a nuclear component. The nuclear component was identified as the ubiquitous
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transcription factor AP-1 (for Activator Protein-1), and consists of dimers of Fos- and Jun- 
family proteins. The cytoplasmic component was purified based on its ability to bind 
independently, in the absence of AP-1 proteins, to the distal NFAT site of the murine IL-2 
promoter and as an NFAT:AP-1 complex to the human granulocyte/macrophage colony- 
stimulating factor (GM-CSF) promoter. The cytoplasmic component appears in the nucleus as a 
result of calcium mobilisation and calcineurin activation (Masuda et ah, 1998). At present, five 
members of the NFAT family have been described in vertebrates. They are referred to as 
NFATcl (NFATC/NFAT2), NFATc2 (NFATp/NFATl), NFATcS (NFATx/NFAT4), NFATc4 
(NFAT3), and NFAT5 (Rao et ah, 1997). All members of the NFAT family except NFATS are 
activated by calcineurin. Although NFAT proteins are expressed in many cell types, NFATcl 
and NFATc3 isoforms are especially abundant in skeletal muscle. Members of the NFAT family 
have in common the following characteristics: (1) they are related by sequence similarity; (2) all 
five members cooperate with AP-1 polypeptides and bind the distal NFAT site of the IL-2 
promoter in vitro', and (3) when over-expressed in appropriate cell lines, all can induce 
transcription from NFAT reporter constructs upon stimulation. There are tluee functional 
domains in NFAT proteins: the ReZ-similarity domain (RSD), which is responsible for the DNA- 
binding activity and interaction with AP-1 polypeptides; the NFAT-homology region (NHR), 
which regulates the intracellular localisation; and the transcriptional-activation domains (TADs) 
(Rao et ah, 1997). NFAT transcription factors are subject to a dynamic and reversible cycle of 
phosphorylation/dephosphorylation that controls their localisation to the nucleus and activation 
of NFAT-dependent genes. In unstimulated cells, NFAT proteins are maintained in the 
cytoplasm by phosphorylation of a serine-rich region near their amino-teimini. 
Dephosphorylation of these serines by calcineurin umnasks two nuclear localisation sequences, 
resulting in rapid nuclear translocation. Once in the nucleus, dephosphorylated NFATcl proteins 
have been shown to be rephosphorylated by one or more priming kinases that create a phospho- 
recognition site for glycogen synthase-3 kinase (GSK3) resulting in their translocation back to 
the cytoplasm and termination of calcineurin-regulated transcription. NFATc3 has also been 
shown to be phosphorylated in the nucleus by Jw7?-amino-terminal kinase (INK) and the 
combination of MEK kinase-1 (MEKKl) and casein kinase-la (Rao et ah, 1997). Obseiwations 
correlate with in vitro studies demonstrating the role for NFATc2 in myoblast fusion and for 
NFATc3 in myoblast differentiation (Abbott et ah, 1998). The role for calcineurin/NFAT 
signalling pathway in the regulation of skeletal muscle slow-to-fast fibre type switch have also 
been demonstrated by in vitro and in vivo analysis (Abbott et ah, 1998). It has been proposed that 
phosphorylation stimulates nuclear export of NFATs hy exposing a nuclear export sequence or
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regulating the nuclear import sequence. The plethora of kinases and phosphatases that act on 
NFAT proteins provides multiple potential tai'gets for pharmacologic manipulation of NFAT- 
dependent cellular responses.
1.2.3.3. Ca^^/calmodulin/calcineurm/NFAT pathway
The Ca^Vcalcineurin/NFAT signalling pathway was initially defined in T lymphocytes. In 
activated T cells, NFAT proteins are substrates of calcineurin, translocating into the nucleus 
following removal of phosphate groups by calcineurin activity (Rao et al., 1997). Although the 
pathway is simple, multiple levels of regulation impinge upon it, making it adaptable for many 
functions in a wide variety of cell types. In T lymphocytes, antigen recognition by the T-cell 
receptor (TcR) causes an increase in intracellular Ca^ ,^ which activates calmodulin and CiiB to 
bind to Ca^ .^ Growth factors such as IGF-1 have also been reported to activate calcineurin (Musaro 
et al., 2001;DeVol et al., 1990;Coleman et al,1995). Activated calmodulin binding to calcineurin 
leads to a confoimational change which allows the auto-inhibitory domain of CnA to move away 
from the catalytic active site of calcineurin, and the phosphatase activity of calcineurin is activated 
(Masuda et al., 1998). Activated calcineurin binds and dephosphorylates members of the NFAT 
family of transcription factors. In resting cells where Ca^  ^concentration is low, calcineurin, which 
exists in an inactive form, is unable to bind calmodulin. Thereafter, NFAT proteins are 
phosphorylated and retained in the cytoplasm. Increases in intracellular calcium concentrations 
within a cell allow binding of calcium to the calmodulin-calcineurin complex thereby increasing 
the complex’s phosphatase activity (Rao et al., 1997). In signalling pathways that lead to a rise in 
intracellular Ca^^concentration, activated calcineurin dephosphorylates a conseiwed serine in the 
amino terminus of NFAT proteins, which, after removal of phosphate, are translocated into the 
nucleus to serve as subunits of transcription factor complexes (Crabtree and Olson, 2002;Graef et 
al, 2001). NFAT transcription factors contain the RSD that is sufficient for DNA recognition and 
cooperative binding interactions with other transcription factors, such as activator protein-1 (AP-1) 
(Crabtree, 1999). T cell activation leads to enhanced-transcription of the T cell gene encoding IL-2 
(Crabtree, 1999;Crahtree, 2001 ; Crabtree, 2002).
1.2.3.4. Calcineurin and Myocyte Enhancer Factor-2 (MEF2)
There are four vertebrate MEF2 genes - MEF2A, MEF2B, MEF2C and MEF2D. MEF2 proteins 
are expressed, at high levels in both muscle cell and neurons, and at lower levels in many tissues
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and a wide range of cell types, however, it is only in the developing cardiac, skeletal and smooth 
muscle that MEF2 activates transcription and act as a target for many signalling pathways 
involving calcium (Seale and Rudnicki, 2000). In skeletal muscle, transcriptional activation of 
slow muscle-specific genes is mediated by calcineurin-dependent activation of NFAT and MEF2 
transcription factors (McKinsey et ah, 2002;Naya et al., 1999;Wu et al., 2000;Wu et al., 2001). 
An essential role for MEF2 factors has been implicated in the formation of slow twitch skeletal 
muscle fibres. At a molecular level, MEF2 transcriptional activity can be stimulated by 
calcineurin either directly by dephosphorylation of MEF2 or indirectly by the association of 
active NFAT with MEF2 bound to DNA (Liu et al., 1997). Upon déphosphorylation by 
calcineurin, NFATc2 translocates to the nucleus where it directly associates with MEF2A and 
MEF2D (Blaeser et al., 2000;Youn et al., 2000). MEF2-NFATc2 interactions appear to play 
cmcial roles in the control of slow twitch fibre genes in skeletal muscle (Chin et ah, 1998). hi 
addition to calcineurin, other Ca^'^-dependent signalling pathways, such as the Ca^'^-calmodulin- 
dependent protein kinase (CaMK), have been shown to control MEF2 activity and affect muscle 
phenotype. An indirect target of calcineurin activity, thiough MEF2 activation, is the up- 
regulation of the peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-la) 
promoter (Czubryt et ah, 2003;Handschin et ah, 2003). PGC-la, also known as Pgc-1 and 
Ppargc-1, was shown to induce mitochondria biogenesis, respiration in cultured cells. When 
PGC-la was overexpressed in the fast muscles of transgenic mice, an increase in slow muscle 
fibres was observed (Lin et ah, 2002). During embryogenesis and in adult tissues, MEF2 genes 
are expressed in myogenesis and morphogenesis of striated and nonstriated muscle cell types. 
MEF2 binds directly to the promoters or enhancers of the majority of muscle-specific genes and 
interacts with members of the MyoD family of basic helix-loop-helix (bHLH) proteins to 
activate the skeletal muscle differentiation program (Black and Olson, 1998; Perry and Rudnicki,
2000).
1.2.3.5. Calcineurin expression in skeletal muscle
1.2.3,5.1. Calcineurin expression in skeletal muscle differentiation
Calcineurin activity is essential for activation of the skeletal muscle differentiation programme, 
which involves irreversible withdrawal of myoblasts from the cell cycle, fusion to form 
multinucleate myotubes, and transcriptional activation of muscle-specific genes (Berchtold et ah.
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2000;Delling et al., 2000;Friday et al., 2000). NFAT transcription factors are differentially 
translocated from the cytoplasm to the nucleus at different stage of myoblast differentiation in 
response to distinct signals in the cytoplasm. Upon fusion, myohlasts cease to proliferate and 
differentiate by activating a set of muscle-specific genes to become myotubes, which are further 
remodelled into myofibres. The myogenic basic helix-loop-helix transcription factors, MyoD, 
myogenin, Myf5, and MRF4, are up-regulated in fonning myotubes to initiate and maintain the 
expression of muscle-specific genes (Molkentin and Olson, 1996). Expression of Myf5, MyoD, 
and myogenin has been shown to be regulated by calcineurin activity at the level of gene 
transcription (Friday et ah, 2003;Friday and Pavlath, 2001). In response to injury, adult skeletal 
muscle has a remarkable ability to regenerate. Quiescent reseiwed cells, satellite cells, become 
activated and migrate to the site of injury where they proliferate, differentiate, and fuse to form 
new myofibres. The role of calcineurin in regeneration has been studied using CsA 
administration following injury. Studies showed inliibition of formation of new myofibres and 
that calcineurin activity is needed for muscle precursor cell differentiation. In these studies, 
expression of calcineurin and dephosphorylated NFATcl was markedly increased in 
regenerating muscle, although calcineurin activity was not measured (Abbott et ah, 1998;Friday 
et ah, 2000;Sakuma et al., 2003).
1.2.3.5.2. Calcineurin expression and skeletal muscle size
The role of calcineurin as a mediator in skeletal muscle growth and hypertrophy is controversial 
and has been a matter of debate (Biring et ah, 1998;Bodine et ah, 2001b;Duim et ah, 2000;Dunn 
et ah, 2002;Dupont-Versteegden et ah, 2002;Musaro et ah, 1999;Semsarian et ah, 1999;SeiTano 
et ah, 2001 ;Spangenhurg et ah, 2001). The role of calcineurin during muscle atrophy is also 
unclear (Glass, 2003a;Glass, 2003b). Several studies reported that skeletal muscle hypertrophy 
was mediated by a Ca^'*'-dependent calcineurin signalling pathway (Dunn et ah, 1999; Dumi et 
ah,2000;Dumi et ah, 2002;Dupont-Versteegden et ah, 2002;Mitchell et ah, 2002;01son and 
Williams, 2000a;Semsarian et ah, 1999). However, other published data indicated that 
calcineurin did not appear to control muscle growth (Glass, 2003a; Glass, 2003b;Serrano et ah, 
2001). Strong support suggesting that calcineurin does not influence myofibre size came fiom 
studies of transgenic mice expressing activated calcineurin in skeletal muscle in which there was 
no evidence of hypertrophy (Naya et ah, 2000;Wu et ah, 2001). Bodine et al. (2001b) provided 
evidence that the calcineurin pathway was not activated during hypertrophy in vivo, and the 
pharmacological inhibitors of calcineurin activity did not blunt hypertrophy or atrophy. Several
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studies have shown variable effects on muscle hypertrophy and gi'owth when administrating CsA 
(Bigard et ah, 2000;Biring et ah, 1998). Whereas some groups have reported that CsA inliibits 
compensatory hypertrophy (Dunn et al., 1999), others have seen no effect (Musaro et ah, 
2001;Serrano et ah, 2001 ;Dupont-Versteegden et ah, 2002). One explanation for the conflicting 
results is the recent finding that the dose of drug, length of treatment, and muscle type are critical 
parameters to consider when analysing the effect of CsA on muscle size (Mitchell et ah, 2002). 
However, in vitro inliibition of calcineurin-mediated nuclear translocation of NFAT using CsA 
did not result in an inhibition of IGF-1-mediated hypertrophy of myotubes (Rommel et ah,
2001), and several groups were able to deliver sufficient levels of CsA in vivo so as to inliibit 
other markers of calcineurin activity in skeletal muscle, and yet inhibition of hypertrophy was 
not detected (Musaro et ah, 2001;Serrano et ah, 2001 ;Dupont-Versteegden et ah, 2002).
1.2.3.5.3. Calcineurin expression determines slow muscle fibre type gene expression
Transcriptional activation of slow muscle fibre-specific transcription is mediated by a 
combinatorial mechanism involving proteins of the NFAT and MEF2 families (Chin et al, 1998). 
NFAT acts in concert with MEF2 transducing the calcineurin signal to the slow muscle fibre 
type specific promoters (Wu et ah, 2000). Moreover, calcineurin induces the required binding of 
MEF2 to activate slow muscle fibre-specific gene promoters. The requirement of MEF2 is based 
on the fact that the mutation of the NFAT binding motif is insufficient to completely inliibit 
transcriptional regulation by calcineurin (Chin et ah, 1998 ;Calvo et al, 1999;Esser et ah, 1999). 
Within slow muscle gene promoters, exists a binding motif, which contains a MEF2 binding site 
within the A/T rich elements, an NFAT binding site (Nakayama et ah, 1996, Calvo et ah, 1999). 
It has been found that mutation of the MEF2 binding element results in a loss of muscle specific 
gene expression of the slow muscle gene promoter (Calvo et ah, 1999). It has also been found 
that a constitutively active calcineurin in transfected C2C12 myoblasts increased the 
transactivating function of MEF2 (Wu et ah, 2000). Activation of NFAT, alone, is not as 
effective as NFAT and MEF2 acting in concert to regulate slow muscle fibre-specific genes. 
Ca^^/ calmodulin/ calcineurin/NF AT pathway plays an important role in controlling slow muscle 
gene expression (Kuhis et ah, 1997;Schiaffino and SeiTano, 2002). It has been shown that rapid, 
repetitive, high-amplitude calcium transients associated with skeletal muscle stimulation, 
activation, and contraction are sufficient to activate NFAT translocation and subsequently 
transfonn fibres to a slow muscle gene program (Kubis et ah, 2003;Abbott et ah, 1998). Ras 
signalling through a mitogen-activated protein kinase (MAFK)/extracellular signal-regulated
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kinase (ERK) pathway is another important mediator of slow muscle fibre-specific gene 
activation (Buckingham, 2001;Murgia et ah, 2000;Schiaffmo and Serrano, 2002). Ras- 
MAPK/ERK signalling has been shown to be involved in promoting nerve-activity-dependent 
differentiation of slow muscle fibre in vivo (Schiaffino and Sen'ano, 2002). hicreased 
neuromuscular activity regulates the dephosphorylation of NFAT by calcineurin and eventually 
results in an alteration in MyHC isoform expression (Schiaffino and Serrano, 2002). A major 
contributing factor to the establisliment of skeletal muscle fibre type is neural control. Long­
term effects of motor neurons on skeletal muscle fibre phenotype are mediated by two distinct 
mechanisms: transmission of electrical activity and release of specific neural factors (Schiaffmo 
and Serrano, 2002). Signals of electrical activity modulate calcium concentrations in myofibre. 
Calcium signalling plays a crucial role in determining, maintaining, and transfomiing muscle 
fibre types. Cytosolic calcium sensor could potentially distinguish skeletal muscle electrical 
activity, which affects globally the whole muscle fibre by influencing MyHC isofonn gene 
expression. Since Ca^’*’ is released into the cytosol from the sarcoplasmic reticulum during 
skeletal muscle contraction, a decreased number of Ca^  ^release events could act as a signal for 
reduced electrical activation (Talmadge, 2000). The protein calcineurin could act in concert with 
calmodulin as a calcium sensor in skeletal muscle (Chin et ah, 1998). Thus, increased muscle 
contractile activity and the resulting sustained elevations in cytosolic Ca^ "*" could potentially lead 
to altered fibre type-specific gene expression via the calcineurin signalling. Slow muscle fibres 
are characterised by a high, sustained calcium concentration, whereas short transient calcium 
elevations are found in fast muscle fibres. A sustained graded increase in intracellular calcium is 
necessary and sufficient to induce NFAT nuclear accumulation whereas transient pulses were not 
(Crabtree, 1999;Dolmetsch et ah, 1997;Dolmetsch et ah, 1998;Li et ah, 1998;Timmerman et ah, 
1996). Translocation of NFAT has also been demonstrated to be sensitive to changes in 
intracellular calcium concentration that are evoked by stimulation patterns typically experienced 
by slow skeletal muscle (Liu Y et ah, 2001). A number of in vivo and in vitro studies have 
provided evidence that calcineurin activity is required for induction and maintenance of the 
oxidative slow muscle gene program (Bigard et ah, 2000;Higginson et ah, 2002;Naya et ah, 
2000;Parsons et ah, 2003;Serrano et ah, 2001 ;Wu et ah, 2001;Chin et ah, 1998). Studies have 
shown that the translocation of NFAT activates many muscle fibre-specific genes such as, Myf5, 
myoglobin, MyHC, sarcomeric mitochondrial creatine kinase and slow isoform of troponin I 
(Tnis). Muscle fibre-specific proteins encoded by these genes, which are expressed in higher 
amounts in slow muscle fibres, contain NFAT response elements (NREs) in the regulatory 
regions of their specific genes (Chin et ah, 1998). A unique difference between the primary DNA
22
elements responsible for regulating the slow muscle fibre-specific troponin I (TnIs) and the fast 
muscle fibre-specific troponin I (Tnlf), or for regulating the slow upstream regulatory element 
(SURE) and fast intronic regulatory element (FIRE), is the inclusion of a consensus NFAT 
response elements (NRE) in the SURE element that is omitted fiom FIRE. Thus, the SURE 
element could confer Ca^^-sensitivity to the Tnis gene via the NRE, resulting in enhanced 
transcription of the Tnis gene under conditions of elevated cytosolic Ca^  ^ (e.g., increased 
contractile activity) (Abbott et al., 1998). In the presence of activated calcineurin, the MyHC lla 
upstream promoter show a greater activation compared to the upstream region of MyHC lib, 
suggesting that calcineurin may play a role in transition between fast subtypes (Allen et al., 
2001;Allen and Leinwand, 2002). Other studies performed in skeletal muscle tissue culture 
demonstrate that calcineurin activates the slow fibre-specific myosin (Delling et al., 
2000;Meissner et al., 2001), as well as promoting expression of oxidative proteins, such as 
myoglobin (Chin et al., 1998). Some studies suggest that elevated neuromuscular activity, 
induced by exercise, can decrease the activities of glycogen synthase kinase-3 (GSK-3) 
(Markuns et al., 1999), an enzyme that has been reported to phosphorylate NFAT within the 
nucleus (Beals et al., 1997), resulting in NFAT translocation out of the nucleus. Thus, 
neuromuscular activity may enhance NFAT binding to nuclear DNA by enhancing its 
translocation into the nucleus (via dephosphorylation by calcineurin) and by inhibiting nuclear 
export (via inliibition of rephosphorylation by GSK-3).
1.3. MICROARRAY TECHNOLOGY
Over the past few years, muscle biology has seen increasing application of microanay 
technology. Studies using micro arrays have described various gene expression profiles of 
skeletal muscle in different biological contexts, such as the micro array study of molecular 
pathophysiology and targeted therapeutics for muscular dystrophy (Hoffinan and Dressman,
2001), and the microarray detection of activation of a myogenic transcription program (Klian et 
n/.,1999). However, the undeipinning knowledge of molecular pathways regulating skeletal 
muscle developmental, physiological and pathological processes has so far not been fully 
revealed.
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1.3.1. GENERAL DESCRIPTION OF DNA MICROARRAYS
All eukaryotic gene is a combination of deoxyribonucleic acid (DNA) segments that together 
constitute an expressible unit. The segments of a gene consist of a transcription unit and 
regulatory sequences. Gene expression refers to the process by which a gene’s coded information 
is converted into the structures that present and operate in a cell. Expressed genes include those 
that are transcribed into messenger ribonucleic acids (mRNAs) and then translated into proteins 
and those that are transcribed into RNAs but not translated into proteins, for instance, transfer 
RNAs (tRNAs) and ribosomal RNAs (rRNAs). Due to alternative splicing and post-translational 
modifications, one gene can produce a variety of proteins.
A major goal of gene expression profiling studies is to determine the pattern of genes expressed 
under specific circumstances or in a specific cell. One of the contributions of these studies has 
been to help us understand genes and their product functions and interactions, and most 
importantly of all, how all of these make organisms function the way they do. The primary 
approach to measuring gene expression has been to focus on the levels of mRNAs rather than 
proteins. The protein-based approaches are generally more difficult, less sensitive and have a 
lower thioughput than RNA-based ones. More importantly, mRNA levels are immensely 
informative about cell state and the activity of genes, and for most genes, changes in mRNA 
abundance are related to changes in protein abundance (Lockhart and Winzeler, 2000). 
Traditional tecliniques for the study of the regulation of gene expression are constrained by the 
limited amount of data obtained from one experiment and are time consuming to perform. To 
study simultaneously the expression of thousands of genes in a cell or tissue, and furthermore, to 
enable global compaiisons between biological systems rather than detailed examination of single 
genes, high-tliroughput experimental methodologies combined with statistical and computational 
analysis of the results need to be applied to the study of gene regulatory networks and pathways 
(Hieter and Boguski, 1997;Emmert-Buck et al., 2000;Lee and whitmore, 2002). The application 
of microarray technology has met these challenges. Generally speaking, a microarray is a tool 
that enables parallel analysis of the vast infoimation content resident in complex biochemical 
target samples (Schena et al., 1995;Marcotte et al., 2001). The tenn microarray refers to a 
microscopic, hybridisation-based, ordered anay of nucleic acids, proteins, small molecules, cells 
or other substances that are chemically attached or synthesized as probe onto a substrate. This 
substrate can be a coated microscope glass slide, a silicon chip, a nylon membrane, or a small.
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microsphere-sized bead. According to the aixayed material, micro arrays can be classified into 
different categories, such as DNA microarrays, protein microarrays, small molecule microarrays, 
cell microanays, tissue microarrays and chemical microarrays, etc (Lander, 1999;Southern et ah, 
1999). Microarray teclmology has led to a rapid increase in the amount of information available 
about gene expression profiles and, hence, enhances our understanding of diverse biologic and 
pathophysiologic processes at the molecular level (Blohm and Guiseppi-Elie, 2001). As the goal 
of this project was to develop a microarray for gene expression profiling studies, DNA 
microarrays shall be the focus of the following part of this chapter, especially cDNA 
microarrays.
1.3.2. TYPES OF DNA MICRO ARRAYS
A DNA micro array is an ordered array of DNAs (termed the probes) gridded and attached onto a 
miniaturised solid-state matrix. There are several names for this teclmology —  DNA 
microaiTays, DNA arrays, DNA chips, gene chips, and others. Sometimes a distinction is made 
between these names but in fact they are all synonyms as there are no standard definitions for 
which type of DNA microan'ay should be called by which name. According to the number of 
probes immobilised on a solid matrix, DNA microarrays can be classified into three categories: 
high-density, medium-density and low-density arrays. Each high-density DNA array contains 
many tens of thousands of genes, whereas medium- and low-density contain on the order of 
between a few thousand and a handful of genes for each aiTay. The high- and medium-density 
DNA microarrays are cuiTently the most widely used tools for simultaneous, large-scale analysis 
of gene expression. Therefore, in this thesis, the term DNA micro array refers to the high- and 
medium-density microarray in most circumstances. DNA microarrays can also be divided into 
two groups, according to the arrayed material: complementary DNA (cDNA) and 
oligonucleotide microaiTays. These two types of aiTays will be reviewed in the following 
sections. DNA microarrays make use of the sequence resources created by the genome projects 
and other sequencing efforts to answer the question, what genes are expressed in a particular cell 
type of an organism, at a particular time, under particular conditions. For instance, they allow 
comparison of gene expression between normal and diseased cells, or between eaiiy-stage 
disease tissues and late-stage disease tissues. In gene expression studies, DNA microanays can 
be exposed to labelled nucleic acids (termed the targets) from biological samples for the
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detections of hybridisation. Through image analysis, the amount of target that hybridises to one 
of the micro array probes gives a measure of the abundance of that particular transcript within the 
target sample. Thus, expression patterns of many different genes can he studied simultaneously 
with DNA microarrays.
1.3.2.1. cDNA microarrays
The cDNA microanay is one technological approach that has the potential to accurately measure 
changes in global mRNA expression levels in various tissues. A cDNA microarray comprises a 
collection of gene sequences which are usually purified PCR products ranging in size from 100- 
2,000 bp derived fiom cDNA libraries, cDNA clone collections or expressed sequence tag (EST) 
clones. Now, the question arises as to what cDNA, cDNA library and EST are. A cDNA is a 
single stranded DNA molecule with a nucleotide sequence that is complementary to an mRNA 
molecule (Bowtell, 1999;Schulze and Downward, 2001). A theoretical complete cDNA library 
represents all of the genes that are expressed in a particular tissue or organism, at a particular 
time. The prevalence of a particular cDNA clone in the library is indicative of the abundance of 
the corresponding mRNA and therefore the expression level of the coding sequences of a 
specific gene. ESTs are partial gene sequences of cDNA fragments, generated thiough single 
read, but eiTor- prone sequencing (Devaux et al., 2001;Southem et al., 1999). ESTs often, but not 
necessarily represent the cDNAs they derived from. It is well Imown that RNA molecules are 
exceptionally labile and difficult to amplify in their natural form. Unlike an mRNA, a cDNA can 
be easily propagated and sequenced. For this reason, the information encoded by the mRNA is 
converted into cDNA and then is inserted into a self-replicating vector. There are six basic steps 
in constructing a cDNA library: (1) purification of mRNA using chemical extraction and an 
oligo-dT cellulose column. (2) first strand cDNA synthesis from purified mRNA template by the 
action of viral RNA-dependent DNA polymerase called reverse transcriptase, with the help of 
oligo-dT primers, random hexanucleotide primers, or gene-specific primers. (3) second strand 
cDNA synthesis requiring E. coli RNase H and DNA polymerase I for a priming event (4) 
blunting cDNA tennini and ligating adaptor oligos (5) ligating cDNA into vector (6) Packaging. 
Bacteriophages are widely used as cloning and expression vectors. Bacteriophages (also called 
phages) are any vimses that infect bacteria. When phages infect bacteria, only the phage DNA 
enters the bacterial host cell and initiates the replication events that lead to the production of 
several hundred progeny viruses in every infected cell. Lyses of infected bacteria is detected by 
the appearance of plaques in a bacterial Tawn’ grown on solid media or by the inliibition of
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bacterial gi*owth in liquid cultures. Once the information is available in the form of a cDNA 
library, individual processed segments of the original genetic information can be isolated and 
examined with relative ease (Forozan et al., 1997).
cDNA micro arrays are produced by robotic deposition of cDNA sequences or ESTs that are 
applied individually to precise locations on a solid matrix, usually nylon or glass. Normally, a 
few nanolitres of PCR-amplified clone inserts are arrayed. Necessary sequencing information on 
the cDNAs is not required. Inserts are amplified using either vector-specific or gene-specific 
primers. PCR products are purified to remove unwanted salts, nucleotides, detergents, primers 
and proteins presenting in the PCR mixture. Purified PCR products, which are typically 100- 
500pg/ml, are printed at specified sites on either glass or membrane matrices using high- 
precision aiTaying robots (anayers). Computer-controlled robots are designed to automatically 
collect samples simultaneously from microtitre plates with multiple pins. Each pin collects 
between 250 and 500 nanolitres of solution and deposits 0.25-1 nanolitres onto each slide. 
Robots are programmed so that successive spots are spaced avoiding contact with adjacent spots. 
Spots are typically 50-300 pm in size and are spaced about the same distance apart (Duggan et 
al, 1999). DNA is cross-linked to the solid support by ultraviolet inudiation, chemical linkers or 
baking at 80°C. The state of bound cDNA is ill-defined. It is deposited in double-stranded form, 
intra-strand cross-linked to some extent, and may well have multiple constraining contacts with 
the matrix along its length. Therefore, a cDNA microarray is probably not the best hybridisation 
probe (Southern et a/., 1999). The cDNA micro arrays can be subsequently hybridised to two 
differentially fluorescently labelled targets. The tai'gets are pools of cDNAs, which are 
generated after isolating mRNA Eom cells or tissues in two states that one wishes to compare. 
The use of long target sequences (<2 kbp) can increase detection sensitivity for cDNA 
microarrays. The advantage of cDNA microarray technology is that it is relatively accessible and 
cost-effective. cDNA microaiTay hybridisation does not need specialized equipment, and data 
capture can be earned out using equipment that is very often already available in a laboratory 
(Cheung et al, 1999). Prefabricated cDNA microanays are relatively cheap, and in-house 
production of cDNA microan ays is within the reach of many researchers, affording flexibility of 
design to meet the specific goals of different scientific experiments. On the other hand, there are 
several disadvantages to this type of biological tool. (1) One of the weaknesses is, as previously 
described, in the state of double-stranded cDNAs on a microarray. (2) Sequence homologies 
between clones representing different closely related members of the same gene family may
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result in a failure to specifically detect individual genes. However, closely related genes can 
often be distinguished by using probes corresponding to the 3’-untranslated region of an mRNA, 
as these regions often display gene-specific sequence diversity. (3) As each cDNA fragment 
must be synthesized, purified, and stored before an*ay constmction, the curation of extensive 
clone sets is a critical factor in microaiTay fabrication. According to the previously published 
assessment, even the best maintained clone stocks for commercial manufacture of cDNA 
microaiTays are prone to contamination with incorrect plasmids, and mix-ups over clones of 
different identities (Halgren et al., 2001).
1.3.2.2. Oligonucleotide microarrays
The temi oligonucleotide refers to a short length of single-stranded polynucleotide chain that is 
usually less than 30 residues long. Obviously, an oligonucleotide micro array is a very large set of 
oligonucleotide probes, which are attached to a solid support. This type of array differ from other 
fonnats in that the probe is synthesised in situ on the surface of a matrix as opposed to being 
generated separately and then spotted on the surface. Oligonucleotide microarrays are effective 
tools for profiling gene expression, and monitoring single nucleotide polymorphisms (SNPs) or 
mutations (Lipshutz et ah, 1999;Southern et al., 1999). A SNP is a position in a genome where a 
single base (Adenine, Cytosine, Guanine, or Thymine) is altered, so that some individuals have 
one DNA base whilst others have a different base resulting in DNA sequence variation. SNPs 
and point mutations are structurally identical, differing only in their frequency. Variations that 
occur in 1% or less of a population are considered point mutations, and those occuiTing in more 
than 1% are SNPs. Single base insertion/deletion variants are not fonnally considered to be 
SNPs. SNPs may be responsible for many inheritable differences between individuals. Some 
SNPs are the cause of genetic diseases. To prepare high-density oligonucleotide microanays, 
short 20-mer to 25-mer are chosen from the mRNA reference sequence of each gene, and are 
synthesised in situ, either by photolithography onto silicon wafers or by ink-jet teclinology. For 
low-density arrays, pre-synthesised oligonucleotides can be printed onto glass slides just like 
long probes (Cumiingham, 2000;Helmberg, 2001). Two techniques, photolithogiaphy and solid- 
phase DNA synthesis, have been used in light-directed synthesis for the construction of high- 
density DNA arrays that display a multitude of oligonucleotides. Affymetrix, which developed 
this method, attaches synthetic linkers, modified with photo-chemically removable protecting 
groups, to a solid support, and direct ultraviolet light through holes of masks in order to 
deprotect and activate selected sites on the matrix. Synthesis of oligonucleotides involves both
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light-directed removal of blocking groups (deprotection) from the end of the growing base chain, 
and coupling of one nucleotide at a time with the base chain at the activated sites. Repetition of 
this process with different masks allows the complete aiTay of thousands of short 
oligonucleotides to be constructed (Lipshutz et ah, 1999;Gerhold et ah, 1999). Methods based on 
synthetic oligonucleotides offer the advantage that because sequence information alone is 
sufficient to generate the DNA to be aiTayed, no time-consuming handling of cDNA resources is 
required. Also, probes can be designed to represent the most unique part of a given transcript, 
making the detection of closely related genes or splice variants possible. Although limited 
binding affinity of short oligonucleotides may result in less specific hybridisation and reduced 
sensitivity, the arraying of pre-synthesised longer oligonucleotides (50-100 mers) has been 
developed to counteract these disadvantages (Granjeaud et ah, 1999).
1.3.3. JUSTIFICATION OF USE OF MICROARRAYS IN COMPARISON 
WITH mRNA DIFFERENTIAL DISPLAY AND REPRESENTATIONAL 
DIFFERENCE ANALYSIS
DNA microarrays are used to study simultaneously the expression of thousands of genes in a cell 
or tissue, and furthermore, to enable global comparisons between biological systems rather than 
detailed examination of single genes. cDNA clone stocks for microaiTay construction can 
provide full length or at least good length cDNA clones for further functional study. mRNA 
differential display technology allows detection and isolation those genes that are differentially 
expressed in various cells or under altered conditions by systematic amplification of the 3' 
terminal portions of mRNAs and resolution of those fragments on a DNA sequencing gel (Liang 
and Pardee, 1992). Using anchored oligo-dT primers designed to bind to the 5' boundary of the 
poly-A tails for the reverse transcription, followed by PCR amplification with additional 
upstream primers of arbitrary sequences, mRNA sub-populations are visualised by denaturing 
polyacrylamide electrophoresis. This allows direct side-by-side comparison of most of the 
mRNAs between or among related cells. This method is thus far unique in its potential to 
visualise all the expressed genes in a eukaryotic cell in a systematic and sequence-dependent 
manner by using multiple primer combinations. More importantly, this method enables the 
recovery of sequence information and the development of probes to isolate their cDNA and 
genomic DNA for further molecular and functional characterisations. Representational 
difference analysis (RDA) is a technique for the identification of specific differences between
29
two mRNA populations (Lisitsyn et a l, 1993). Genomics or cDNA sequences from two samples 
are PCR amplified and differences between two complex sets of genomes analysed using 
subtractive DNA hybridisation. This method, allows the selective amplification and cloning of 
transcripts that differ in abundance between two populations.
1.4. JUSTIFICATION OF WORK
The major goal of the study described in this thesis was to construct a porcine skeletal muscle 
cDNA microarray. It was anticipated that the completed porcine cDNA microarray could be 
utilised for profiling high thi'oughput gene expression, identifying simultaneously alterations in 
the transcript level of thousands of transcriptomes, and investigating different molecular 
pathways related to porcine skeletal muscle in various biological contexts. The micro array 
construction and the subsequent utilisation are described in the following chapters of this thesis.
The porcine cDNA microaiTay was to be assembled from two porcine skeletal muscle cDNA 
libraries. In the absence of a known porcine genome, this approach was expected to allow the 
constmction of a valid tool for profiling large-scale gene expression in porcine skeletal muscles. 
The recombinant plasmid DNAs, polymerase chain reaction (PCR) products, and purified PCR 
products, to be used for the constmction of the porcine skeletal muscle cDNA microarray, would 
be characterised to ensure that relevant cDNA fragments were present. The purified, PCR- 
amplified cDNA fragments would then be used to construct the micro array which would be used 
for subsequent experiments.
Once constructed, the porcine cDNA micro array would be evaluated to optimise the 
experimental conditions for use. The porcine cDNA microaiTay would also be evaluated for its 
effectiveness for high throughput gene expression profiling. Two experiments would be earned 
out to analyse differential gene expression. One would aim at revealing molecular mediators 
regulating phenotypic differences between porcine psoas red and longissimus dorsi white 
skeletal muscle. The other would aim at investigating ionomycin-regulated genes involved in 
porcine skeletal muscle.
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CHAPTER TWO
CONSTRUCTION OF A PORCINE SKELETAL 
MUSCLE cDNA MICROARRAY
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2.1. INTRODUCTION
Construction of human skeletal muscle cDNA micro array has previously been reported (Noguchi 
et ah, 2003; Campanaro et a l, 2002). To date, development of porcine skeletal muscle DNA 
microarrays appear not to have been described. One reason for this could be that there is 
insufficient sequence information on pigs for designing a comprehensive DNA microarray 
(Davoli et ah, 1999;Davoli et ah, 2002). This chapter describes the constmction of a porcine 
skeletal muscle cDNA micro array, which was the major goal of this project. Skeletal muscle 
biological processes are controlled by various cell-signalling pathways coordinating the action of 
thousands of genes. To progiess towards a better understanding of molecular basis underlying 
skeletal muscle biology, questions about skeletal muscle developmental, physiological and 
pathological processes are being addressed with DNA microarray approach, which has provided 
a means to simultaneously measure mRNA abundance for tens of thousands of genes in parallel 
in a single experiment. cDNA micro arrays have been commercially available for muscle in other 
species (Campanaro et ah, 2002;Noguchi et ah, 2003), but no skeletal muscle specific cDNA 
microaiTay has yet been described for porcine, which is both an important target farm animal 
species and an invaluable large animal experimental model for skeletal muscle research. To 
evaluate gene expression at large scale and allow identification of differentially expressed genes 
in skeletal muscles, a porcine micro array containing 5,500 cDNA fragments was developed by 
this project for the following potential uses. The fundamental prospective uses of this microarray 
include profiling temporal muscle gene expression from embryo to adult, characterising spatial 
gene expression between phenotypically distinct muscles within the same animal, profiling 
changes in gene expression under different metabolic status, and providing underpimiing 
Imowledge of molecular mechanisms of skeletal muscle diseases. This cDNA microarray can 
also be used to identify known and unknown genes that associate with particular muscle quality 
traits, so that selection of animals can be facilitated by genotyping based on levels of gene 
expression. This chapter is about the design and de novo construction of this cDNA microarray.
2.2 MATERIALS AND METHODS
2.2.1. MATERIALS
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2.2.1.1. cDNA libraries
Complementary DNA (cDNA) libraries represent the information encoded in the messenger 
RNA (mRNA) of a particular tissue or organism. The construction of the porcine skeletal muscle 
cDNA microarray was based on the use of two developmentally distinct, directionally cloned, 
representative porcine skeletal muscle lambda ZAP Express® cDNA libraries, which were 
previously made in the Molecular Medicine Laboratory, Department of Veterinary Pathology, 
University of Glasgow Veterinary School. One of the libraries was derived from the longissimus 
dorsi muscle of a 50-day-old Meishan x Large White porcine foetus; the other was made fr'om 
the gastrocnemius muscle of a 3-day-old Meishan x Large White pig. The longissimus dorsi 
muscle extends the length of the spinal column on either side of the vertebrae, while the 
gastrocnemius muscle extends from the distal femur to the calcaneus of the hock joint. Both 
cDNA libraries were not normalised nor subtracted. The morphological and physiological 
properties of both muscles are similar. No other cDNA library was available at the starting point 
of the microaiTay construction. Constmction of both cDNA libraries was earned out using the 
Zap Express® cDNA Synthesis Kit and Gigapack® III Gold Cloning Kit (Stratagene). First strand 
cDNA was synthesised by reverse transcription using oligo (dT) linker-primer that contained a 
Xhol recognition site within it. Following double-stranded cDNA synthesis, AcoRI adapters 
were ligated to the blunt ends, and the samples were digested with Xhol, The result was cDNA 
fragments with an EcoK I sticky end on one side and a Xhol sticky end on the other. These 
cDNAs were ligated directionally in the ZAP Express® vectors. The vectors were then packaged 
using Gigapack III Gold packaging extracts and were plated on the Escherichia coli {E. coli) 
XL 1-Blue MRF’ cells. Both cDNA libraries, each with approximately 1x10^ primary plaques, 
have been extensively characterised by sequencing and screening and shown to be highly 
representative (unpublished data). They had been used to isolate several full-length cDNA 
clones, including porcine myosin heavy chains (MyHCs) (6.0kb) and transcription factors, such 
as the Nuclear Factor of Activated T cells (NFAT2) and GATA binding protein 2 (GATA2) 
(Beuzen et al., 2000;Chang et al., 2003;Sun et al., 2001). The amplified cDNA libraries were 
kept as aliquots in 7% [volume/volume (v/v)] sterile filtered dimethyl sulphoxide (DMSO) 
(Sigma), at -80°C. To start the process of microarray construction, aliquots of each cDNA library 
contained in vials were removed fi’om the -80°C freezer, thawed at room temperature, and were 
then ready for the following mass excision of pBK-CMV phagemid vector from ZAP Express® 
vector.
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2.2.1.2. Bacteria and culture media
2.2.1.2,1. Bacteria
Two strains of E. coli (XL 1-Bine MRF’ and XLOLR) were used in this study. Stratagene 
supplied both. Detailed information about their origin and properties is described in the 
instruction manual of the ZAP Express® cDNA synthesis kit (Catalogue #200403, Stratagene). 
Their practical features are summarised in Table 2:1 below.
Table 2:1 Summary of the main features of XL 1-Blue MRF’ cells and XLOLR cells
XLl-Blue MRF’ cells XLOLR cells
E. coli strain E. coli strain
XLl-Blue MRF’ cells are for amplifying 
libraries and plating amplified libraries. 
XLl-Blue MRF’ cells allow the amplified 
ZAP Express® cDNA library to grow very 
efficiently on the XLl-Blue MRF’ strain.
XLOLR cells are lambda bacteriaphage 
resistant nonsuppressing E. coli host strain 
for plating in vivo excised phagemids. 
XLOLR cells are resistant to lambda phage 
infection.
LB-tetracycline agar plates for XLl-Blue 
MRF’ bacterial streak
LB-tetracycline agar plates for XLOLR 
bacterial streak
2.2.1.2.2. Culture m edia
Media used throughout the study was based on Luria-Bertani (LB) broth. LB-tetracycline agar 
plates were used for maintenance of the E. coli cells. LB-kanamycin agar plates were used for 
selecting the transfoimed XLOLR cells containing the kanamycin-resistant pBK-CMV plasmid 
vector and cDNA insert, if one was present. Details of these media are described in the Appendix.
2.2.1.3. Phage strains
Two phage strains (ZAP Express® vector [Fig. 2:1] and ExAssist® interference-resistant helper 
phage) were used in this study. Stratagene supplied both. Detailed infoimation about their origin 
and properties is given in the instruction manual of the ZAP Express® cDNA synthesis kit 
(Catalog #200403). Their main features are summarised in Table 2:2.
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Table 2:2 Summary of main features of ZAP Express® vector and ExAssist® interference- 
resistant helper phage
ZAP Express vector ExAssist interference-resistant helper 
phage
The ZAP Express® vectors are pre-digested 
with EcoK I and Xho I by the manufacturer. 
The unidirectional cloning sites of the ZAP 
Express® vectors are EcoK l-Xho I.
Inserts are cloned in sense orientation as 
EcoR l-Xho I fragments into the ZAP Express® 
vectors.
ZAP Express vector
Combines lambda bacteriophage vector system 
with pBK-CMV phagemid/plasmid system. 
Allows both eukaryotic and prokaryotic gene 
expression.
Has 12 unique cloning sites.
Can accommodate DNA inserts from 0 to 12 
kb in length.
Inserts cloned into the ZAP Express® vectors 
can be excised out of the lambda bacteriophage 
to generate sub clones in the kanamycin- 
resistant pBK-CMV phagemid vector.
ExAssist interference-resistant 
helper phage
• Is filamentous (M l3) interference- 
resistant helper phage.
• This helper phage with XLOLR strain 
is designed to efficiently excise the 
pBK-CMV phagemid vector from the 
ZAP Express® vector.
• Contains an amber mutation that 
prevents replication of the helper phage 
genome in a nonsuppressing E. coli 
strain such as XLOLR cells.
•  Allows only the excised pBK-CMV 
phagemid to replicate in the E. coli 
XLOLR host cells, removing the 
possibility of co-infection from the 
ExAssist® interference-resistant helper 
phage.
pBK-CMV phagemid/plasmid vector
Has 17 unique cloning sites flanked by T3 and 
T7 promoters.
Has T7 primer binding site and T3 primer 
binding site for DNA sequencing.
Can infect E. coli and replicate autonomously 
as plasmid DNA.
Carries kanamycin-resistance gene for stable 
selection of the plasmid clones.
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2.2.1.4. Restriction endonucleases
Two restriction endonucleases, EcoR I (GibcoBRL, UK) and Xho I (GibcoBRL, UK) were used 
in this study for digestion of pBK-CMV plasmid DNAs. Both EcoR I and Xho I are 1 OU/pi in 
concentration, and use I Ox SuRE/CUT buffer H for enzyme digestion.
2.2.1.5. Commercial kits
The commercial kits used in this study and their uses are summarised in Table 2:3 
2.2.2. METHODS
The process of constmction of the microarray includes the actual construction process and its 
associated quality assurance process. The important methods used in this study to produce the 
porcine skeletal muscle cDNA microarray from the two porcine skeletal muscle cDNA libraries 
are set out in Figure 2:2. The main construction process refers to the following eleven steps: (1) 
mass excision of pBK-CMV phagemid vector from ZAP Express® vector, (2) colony blot 
hybridisation, (3) colony selection, (4) cultivation of the selected colonies in 96-well flat-bottom 
blocks, (5) plasmid DNA extraction in 96-well plate format for the selected colonies, (6) storage 
and naming of the plasmid DNAs, (7) PCR in 96-well plate format for amplification of the 
cDNA inserts contained in plasmid DNAs of the selected colonies, (8) PCR purification in 96- 
well plate foimat, (9) storage and naming of the purified PCR products, (10) Microan*ay printing, 
(11) storage of the microarray slides. The associated quality assurance process refers to the 
following eight steps: (1) individual bacterial culture of randomly picked colonies, (2) plasmid 
DNA extraction from the randomly picked colonies, (3) Southern blot hybridisation, (4) 
detection of presence of the cDNA fi*agments by restriction enzyme digestion and agarose gel 
electrophoresis, (5) sequencing of plasmid DNAs derived from the selected colonies, (6) dot blot 
hybridization, (7) microaiTay hybridisation using Cy3 labelled T7 primer target, (8) microarray 
hybridisation using both Cy3 labelled target and Cy5 labelled target.
37
Table 2:3 The commercial kits used in this study and their uses
Commercial kits Use of the kits
ZAP Express® cDNA synthesis kit 
(Stratagene)
Part of this kit was used for mass excision of pBK-CMV 
phagemid vector from ZAP Express® vector.
Dynabeads mRNA Direct' '^  ^kit 
(Dynal LTD)
This kit was used for mRNA extraction fi'om skeletal muscle 
tissues or cells.
Reverse Transcription System 
(Promega)
This kit was used for single-stranded cDNA synthesis.
Random Primers DNA labelling 
System (Life Technologies)
This kit was used for labelling [a - ^^ P] to cDNA probes.
The [a - ^^ P] labelled cDNA probes were applied to colony 
blot hybridisations, Southern blot hybridisations and dot blot 
hybridisation.
QIAprep Spin Miniprep kit 
(QIAGEN)
This kit was used for individual extraction of plasmid 
DNAs, which were for quality assurance during the 
microarray construction.
QIAprep 96 Turbo Miniprep kit 
(QIAGEN)
This kit was used for 96-well plate format plasmid DNA 
extraction.
HotStarTaq Master Mix kit 
(QIAGEN)
This kit was used for the 96-well plate format hot start PCR.
QIAquick 96 PCR Purification kit 
(QIAGEN)
This kit was used for 96-well plate format purification of 
PCR products.
QIAvac 96 Vacuum Manifold 
(QIAGEN)
This kit was used along with a vacuum pump for providing 
negative vacuum environment, which was required by both 
QIAprep 96 Turbo Miniprep Kit and QIAquick 96 PCR 
Purification kits.
Thermo Sequenase Cycle 
Sequencing kit 
(Amersham Life Science)
This kit was used for sequencing reactions.
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Figure 2:2 The entire process of microarray construction in this study
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2.2.2.I. In vivo mass excision of pBK-CMV phagemid vector from ZAP Express vector
A large number of isolated cDNA fragments are crucial for constmcting a cDNA microarray. 
However, each cDNA fragment of the two cDNA libraries used in this study was a 
recommbinant insert contained within the multiple cloning site of pBK-CMV sequence, which 
combined with the sequence of the ZAP Express® vector. In order to obtain isolated cDNA 
fragments fi*om both cDNA libraries, in vivo mass excision was carried out following 
manufacturer’s protocol. Through in vivo mass excision, linear pBK-CMV sequences containing 
cDNA inserts were converted to circular pBK-CMV phagemids containing the cDNA inserts 
(Fig. 2:3). These phagemids were later transformed into E.coli XLOLR cells.
The ZAP Express® vector, which contains pBK-CMV sequence and lambda DNA, is designed to 
insert cDNA hagment within the pBK-CMV sequence. During in vivo mass excision, E.coli 
XLl-Blue MRF’ cells are simultaneously infected with both the ZAP Express® vector and the 
ExAssist® interference-resistant helper phage (Stratagen, UK). Inside each infected XLl-Blue 
MRF’ cell, proteins Rom the helper phage recognise initiator and temiinator domains within the 
ZAP Express® vector, and new single-stranded DNA fi*agments are then synthesised. Each of 
these synthesised DNA molecules includes the complete sequence of pBK-CMV phagemid 
vector and the sequence of the insert, if one is present. The synthesised DNA molecules are 
circularised by the gene II product from the helper phage, “packaged” into phagemid particles, 
and secreted from the XLl-Blue MRF’ cell. These phagemids become plasmids after infecting E. 
coli XLOLR cells. Colonies of the transformed XLOLR cells containing pBK-CMV plasmids 
grow in the presence of kanamycin on LB agar plates as the pBK-CMV vector contains the 
kanamycin-resistance gene.
XLl-Blue-MRF' cells were cultured overnight in LB broth, which was supplemented with 0.2 % 
(w/v) maltose and 10 mM MgS04 at 30°C with shaking at 200 rpm in a Gallenkamp Orbital 
Incubator. XLOLR cells were cultured overnight in NZY broth without supplementation under 
the same conditions. XLl-Blue-MRF' and XLOLR cells were haiwested separately hy spinning at 
lOOOxg in Beckman GPR Centrifuge (Beckman, UK), and resuspended in 10 inM MgS04. In 
order to obtain a final concentration of 8x10^ cells/ml, which was equal to an optical density 
(OD) of 1.0 at 600 nm, the concentration of the suspension was determined
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Figure 2:3 ZAP Express® vector excision
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Individual lambda phage or an amplified library are allowed to infect E. coli cells 
which are co-infected with filamentous helper phage. Inside the cell, trans-acting 
proteins from the helper phage recognise initiator (I) and terminator (T) domains 
within the ZAP Express® vector arms. Both of these signals are recognised by the 
helper phage gene II protein and a new DNA strand is synthesised, displacing the 
existing strand. The displaced strand is circularised and packaged as a filamentous 
phage by the helper phage proteins, and secreted from the cell. pBK plasmids are 
recovered by infecting an F’ strain and growing in the presence of kanamycin.
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using a Beckman DU“ 640 spectrophotometer (Beckman Coulter, Inc., USA) at a wave length of 
600nm.
A portion of the amplified ZAP® Express cDNA library was combined with XLl-Blue-MRF' 
cells at a multiplicity of infection (MOI) of 1:10 lambda phage-to-cell ratio in a 50-ml Falcon 
tube (Becton Dickinson Lab ware). In order to ensure statistical representation of the excised 
clones, 10- to 100-fold more lambda phage than the size of the primary library was excised. 
ExAssist® interference-resistant helper phage was then added to the tube at a ratio of 10 helper 
phage to 1 cell to ensure that every XLl-Blue-MRF' cell was co-infected with ZAP® Express 
lambda phage and ExAssist® interference-resistant helper phage. The 50 ml Falcon tube 
containing the mixture of lambda phage, XLl-Blue MRF' cells and helper phage, was incubated 
at 37°C for 15 minutes to allow absorption. After incubation, 20 ml of NZY broth was added to 
the mixture, and the Falcon tube was incubated for 2.5-3 hours at 37°C with shaking at 200 ipm 
in an Orbital hicubator SI 50 (Stuart Scientific). After incubation, the Falcon tube containing the 
mixture was heated at 65-70°C for 20 minutes in a waterbath (Grant Instruments Ltd). The debris 
was spun down at lOOOxg for 10 minutes, and the supernatant was decanted into a new 50 ml 
Falcon tube.
The concentration of the excised phagemids was determined by combining 1 pi of the 
supernatant with 200 pi of the previously prepared XLOLR cells in a 1.5-ml microcentrifuge 
tube. This microcentrifuge tube was then incubated at 37°C for 15 minutes. After incubation, 40 
pi of 5 X concentrated NZY broth was added to this 1.5 ml microcentrifuge tube, which was then 
incubated at 37°C for 45 minutes. A hundred microlitres of the incubated cell mixture was plated 
onto each LB-kanamycin agar plate using sterile plastic spreaders, which contained 50 pg/ml 
kanamycin (Sigma-Aldrich), in 90 mm petri dishes (Bibby Sterilin Ltd). The LB-kanamycin agar 
plates were incubated overnight at 37°C. Colonies appearing on these plates were XLOLR cells, 
each of which contained the pBK-CMV double-stranded plasmid. ExAssist® interference- 
resistant helper phage would not grow since the helper phage was unable to replicate in XLOLR 
cells and did not contain kanamycin-resistance genes. XLOLR cells were also resistant to 
lambda phage infection, thus preventing the ZAP Express® lambda phage contamination after 
excision. At this stage, the XLOLR bacterial colonies on the LB-kanamycin plates could be
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selected for plasmid DNA extraction and, for further bacterial culture in downstream colony 
hybridisation.
2.2.2.2. Colony blot hybridisations
After in vivo mass excision, cDNA fragments contained in the ZAP Express® vectors were 
converted into pBK-CMV phagemids, which were transfonned into E. coli XLOLR cells to 
become pBK-CMV plasmids. In order to select cDNA inserts for the cDNA microarray 
construction, colony blot hybridisations were earned out on 17,600 bacterial colonies of 
transfonned E. coli XLOLR cells, immobilised on 40 nylon membranes. Colony selection was 
then perfonned based on the intensity of hybridisation signals on autoradiograph films, as an 
indication of expression copies of each mRNA transcript in the two skeletal muscles from which 
the cDNA libraries were made. The process of colony hybridisation was divided into three steps: 
(1) preparation of nylon membranes on which E, coli XLOLR bacterial colonies were 
immobilised; (2) the preparation of [a - ^^ P] labelled porcine skeletal muscle cDNA probes (this 
step included mRNA extraction fi*om muscle tissues, single-stranded cDNA synthesis using 
reverse transcription reaction, and [a - ^^P] labelling of the synthesised cDNA); (3) the [a - ^^ P] 
labelled cDNA probe obtained from the step (2) was hybridised to nylon membranes obtained 
from the step (1).
2,2.2.2,1. Membrane preparation fo r  colony blot hybridisations
The transformed E. coli XLOLR cells were plated onto LB-kanamycin agar plates (90 mm 
Sterilin Petri, Dishes Bibby Sterilin Ltd). From these plates, individual bacterial colonies were 
randomly picked using autoclaved toothpicks, and transferred immediately onto new LB- 
kanamycin agar plates in 243x243x25 mm square Bio-Assay dishes (Nalge Nunc International). 
Approximately, 17,600 colonies in total were randomly picked from the 90 mm Sterilin Petri 
Dishes, and transfeiTed onto 40 LB-kanamycin agar plates in 243x243x25 mm square Bio-Assay 
dishes, with 440 colonies on each square agar plate, for overnight bacterial culture at 37°C. 
Before starting this process of bacterial transfer, a paper giid with 440 sub-grids numbered from 
1 to 440 (Fig. 2:4) was attached on the underside of each 243x243x25 mm square Bio-Assay 
plate. Hence, the surface of each square agar plate was divided into 440 sub-grids. During the 
process of bacterial transfer, each randomly picked colony was transferred individually to the
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Figure 2:4 A paper grid, which has 440 sub-squares 
labelled with numbers from 1 to 440, was attached to 
the underside of the 243x243x25 mm Bio-Assay dish
- 4M M»? •»
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centre of each sub-grid. Each transferred colony was spaced about 1 cm distance apart from 
neighbouring colonies. After overnight bacterial culture, a 200x200 mm Hybond-N+ nylon 
membrane (Amersham Pharmacia Biotech) was laid gently onto the surface of each square agar 
plate, and then peeled back slowly. The bacteria-attached nylon membranes were air dried, with 
the bacteria side facing up, on a piece of Whatman clnomatogiaphy paper (Whatman 
hiternational Ltd) for 2-3 hours. Finally, the attached colonies were immobilised on the nylon 
membranes using ultraviolet (UV) crosslinking for about 15 seconds in a XL-1500 UV 
crosslinker (Spectronics Coiporation).
2,2.2>2.2. Probe preparation for colony hybridisations
2.2.2.2.2.1. mRNA extraction
Direct isolation of messenger RNA (mRNA) from the longissimus dorsi muscle of a 50-day-old 
Meishan x Large White porcine foetus, and from the gastrocnemius muscle of a 3-day-old 
Meishan x Large White pig were carried out separately using the Dynabeads® mRNA DIRECT' '^  ^
Kit (Dynal Biotech). All skeletal muscle tissues used for the mRNA extractions were stored in 
liquid nitrogen since obtained. The use of the Dynabeads® mRNA DIRECT^'^ Kit relies on the 
base pairing between the poly A tails of most mRNAs and the oligo dT sequences bound to the 
Dynalbeads® smTaces. Dynabeads® are the monodisperse polymer particles, which exhibit 
magnetic properties when placed within a magnetic field, but have no residual magnetism when 
removed from the magnetic field. Dynabeads® oligo (dT)z5 combine oligo dT sequences with 
magnetic properties of the Dynabeads®. Using a magnet like the Dynal Magnetic Particle 
Concentrator (Dynal MPC®), Dynabeads® oligo (dT)25 can be used to isolate mRNA directly 
from crude extracts of animal tissues.
Each frozen muscle tissue was freeze-fi'acture pulverized rapidly to a powder while frozen in 
liquid nitrogen using mortar and pestle, which were previously baked at 80°C for 24 hours and 
pre-cooled with liquid nitrogen before use. The frozen powdered muscle tissue was weighed 
rapidly into approximately 50 mg portions using AB54 Analytical Balance (Mettler Toledo), foil 
and forceps pre-cooled with liquid nitrogen. The muscle was kept frozen thioughout this 
aliquoting process to avoid mRNA degradation. Each portion of the frozen powdered muscle 
tissue was transferred immediately to a 2 ml RNAase-free microcentrifuge tube, which had been
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pre-cooled in dry ice. One millilitre Lysis/Binding Buffer was added into each microcentrifuge 
tube containing muscle fragments, and the mixture was homogenised using T8.01 Netzgerat 
Homogeniser (Janke & Kunkel Gmbtt & Co., ÏKA Laborteclmik) for about one minute until 
complete lysis was obtained. The lysate was spun for one minute in a Biofuge Pico 
Microcentrifuge (Heraeus Instruments) to remove debris. The supernatant was used in 
combination with Dynabeads® oligo (dT)25.
Dynabeads® oligo (dT)25 was supplied as a suspension in phosphate-buffered saline (PBS) in a 
stock tube. The Dynabeads® oligo (dT)25 was resuspended by thorough shaking the stock tube 
before use. Two hundred and fifty microlitre suspension containing Dynabeads® oligo (dT)25 was 
transferred from the stock tube to a 1.5 ml RNAase-free microcentrifuge tube placed in a Dynal 
MPC® magnet. When the suspension was clear, supernatant was removed from the tube and 
discarded. The tube was removed from the Dynal MPC®, and the Dynabeads® oligo (dT)25 left 
inside the tube was resuspended in 200 pi Lysis/Binding Buffer. This tube was then returned to 
the Dynal MPC®. When the suspension was clear, supernatant was removed from the tube and 
discarded. The Dynabeads® oligo (dT)25 left inside the tube was ready for combination with the 
clarified muscle tissue lysate.
The muscle tissue lysate was added into the tube containing the washed Dynabeads® oligo (dT)25. 
The lysate was mixed with the Dynabeads® oligo (dT)25 by rotating the tube on a Denley A600 
Rocker (Denley-Tech Ltd) for six minutes at room temperature to allow mRNA and oligo dT 
sequence to aneal. This tube was then placed in the Dynal MPC®. When the suspension was 
clear, supernatant was removed from the tube and discarded. The Dynabeads® oligo (dT)25, with 
captured mRNA, was washed twice with Washing Buffer A (see Apendix) (1 ml Washing Buffer 
A was used each time), then, once with Washing Buffer B (see Apendix) (1 ml Washing Buffer B 
was used), and finally, once with Ix concentration Reverse Transcription Buffer (1 ml IxReverse 
Transcription Buffer was used) at room temperature using the Dynal MPC®. Twenty-one 
microlitre 10 inM Tris-HCl (pH 7.5) was mixed with the Dynabeads® oligo (dT)25 left inside the 
tube for elution of the captured mRNA from the Dynabeads® oligo (dT)25. The tube containing 
the mixture was incubated at 65°C water bath (Grant Instruments Ltd) for 2 minutes, and then 
placed in the Dynal MPC®. When the suspension was clear, the supernatant containing mRNA 
was transferred to a new 1.5 ml RNAase-fr*ee microcentrifuge tube, ready for cDNA synthesis.
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2.2.2.2.2.2. Single-stranded cDNA syntheses
Single-stranded cDNA was synthesised from the poly(A)+ mRNA using a reverse transcription 
system (Promega). Nine microlitres (about 2 pg) poly(A)+ mRNA extracted from the muscle 
tissue were placed in a sterile 1.5 ml microcentrifuge tube. The poly(A)+ mRNA contained in the 
tube was incubated at 70°C in a water bath (Grant Instruments Ltd) for 10 minutes, spun briefly 
in a Biofuge pico microcentrifuge (Heraeus Instruments), and was then placed on ice. Prior to 
setting up a 40 pi reverse transcription reaction, a 31 pi reagent mixture including water, buffer, 
dNTPs, MgCB, primers, Recombinant RNasin® Ribonuclease Inliibitor, and AMV Reverse 
Transcriptase was set up in a new sterile 1.5 ml micro centrifuge tube (see Table 2:4). The 
mixture was added into and mixed with the poly(A)+ mRNA kept in the microcentrifuge tube, 
which had been placed on ice, to set up a 40 pi reverse transcription reaction. The reaction was 
first incubated at room temperature for 10 minutes, and then at 42°C for 15 minutes. The 
incubation at room temperature was to allow extension of the primers so they remained 
hybridised when the temperature was raised to 42°C. After incubation, the reaction was heated at 
99°C in a heat block (Techne Dri-Block) for 5 minutes, and then incubated on ice for 5 minutes. 
The AMW reverse transcriptase was inactivated. At this stage, the synthesised single-stranded 
cDNA was ready to be labelled with [a-^^P]. The synthesised single-stranded cDNA could be 
stored at -20°C in a freezer for future use.
Table 2:4 Reverse transcription reaction for single-stranded cDNA synthesis
Reverse transcription reaction component Amount
MgCh (25 mM) 8.0 pi
Reverse Transcription Buffer (lOxconcentration) 4.0 pi
dNTP Mixture (10 mM) 4.0 pi
Recombinant RNasin® Ribonuclease Inhibitor 1.0 pi
AMV Reverse Transcriptase (high concentration) 1.5 pi (^ 30 U)
Random Primers (0.5 pg/pi) 2.0 pi 1 pg)Poly(A)+ mRNA 9.0 pi
Nuclease-Free Water 10.5 pi
Final volume 40.0 pi
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2.2.2.2.23. Labelling single-stranded cDNAs with [a  -
Single-stranded cDNAs, synthesised by reverse transcription reactions, were labelled with [a- 
using Random Primers DNA labelling Systems (Life Technologies). The [a-^^P] labelled 
cDNAs were used as radioactive probes in colony blot hybridisation. To set up a labelling 
reaction, a 1.5 ml microcentrifuge tube containing 5 pi (approximately 25 nanograms) 
synthesised cDNA was removed from the -20°C freezers. The cDNA was thawed on ice, and 18 
pi of autoclaved double distilled water (ddHaO) was added into the tube. The diluted cDNA was 
denatured by heating the tube at 100°C for 5 minutes in a heat block (Techne Dri-Block). The 
tube was immediately placed on ice. On ice. The labelling mixture which contained 2pi dATP 
solution, 2pi dGTP solution, 2pl dTTP solution, 15pl Random Primers Buffer Mixture, Ipl 
Klenow Fragment and 5 pi 370 MBq/ml [a-^^P]dCTP (Amersham Pharmacia Biotech) 
(approximately 1.85 MBq in total), was gently mixed, centrifuged briefly at 5000 ipni in a 
Biofuge Pico Centrifuge (Heraeus Instruments), and incubated at 37°C in a waterbath (Grant 
Instruments Ltd) for 3 hours. In order to separate labelled probe fr'om unincorporated 
nucleotides, the labelling mixtme was purified using a Nick' '^  ^ Column (Amersham Pharmacia 
Biotech) following the manufacturer’s protocol. First of all, the NICK^^ Column was 
equilibrated twice by allowing 3 ml distilled water to enter the gel bed of the column each time. 
Then, the labelling mixture, which was 27 pi in total, and 473 pi of distilled water was made to 
enter the gel bed in turn. The purified sample was eluted by another 400 pi of distilled water. 
Two microlitres of the purified labelling mixture was mixed in a plastic scintillation vial with 5 
ml of Ecoscint™ A scintillation solution (National Diagnostics). The average count per minute 
(cpm) of the 2 pi aliquot contained in the vial, which represented the proportion of the 
radionucleotide incoiporated into the probe cDNA, was counted using a LSI801 Beckman 
Counter (Beckman).
2.2.2.23. Colony blot hybridisations
A total of forty 200x200 imn Hybond-N+ nylon membranes, carrying immobilised bacterial 
colonies, were hybridised with [a-^^P] labelled cDNA probe, derived from the same muscle type 
and stage of development as that used for the library construction. All colony hybridisations 
were carried out in Schott GL45 glass hybridisation tubes (Stuart Scientific) in a hybridisation
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oven (Stuart Scientific) with a rotating speed of 10 revs/minute. Each nylon membrane was first 
washed inside the hybridisation tube at 55°C for 30 minutes with about 200 ml washing buffer 
containing 5xSSC and 0.5% SDS. The washing buffer was decanted, and the tube was replaced 
with 20 ml prehybridisation buffer [50% foimamide, 5xSSC, 5xDenhardfs, O.IM EDTA, 1% 
SDS, 50mM sodium phosphate buffer (pH7.0) and 200 pg/ml sheared salmon speim DNA] (see 
Appendix). The membrane was prehybridised with prehybridisation buffer at 65°C for 1 hour 
followed by overnight hybridisation at 60°C soaked in the same 20 ml prehybridisation buffer 
with an addition of [a-^^P]dCTP labelled cDNA probe, at a concentration of 2x10^ cpm/ml. The 
hybridised membrane was washed with washing buffer which contains 2xSSC and 0.1% SDS, at 
55°C for 3-4 times, each time for 40 minutes with about 200 ml washing buffer. After washing, 
the membrane was exposed to a Hyperfilm^'^ MP high performance autoradiograph film 
(Amersham Pharmacia Biotech) in a Kodak X-Omatic cassette (Eastman Kodak Company) at - 
80°C for about 3 days. The film was then developed using a Compact X4 automatic x-ray film 
processor (Xogi'aph Imaging Systems Ltd).
2.2.2.3. Clone selection
Colonies were selected based on relative signal intensity found on the Hyperfilm’^'^  MP high 
perfoimance autoradiograph films. Selection emphasis was on those colonies with weak to 
moderate hybridisation signals. About 10 colonies with strong hybridisation signals was also 
selected from each square agar plate. On average, about 100-200 weakly to moderately expressed 
colonies and 10 highly expressed colonies were selected fiom each LB-kanamycin square Bio- 
Assay agar plate. The reasons for this selection are given in the discussion of this chapter. These 
selected colonies were transferred using sterile pipette tips (Sarstedt) from the square Bio-Assay 
plates to the 96-well flat-bottom blocks for bacterial cultivation.
2.2.2.4. Bacterial culture of selected clones in 96-well flat-bottom blocks
Five thousand five hundred separate bacterial cultures of the selected colonies, which mostly 
gave weak to moderate hybridisation signals, were earned out using terrific broth ( G ib c o B R L ,  
Life Technologies) (see Appendix) in 96-well flat-bottom blocks (QIAGEN) [Fig. 2:5 (A)]. One 
millilitre of 50 mg/ml kanamycin was added into 1000 ml terrific broth using a sterile Plastipak® 
syiinge (Becton Dickinson). The broth containing kanamycin was mixed gently and poured into
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Figure 2:5 QIAGEN 96-well flat-bottom block 
and QIAGEN 96-weII format filter plate
(A)
Picture (A) shows a QIAGEN 96-well flat-bottom block used for bacterial culture during microarray construction. The difference in the colour of the flat-bottom blocks in picture (A) is because the two photographs were taken using two different cameras.
(B)
Picture (B) shows a QIAGEN 96- 
well format filter plate, its silica- 
gel membranes and nozzles. All 
TurboFilter 96 plates, QIAprep 96 
plates and QIAquick 96-well 
plates are in the same form as this 
96-well format filter plate shown 
in picture (B)
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a sterile plastic disposable reagent reservoir (Sigma) for dispensing by a multichamrel pipette 
(Eppendorf). Each well of a 96-well flat-bottom block was filled with 1.3 ml of the terrific broth, 
and was then inoculated with a single bacterial colony on a 243x243x25 mm Bio-Assay plate 
using a sterile yellow pipette tip (Sarstedt). The wells of each block were sealed with plastic 
adhesive tape (QIAGEN). Five to six holes were pierced in the tape with a sterile BD 
microlance’''^  3 needle (Becton Dickinson) above each well for aeration during culture. The 
cultures were incubated for 24 hours at 37°C with shaking at 300 rpm in an Orbital Incubator SI 
50 (Stuart Scientific). After incubation, the block was sealed by the addition of a new plastic 
adhesive tape, and bacterial cells in the block were harvested by centrifugation for 5 minutes at 
1500x g in a Sorvall Legend RT centrifuge (Heraeus). After centrifugation, the plastic adhesive 
tapes were peeled off. The media in all wells were removed by quickly inverting the block over a 
waste container. Any remaining droplets of media were removed by tapping the inverted block 
fiimly on a stack of absorbent paper. The bacterial pellets in the 96-well flat-bottom blocks were 
ready for plasmid DNA isolation.
2.2.2.5, Plasmid DNA extraction in 96-well plate format
A total of 5,500 plasmid DNAs was extracted separately from the selected colonies using 
QIAprep 96 Turbo Miniprep Kits (QIAGEN) [Figs 2:5 (B) and 2:6] following the 
manufacturer’s protocol. QIAprep 96 plates combined the convenience of multiwell technology 
with the selective binding properties of silica-gel membrane [Fig. 2:5 (B)]. The isolation of 
plasmid DNAs using the QIAprep 96 Turbo Miniprep Kits was based on alkaline lysis of 
bacterial cells followed by adsorption of DNA onto silica-gel membrane in the presence of high 
salt. The procedure for plasmid DNA extraction consisted of thi'ee basic steps: (1) preparation 
and clearing of bacterial lysate (2) adsoiption of DNA onto the silica-gel membrane of the 
QIAprep 96 plate (3) washing and elution of plasmid DNA. The materials used in the isolation of 
plasmid DNAs in 96-well plate foimat are given in Table 2:5.
2.2.2.5.1. Preparation and clearing o f  bacterial lysates
Two hundred and fifty microliters of Buffer PI containing 100pg/ml RNAase A were added to 
each bacterial pellet in the 96-well flat-bottom block. The block was then sealed with a plastic 
adhesive tape. The bacterial pellets in the block were resuspended by vortexing until no cell
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clumps were visible. The plastic adhesive tape was then removed from the block, and 250 pi 
Buffer P2 was added to each sample in the block. The block was sealed with a new plastic 
adhesive tape, and each sample in the block was mixed by gently inverting the block until the 
solutions became viscous and began to clear. After the block was incubated at room temperature 
for 5 minutes, the plastic adhesive tape was removed from the block, and 350 pi Buffer N3 was 
added to each sample in the block. The block was then sealed with a new plastic adhesive tape, 
and each sample in the block was mixed by gently inverting the block until the solutions became 
cloudy. The plastic adhesive tape was then removed from the block.
The TurboFilter 96 plate was placed in the QIAvac top plate, while the QIAprep 96 plate was 
positioned under the TurboFilter 96 plate. The bacterial lysates in the 96-well flat-bottom block, 
each of which was approximately 850 pi, were transferred to the TurboFilter 96 plate using a 
multichannel pipette (Eppendorf). Vacuum pressure [-200 millibar (mbar) to -600 mbar] 
generated by the vacuum pump was applied to the TurboFilter 96 plate until all lysates passed 
tlnough the filters of TurboFilter 96 plate with a flow rate of 1-2 drops/second. The vacuum 
regulator coimected with the vacuum pump was used to regulate the flow rate. The flow-tlnough 
of the TurboFilter 96 plate was collected in wells of the QIAprep 96 plate. The TurboFilter 96 
plate was then discarded.
2.2.2.5.2. Adsorption ofDNA onto silica~gel membrane o f QIAprep 96 plate
The QIAprep 96 plate containing the cleared lysates was placed in the QIAvac top plate, while a 
waste tray was positioned under the QIAprep 96 plate. Vacuum pressure (-200 mbar to -600 
mbar) was applied to the QIAprep 96 plate until all lysates passed through the silica-gel 
membranes of the QIAprep 96 plate. The flow-through was collected in the waste tray and 
discarded. Nine hundred microliters of Buffer PB were added to each well of the QIAprep 96 
plate. Vacuum pressure (-200 mbar to -600 mbar) was then applied to the QIAprep 96 plate. The 
flow-through was collected in the waste tray and discarded.
2.2.2.5.3. Washing and elution o f  plasmid DNAs
The QIAprep 96 plate was washed twice with Buffer PE. Each time, 900 pi of Buffer PE was 
added to each well of the QIAprep 96 plate. The vacuum pressure (-200 mbar to -600 mbar) was
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Table 2:5 Materials used in plasmid DNA extraction in 96-well plate format
QIAprep 96 Turbo Miniprep Kit (QIAGEN)
Kit components Uses of the components
96-well flat-bottom block with 2 ml 
square wells
96-well flat-bottom blocks are for growing, haiwesting, 
and lysing bacterial cultures prior to plasmid DNA 
extraction.
TurboFilter 96 plates (96-well plate 
fomiat)
TurboFilter 96 plates are for filtering and clearing 
bacterial lysate.
QIAprep 96 plates (96-well plate 
foimat)
QIAprep 96 plates contain silica-gel membranes for 
adsoiption of DNA in the presence of high salt.
Ribonuclease A (lOOmg/ml) Ribonuclease A (RNase A) is for the digestion of 
RNA.
Buffer PI Buffer PI is for re-suspending bacteria.
Buffer P2 Buffer P2 is for lysis of bacteria.
Buffer N3 Buffer N3 is for neutralization of the bacteria lysate.
Buffer PB Buffer PB provides the con*ect salt concentration and 
pH for adsorption of DNA to the silica-gel membrane 
of the QIAprep 96 plate.
Buffer PE The ethanol-containing Buffer PE washes salts away 
from the silica-gel membranes.
Buffer EB Elution of plasmid DNAs fr om the silica-gel 
membranes was perfoimed with low-salt Buffer EB.
applied to the QIAprep 96 plate, and the flow-through was collected in the waste tray and 
discarded. After Buffer PE in all wells had passed through the silica-gel membranes of the 
QIAprep 96 plate, maximum vacuum was applied to the QIAprep 96 plate for an additional 10 
minutes to remove residual Buffer PE from the membranes. The vacuum pressure was then 
switched off, and the QIAvac 96 top plate with the QIAprep 96 plate sitting in it was lifted from 
the QIAvac base and vigorously rapped on a stack of absorbent paper until no drops came out. 
The nozzles of the QIAquick 96 plate were blotted with clean absorbent paper. Each DNA
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sample adsorbed on the silica-gel membrane was eluted by adding 110 pi of Buffer EB (10 mM 
Tris Cl, pH 8.5) to the centre of the silica-gel membrane. The QIAprep 96 plate was left to stand 
for a minute, and maximum vacuum was then applied to the QIAprep 96 plate for 5 minutes in 
order to remove residual Buffer PE, which may interfere with subsequent enzymatic reactions.
The flow-through of the QIAprep 96 plate, which was about 70 pi for each well, was collected in 
a Microtesf’’^ U-Bottom 96-well plate (Becton Dickinson), which had been placed under the 
QIAprep 96 plate. Vacuum source was switched off once the process of elution was finished. 
Concentrations of 20 eluted DNAs were detennined separately using a Beckman DU® 640 
spectrophotometer (Beckman Coulter, Inc.).
2.2.2.6. Storage and accounting of plasmid DNAs
Thirty-five microliters of each eluted DNA were transferred using a multichannel pipette to the 
coiTesponding well of a new Microtesf^'^ U-Bottom 96-well plate to produce two sets of the 
plasmid DNA stock. One set was kept as an archive; the other was used as templates for PCR in 
96-well plate format for the microarray construction. Each 96-well plate was labelled with its 
unique plate identity and sealed with a plastic adhesive tape to avoid cross-contamination and 
evaporation. All 96-well plates containing the recombinant plasmid DNAs were kept at -20°C in 
a freezer.
2.2.2.T. PCR in 96-weIl plate format
Five thousand five hundred individual polymerase chain reactions (PCR) to amplify the cDNA 
inserts contained in the plasmid DNAs, derived from the two cDNA libraries, were carried out in 
96-well plate format using HotStarTaq Master Mix kit (QIAGEN). Insert amplification of each 
pBK-CMV vector based plasmid clone was performed with T7 and T3 primers (Table 2:6). The 
HotSarTaq Master Mix contained HotStarTaq DNA polymerase, PCR Buffer with 3 mM MgCE,
400 pM dATP, 400 pM dTTP, 400 pM dOTP and 400 pM dCTP. HotStarTaq DNA polymerase, -i 
which provided hot-stait PCR for higher PCR specificity, was provided in an inactive state with 
no polymerase activity at ambient temperatures. This prevents the formation of misprimed 
products and primer-dimers at low temperatures. HotStarTaq DNA Polymerase is activated by a 
15-minute, 95°C incubation step. To carry out PCR reactions in 96-well plate foimat, reaction 
mixture was made up for 106 PCR reactions using Rainin pipette tips with hydrophobic filters
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(Rainin Instrument) to minimise cross-contamination. Each individual PCR was performed in 
100 pi volumes, using 10 pi of diluted plasmid DNA, which was equivalent to about 15 ng 
miniprep plasmid DNA of original concentration (Table 2:7). All PCR reactions were conducted 
for 35 cycles with dénaturation at 94°C for one minute, continued with annealing at 55*^ C for 45 
seconds, followed by elongation at 72°C for 3.5 minutes. All PCR reactions started with an 
initial activation step of 95°C for 15 minutes, and ended with an additional elongation step of 
72°C for 10 minutes. All PCR reactions were perfoimed using PCR Plate 96 low volume (0.2 
ml) (Eppendorf) on an Eppendorf Mastercycler Gradient PCR machine (Eppendorf). Half of the 
total PCR amplification products, which were 2750 individual PCR products, were checked 
routinely for DNA yield and size by agarose gel electrophoresis.
Table 2:6 T7 and T3 primers used for insert amplification by PCR
Primername Mamifactorature
Melting
temperature(Tm)
Primer
length Primer sequences
T7 MWG Biotech, 
Germany
58.4°C 22-mer 5’-GTAATACGACTCACTATAGGGC-3’
T3 MWG Biotech, 
Germany
58.9°C 23-mer 5’-CGAAATTAACCCTCACTAAAGGG-3 ’
Table 2:7 Reaction mixture for each PCR in 96-well plate foimat
PCR in 96-well format
Reaction mixture for Reaction mixture for
a single PCR reaction 106 PCR reactions
Diluted plasmid DNA(s) 10 pi
T7 primer (20 pmol/pl) 4 pi 424 pi
T3 primer (20 pmoEpl) 4 pi 424 pi
HotStarTaq Master Mix 50 pi 5300 pi
Distilled water 32 pi 3392 pi
Total volume 100 pi
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2.2.2.S. Purification of PCR product in 96-well plate format
All 5,500 PCR products were purified in 96-well plate format using QIAquick 96 PCR 
Purification kit which included Buffer PB, Buffer PE, Buffer EB, and QIAquick 96-well plates 
(QIAGEN). The QIAquick 96-well plates are in 96-well plate format and contain silica-gel 
membrane for adsorption of DNA in the presence of high salt. Unwanted primers and impurities, 
such as salts, enzymes, unincorporated nucleotides, and detergents (e.g. DMSO) were removed 
from the PCR products tlirough the purification step. All PCR products, each of which was 100 
pi, were transferred using a multichannel pipette fi'om the wells of PCR Plate 96 low volume 
(0.2 ml) (Eppendorf Scientific) into the wells of QIAquick 96-well plate, which was placed in 
the QIAvac 96 top plate. Each 100 pi PCR product was then mixed with 500 pi Buffer PB. 
Vacuum pressure (-200 to -600 mbar) generated by the vacuum pump was applied to the 
QIAquick 96 plate until all the mixtures passed through the membranes of the QIAquick 96 
plate. The following purification procedure was the same as that described in section 2.2.2.5. of 
this chapter for plasmid DNA extraction. The fiow-tlnough of each QIAquick 96 plate, which 
was about 50 pi for each well, were collected in the wells of a Microtesf’'^  U-Bottom 96-well 
plate, which was placed under the QIAquick 96 plate. Vacuum source was switched off once the 
process of elution was finished. Concentrations of the eluted, purified DNAs were detennined 
using Beckman DU® 640 spectrophotometer (Beckman Coulter, Inc.).
2.2.2.9. Storage and accounting of purified PCR products
Twenty-five microlitres of each eluted DNA was transfened using multichannel pipette to the 
corresponding well of a new Microtesf’'^  U-Bottom 96-well plate to produce two sets of the 
purified PCR products stock. One set was kept as an archive; the other was used for microanny 
printing. Each Microtesf^*  ^ U-Bottom 96-well plate was labelled with its unique identity and 
sealed with plastic adhesive tape to avoid cross-contamination and evaporation (Fig. 2:7). All the 
Microtest"'''  ^ U-Bottom 96-well plate containing the purified, PCR amplified cDNA fragments 
were kept at -20 °C in a fr eezer.
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2.2.2.10. Printing microarray slides
After PCR purification, the purified cDNA fragments were transferred from the Microtest"^  ^U- 
Bottom 96-well plates to v-bottom 384-well plates (Genetix) using a Hydra96 Microdispenser 
(Robbins Scientific) for microarray printing. The cDNAs in the 384 well plates were 
resuspended in spotting buffer which contained 600 mM phosphate buffer (pH 8.5) and 0.4% 
SDS. Medium-density, gridded micro arrays were generated on 25mmx75mm, #40004 non- 
barcoded, non-sterile Coming® CMT-GAPS™ Coated glass slides (Corning Microarray 
Teclmology, Coming Incorporated) using a Micro grid II arrayer (Biorobotics Ltd) with a 48 
print pin tool. The Coming® CMT-GAPS™ Coated slides have a uniform coating of pure gamma 
amino propyl silane reacted onto each slide. During microaiTay printing, the temperatures inside 
and outside the Microgrid II arrayer were 17°C and 19°C, respectively; the environmental 
moisture inside and outside the arrayer was 76% and 69%, respectively. All DNA samples 
including cDNA fragments and landing lights were printed in duplicate on each microarray slide. 
After micro array printing, the microarray slides were air-dried at room temperature. The spotted 
DNA fragments were then immobilised to the glass slides by baking at 80°C in a Gallenkamp 
incubator for two hours. A total of 5,500 selected clones were printed onto glass slides, of which 
3,500 colonies derived from the 3-day-old porcine skeletal muscle library and 2,000 colonies 
derived from the 50-day-old porcine foetal skeletal muscle library.
The fluorescent landing lights used for the micro array printing in this study were cyanine 3 
(Cy3)-labelled pGEM-T vector sequences and cyanine 5 (Cy5)-labelled pGEM-T vector 
sequences, both of which were about 160-170 base pairs. Both Cy3 and Cy5 are fluorescence 
cyanine dye (CyDye). Cy3 gives red fluorescence whilst Cy5 produces green fluorescence. The 
landing lights used in this study were included in the microarray, and spotted together with the 
cDNA fragments, which derived from the two skeletal muscle cDNA libraries, onto the glass 
slides for identifying orientation of the completed microarray. The landing lights printed on the 
microarray slides would be fluorescent whenever the microaiTay slides were detected for either 
Cy3 or Cy5 fluorescent images using a laser scanner. All landing lights used in this study were 
previously prepared using PCR by the PIC/Sygen Laboratory, Department of Pathology, 
Cambridge University. The micro array printing of this study was also perfoimed in Cambridge 
University. The landing lights were stored at -20°C. When the microarray printing was to be 
conducted, the vials containing the landing lights were removed from the -20°C freezer, thawed
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on ice, and spotted together with the porcine skeletal muscle cDNA fragments onto the 
microarray slides.
2.2.2.11. Storage of microarray slides
After being baked at 80°C for 2 hours, the immobilised microarray slides were protected from 
light by storing in microscope slide boxes (VWR international), which were kept in a dark and 
dry enviroment at room temperature (20-25°C) for use at a later date. Direct contact with the 
surfaces of the slides, on which the DNA fragments had been printed, was always avoided.
2.2.2.12. Quality controls
Throughout the main process of construction of the micro array, samples were taken to monitor 
the nature, purity and identities of the plasmid DNAs or cDNA fragments. The stages from 
which samples were taken and the procedures earned out are shown diagrammatically in the 
flow chart of Figure 2:2.
2.2.2.12.1. Individual bacterial culture o f  unselected clones
Randomly picked unselected bacteria colonies prepared were to be used in two processes 
(Southern blot hybridisation and dot blot hybridisation). About 300 transformed E. coli strain 
XLOLR colonies obtained tlirough the in vivo mass excision were randomly picked from the 
previously prepared bacterial cultures on the LB-kanamycin agar plates in 90 mm Sterilin round 
petri dishes (see section 2.2.2.1. of this chapter). Each picked colony, which contained the 
recombinant pBK-CMV plasmid vector, was inoculated and grew overnight in 3 ml LB broth 
containing 50 pg/ml kanamycin (Sigma-Aldrich Co) in a 30 ml sterile plastic tube at 37°C with 
shaking at 200 rpm in a SI50 orbital incubator (Stuart Scientific). After incubation, the bacterial 
suspension in each tube was spun at 2,500 rpm for 5 minutes using a Beckman GPR centrifuge 
(Beckman) to obtain the bacteria pellet, which was used straight for individual isolation of the 
plasmid DNA.
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2.2.2.12.2. Individual plasmid DNA extraction
Individual isolation of plasmid DNAs from the randomly picked unselected bacteria colonies 
was carried out using QIAprep Spin Miniprep Kit (QIAGEN) following the manufacturer’s 
protocol, QIAprep spin columns provided by this kit are individual columns containing silica-gel 
membrane for adsorption of DNA in the presence of high salt. All buffers provided by the 
QIAprep Spin Miniprep Kit are the same as that provided by the QIAprep 96 Turbo Miniprep 
Kit (see section 2.2.2.5. of this chapter). Each bacterial pellet kept in the 30 ml sterile plastic 
tube was resuspended by adding 250 pi Buffer PI into the tube. The suspension was transferred 
to a sterile 1.5 ml microcentrifuge tube, and mixed with the added 250 pi Buffer P2 by gently 
inverting the tube 4-6 times. The solution in the tube was later mixed with the added 350 pi 
Buffer N3 by gently inverting the tube 4-6 times, followed by centrifuging the tube at 10,000xg 
for 10 minutes using a Heraeus Biofuge Pico microcentrifuge to form pellet. The supernatant 
was applied using an eppendorf pipette to a QIAprep spin column, which was then spun at 
10,000xg for one minute. The flow-tlii'ough of the column was discarded. The QIAprep spin 
column was washed two times, firstly with 0.5 ml Buffer PB and secondly with 0.75 ml Buffer 
PE, both of which were followed by centrifugation for one minute. The flow-through of the 
column from either wash was discarded. The column was then spun for an additional minute to 
remove residual Buffer PE. In order to elute plasmid DNA, the QIAprep spin column was placed 
in a new sterile 1.5 ml microcentrifuge tube while 50 pi Buffer EB was added onto the centre of 
silica-gel membrane of the column, which was later left to stand for one minute and then 
centrifuged for one minute. The extracted plasmid DNA was used in two ways (Fig. 2:2). One 
portion was subjected to restriction enzyme digestion and gel electrophoresis for Southern blot 
hybridisation. The other was used for dot blot hybridisation and compared with plasmid DNAs, 
which derived from the selected colonies for microarray construction.
2.2.2.12.3. Southern blot hybridisation
After in vivo mass excision and before carrying out colony hybridisations. Southern blot 
hybridisation was performed to identify the relative abundance of different mRNA transcripts in 
porcine skeletal muscles. Plasmid DNAs used in Southern blot hybridisation were extracted from 
randomly picked colonies, which were derived from the 3-day-old porcine skeletal muscle 
cDNA library. All ninety-one plasmid DNAs, which derived fr'om the randomly picked
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imselected bacterial colonies, were doubly digested using restriction endonucleases EcoRl and 
Xhol. A 15 pi reaction of the restriction enzyme digestion was set up for each plasmid DNA by 
adding the DNA template, water, buffer and restriction endonucleases into a sterile 1.5 ml 
microcentrifuge tube (Table 2:8). The tube containing the reaction mixture was incubated at 
37°C for 3 hours in a water bath (Grant Instruments). After incubation, all digested samples were 
subjected to agarose gel electrophoresis. Each digested sample, which was 15 pi in total, was 
mixed with 2.5 pi loading buffer of 6x concentration (see Appendix) and then loaded onto 0.8% 
[weight/volume (w/v)] agarose gel containing 0.2 pg/ml ethidium bromide (EB) (see Appendix). 
One microlitre of 1 pg/pl Ikb DNA ladder (GibcoBRL), which was used as size marker, was 
mixed with 14 pi ddH2Ü and 2.5 pi loading buffer of 6x concentration, and loaded onto the same 
gel. The agarose gel electrophoresis was conducted in Tris-acetate (TAE) buffer with electric 
power of 60 voltages for 3 hours. Using an ultraviolet transilluminator, DNA was visualised.
Table 2:8 Reaction of restriction enzyme digestion
Plasmid DNA
Ecom  (lOU/pl) ( G ib c o B R L )
2Chol (lOU/pl) ( G ib c o B R L )
lOx SuRE/CUT buffer H (Boehringer Mannheim)
ddHiO
1.5 pi
0.8 pi (=8U) 
0.8 pi (—8U)
1.5 pi 
10.4 pi
Total volume 15.0 pi
For Southern blot analysis, the DNA fragments in the agarose gel were denatured by immersing 
the gel in denaturing buffer, followed by neutralisation in neutralisation buffer. Southern blot 
hybridisation was conducted by hybridising the Hybond-N+ nylon membranes, on which the 
DNA fragments had been immobilised, to the [a-^^P] labelled cDNA probe derived from the 
gastrocnemius muscle of a 3-day-old pig. The method used for the Southern blot hybridisation 
was that described for the colony blot hybridisation in section 2.2.2.2.3. of this chapter.
2.2.2.12,4, Detection o f  cDNA inserts during microarray construction
Samples were taken at three stages of microarray constmction to monitor the presence of cDNA 
fragments in the materials intended for inclusion in the micro array. The first sampling stage (Fig.
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2:2) was prior to PCR amplification in 96-well plate format when the material sampled was still 
in the form of plasmid DNA. Two hundred of recombinant plasmid DNAs were detected by 
performing restriction enzyme digestion using EcoR. I and Xho I. The digested samples were 
subjected to agarose gel electrophoresis to ascertain the presence of cDNA fragments and 
evaluate the quantity and quality of the cDNA fr agments. Further samples were taken following 
PCR amplification and after the PCR purification step (Fig. 2:2). Half of the 5,500 PCR products 
and half of the 5,500 purified PCR products for microaiTay incorporation were detected by 
performing agarose gel electrophoresis to ascertain the presence of cDNA fragments and 
evaluate the quantity and quality of the cDNA fragments. The materials and methods used foi- 
restriction enzyme digestion and agarose gel electrophoresis have previously been described in 
the procedures of Southern blot hybridisation (see section 2.2.2.12.3. of this chapter).
2.2.2.12.5. Sequencing ofplasmid DNAs derived from selected clones
Sequencing reactions were performed using a Thermo Sequenase fluorescence cycle sequencing 
Kit (Amersham Life Science). In this sequencing kit, the enzyme, reaction buffer and nucleotides 
were pre-mixed and found in four separate tubes called reagent A, reagent C, reagent G and 
reagent T. In order to prepare a sequencing reaction, 5 pi (2-3 pg) plasmid DNA, 1 pi 2 pmol/pl 
T3 primer and 2 pi of reagent A, C, G or T were mixed thoroughly in a 0.2 ml tube. The 
sequencing reaction started with an initial pre-denatui'ation step of 95°C for 5 minutes, then the 
sequencing reaction was conducted for 25 cycles with dénaturation at 95°C for 30 seconds, 
continued with aimealing at 55°C for 30 seconds, followed by elongation at 72°C for 30 seconds. 
At the completion of the cycling programme, 2 pi formamide loading dye was added to each 
sequencing reaction. The sample was mixed thoroughly, and then denatured for 2 minutes at 
90°C prior to gel electrophoresis. One and a half microlitres of each sequencing reaction product 
was subjected to gel electrophoresis. Sequencing reaction products were analysed on a LI-COR 
DNA sequencer model 4000L (LI-COR Corporation) for 140 plasmid DNAs, derived from the 
selected bacterial colonies. Each cDNA fr agment inserted in the plasmid DNA was amplified by 
sequencing reaction with T3 primer, which sequenced from the 5 ’ end of the insert. The purpose 
of this sequencing effort was to identify the range of genes represented in the microarray. 
However, the location of each clone in the 96-well stock plates was not recorded. To make 4% 
gel mixture solution, 25.2 g of Urea (Fisher Chemicals), 4.8 ml National Diagnostic Gel Mix 
Concentrate Solution and 7.2 ml lOx Tris-boric acid (TBE) buffer (see Appendix) were mixed in
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a beaker. The TBE buffer contained 10.78% (w/v) Tris Base (Sigma), 5.5% (w/v) Boric Acid 
(Sigma) and 0.74% (w/v) EDTA (Sigma). The volume of the gel mixture was brought to 60 ml 
with ddHaO. The solution was stired well with magnetic stirrer, and was allowed to cool in 
fridge. Two 66-cm plates were prepared by washing with 100% ethanol (Bamford laboratories) 
and 100% isopropanol (BDH). The plates were polished off until the surfaee of each plate was 
dry before they were assembled and placed into gel pouring stand. 400 pi ammonium 
persulphate (APS) (Sigma) and 40 pi N, N, N ’, N ’-tetramethylethylenediamine (TEMED) 
( G ib c o B R L )  were mixed with the gel solution before pouring the gel. The comb was carefully 
placed at the top of the gel to create wells. The gel was left to set for 2 hours before being 
inserted into LI-COR machine and loading samples to the wells. The gel was run with a high 
voltage of 2000V for 18-20 hours to get 800-100 bases of sequence fr om the gel. The sequences 
provided by the machine were stored digitally for analysis. The identity for sequencing was 
obtained by caiTying out blast searches.
2,2,2,12,6, Dot blot hybridisation
To evaluate the effectiveness of colony selection, dot blot hybridisation was carried out using 
192 individual plasmid DNAs. Half of these plasmid DNAs were extracted from 96 selected E. 
coli strain XLOLR colonies, derived from the 3-day-old skeletal muscle cDNA library, and 
intended for incorporation in the microarray. The other half were derived from 96 randomly 
picked unselected colonies studied in the quality assurance process (Fig. 2:2). In order to dilute 
the plasmid DNAs, 46 pi ddHzO was added into each well of two 96-well PCR Plates 
(Eppendorf). One of the plates was labelled plate A, the other plate B. Four microlitres of each 
plasmid DNA were added to each well of the 96-well PCR Plates containing ddHiO. The 96 
randomly picked unselected plasmid DNAs were transferred to plate A, whilst the 96 selected 
plasmid DNAs were transfened to plate B. The final volume of each diluted plasmid DNA was 
50 pi. All diluted plasmid DNAs were denatured at 95 °C for 10 minutes using the Eppendorf 
Mastercycler Gradient PCR machine (Eppendorf), followed by adding 50 pi 20xSSC (see 
Appendix) into each denatured DNA sample. The mixtures in plate A were transferred to wells 
of a Scotlab 96-well vacuum manifold (Scotlab) (Fig. 2:8). Negative vacuum generated by
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Figure 2:8 Scotlab 96-well format vacuum 
manifold and Hybaid™ blot processing pump 
used for dot blot hybridisation
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Hybaid' '^^ Blot Processing Pump (Hybaid) (Fig. 2:8) was switched on tlrroughout the transferring 
process, and then switched off once all the samples from plate A had been transfened onto a 
80mmxll5mm Hybond-N+ nylon membrane wetted with lOxSSC (see Appendix) placed inside 
the vacuum manifold. The nylon membrane was removed from the vacuum manifold, labelled, 
washed with lOxSSC, and air-dried for 2 hours on a piece of Whatman clnomatogi'aphy paper. 
The transferred plasmid DNAs were immobilised on the nylon membrane using ultraviolet (UY) 
crosslinking for about 15 seconds in a XL-1500 UV crosslinker (Spectronics Corporation). The 
same procedure followed for plate B. Both nylon membranes, which carried the immobilised 
plasmid DNAs derived from the 3-day-old skeletal muscle cDNA library, were hybridised to the 
[a-^^P] labelled cDNA probe derived from muscle of the same muscle type and stage of 
development. The method used for dot blot hybridisation was that described for colony blot 
hybridisation in section 2.2.2.23. of this chapter.
2.2,2.12,7. Microarray hybridisation using Cy3 labelled T7primer target
The micro array printing process was evaluated by carrying out micro array hybridisation using 
T7 primer, which was labelled with FluoroLink™ Cyanine 3 fluorescent dye (Amersham 
Pharmacia Biotech), as target to hybridise to the cDNA probes immobilised on the micro array 
slide. The microarray hybridisation was performed at early stage of the microarray printing 
process in the PIC/Sygen Laboratory, Department of Pathology, Cambridge University. The 
sequence and manufacturer of the T7 primer used for the hybridisation were that described in 
Table 2:6.
A freshly printed microaiTay slide was air dried inside the Microgrid II arrayer, and then 
removed fr'om the aiTayer to be baked at 80°C-90°C for 2 hours on a heat block (Teclme Dri- 
Block). After baking, the microaiTay slide was immersed in 95°C-100°C ddHzO for 2 minutes in 
a sterile glass beaker, followed by immersing the slide in 100% ethanol kept at room temperature 
in a 50 ml Falcon tube. The slide was dried by centrifugation at low speed for 2 minutes. The 
preparation of the 20 pi T7-Cy3 primer target mixture, which was later applied to the microan'ay 
slide in order to perform the microarray hybridisation, is detailed in Table 2:11. The slide was 
then covered with a BDH glass coverslip, and placed in a hybridisation chamber that could be 
tightly sealed. The hybridisation reaction performed on the microaiTay slide was incubated at 
37°C for 30 minutes in a water bath. After hybridisation, the slide was removed ftom the
6 6
hybridisation chamber, and then immersed in 3xSSC contained in a 50 ml Falcon tube to remove 
the coverslip. The slide was washed twice by immersed firstly in washing buffer containing 
3xSSC and 0.1% SDS, and secondly in 4xSSC. Both washing buffers were kept in 50 ml Falcon 
tubes. Following the washing step, the slide was dried by centrifugation at low speed for 2 
minutes, and then scamied using GenePix 4000A seamier (Axon Instruments, hic,).
The scanned image of the hybridised micro an'ay was used for evaluating the effectiveness of the 
microanay printing process through assessing the quality of the microarray slides (i.e. the 
presence of DNA in every location on the slide for spotting) and the quantity of DNA present. 
As all the cDNA probes immobilised on the microarray slide had been obtained tlirough PCR 
using T7 and T3 primers, the sequence of every single cDNA fragment incorporated in the 
microanay should hybridise with the T7-Cy3 primer target. Thus, after scanning the microaiTay 
slide, according to the amount of spots giving out fluorescence and the fluorescent signal 
intensity of each spot, the effectiveness of the microarray printing process and the amount of 
DNA per spot could be evaluated.
Table 2:9 The T7-Cy3 primer target mixture prepared for the micro array hybridisation
The T7-Cy3 primer target mixture prepared for the microarray hybridisation
20xSSC 5 pi
Salmonsperm DNA 1 pi
10% SDS 1 pi
ddHiO 12 pi
T7-Cy3 primer (1 juM) 1 pi
Final volume 20 pi
2.2,2,12.8. Dual-colour microarray hybridisation
To evaluate hybridisation efficiency of the printed microarray slides, dual-colour micro array 
hybridisation was earned out using both Cy3 labelled cDNAs derived from 91-day-old porcine 
foetal skeletal muscle and Cy5 labelled cDNAs derived from porcine kidney. Both target cDNA 
samples were prepared in the Molecular Medicine Laboratory, Department of Veterinary 
Pathology, University of Glasgow. The hybridisation was perfoimed in the PIC/Sygen 
Laboratory, Department of Pathology, Cambridge University. The method used for mRNA 
extraction and cDNA synthesis was the same as that described in section 2.2.22.2, of this chapter.
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Table 2:10 shows details of the cyanine dye labelling reaction for preparation of microaiTay 
hybridisation target. Cyanine dye labelling reaction was incubated first at 65°C for 5 minutes, 
then at 42°C for 2 minutes. Two microlitres of 200 U/pl Superscript™ II RNase H - Reverse 
Transcriptase ( G jbcqB R L ,  Life Technologies) were then added to each cyanine dye labelling 
reaction. The mixture was incubated at 42°C for one hour. At the completion of the incubation, 
5pi 500 mM EDTA was added to the mixture to stop the labelling reaction. The Cy3-labelled 
target and the Cy5-labelled target were mixed thoroughly. Pre-hybridisation was caiTied out by 
immersing a porcine skeletal muscle cDNA microarray slide in pre-hybridisation solution, which 
contained 1% (0.5 g) BSA and 3xSSC. The pre-hybridisation was incubated at 65°C for 15 
minutes. Following pre-hybridisation, the microanay slide was washed briefly first with ddffgO, 
then with 100% ethanol, and dried by centrifugation, hi order to perform microanay 
hybridisation, the dual-CyeDye labelled cDNA target mixture was added to the microarray slide. 
The microaiTay hybridisation reaction was incubated overnight at 65°C. At the completion of the 
incubation, 5 pi 500 mM EDTA was added to the microanay slide to stop hybridisation reaction. 
Following hybridisation, the microarray slide was washed at room temperature for 5 minutes with 
washing buffer containing 0.5x SSC and 0.01% SDS, and then immersed briefly in 0.06x SSC. 
Immediately after washing, the microarray slide was dried by centrifugation, and scanned using 
GenePix 4000A scanner (Axon Instmments, Inc.) to capture the image, hnage processing was 
perfoimed using GenePix Pro 3.0 software (Axon Instruments, Inc.).
Table 2:10 Cyanine dye labelling reaction for preparation of microarray hybridisation target
Content of the cyanine dye labelling 
reaction
91-day-old porcine 
foetal skeletal muscle Porcine kidney
Oligo dT (500 ng/pl) 2.0 pi 2.0 pi
First strand buffer (5x concentration) 8.0 pi 8,0 pi
dNTPs (lOx low concenreation) 2.0 pi 2.0 pi
FluoroLink™ Cy3-dCTP (Amersham 
Phaimacia Biotech)
2.0 pi
FluoroLink'^'^ Cy5 -dCTP(Amersham 
Pharmacia Biotech)
2.0 pi
DTT (0.1 M) 2.0 pi 2.0 pi
RNAsin 0.5 pi 0.5 pi
DEPC H2O 16.5 pi 16.5 pi
mRNA 5.0 pi («1 pg) 5.0 pi («1 pg)
Total volume 38.0 pi 38.0 pi
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2.3. RESULTS
The entire process of microarray construction included the construction process itself and its 
associated quality controls. Results presented are divided into two sections: results of the 
construction process and results of the quality controls. Results of the constmction process are 
divided into seven parts: (1) in vivo mass excision of pBK-CMV phagemid vector from lambda 
ZAP Express® vector, (2) colony hybridisations, (3) clone selection, (4) plasmid DNA 
preparation of selected clones, (5) PCR in 96-well plate format for amplification and purification 
of the cDNA inserts, (6) microarray printing, (7) clone accounting. Results of the quality controls 
are divided into the six parts: (1) Southern blot hybridisation, (2) detection of cDNA fragments 
by restriction enzyme digestion and agarose gel electrophoresis, (3) sequencing of plasmid 
DNAs derived from selected clones, (4) dot blot hybridisation, (5) microarray hybridisation 
using Cy3 labelled T7 primer target, (6) dual-colour (Cy3 and Cy5) microanay hybridisation.
2.3.1. RESULTS OF MICROARRAY CONSTRUCTION PROCESS
2.3.1.1. In vivo mass excision of pBK-CMV phagemid vector from ZAP Express® vector
To obtain E. coli colonies for microarray construction, in vivo mass excision of pBK-CMV 
phagemid vector from X ZAP Express® vector was carried out based on the two porcine skeletal 
muscle cDNA libraries. One of the libraries was derived from the longissimus dorsi muscle of a 
50-day-old Meishan x Large White porcine foetus; the other was made fr’om the gastrocnemius 
muscle of a 3-day-old Meishan x Large Wlrite pig. Each cDNA library stored at -20°C in 1.5 ml 
microcentrifuge tubes was thawed successfrdly. This step was the starting point for construction 
of the composite microarray in this study. As a direct consequence of the in vivo mass excision 
of pBK-CMV phagemid vector from X ZAP Express® vector, transfoimed kanamycin-resistant 
E. coli strain XLOLR bacterial colonies were obtained. Some difficulties were experienced at 
controlling density of the bacterial colonies on each LB-kanamycin agar plate, which turned out 
to be too high or too low. High density of bacteria on each plate made it difficult for picking 
individual colonies because cross-contamination was likely to happen. Low bacterial density, 
which brought about scarce colonies on each plate, required the use of a large number of such 
plates in order to obtain thousands of colonies for microaiTay construction. This requirement was
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considered expensive and time-consuming. The difficulties were due to lacking of practical 
experience of standard method of ten-fold serial dilution for titrating bacterial concentration. 
Countermeasure to solve the problem was the effort to test repeatedly different dilutions and 
plating volumes of inoculums for achieving consistent colony yield on LB-kanamycin agar 
plates and obtaining the desirable bacterial density. About 50 of such attempts had been made 
until an idea bacterial density (around 500 colonies/per plate) was repeatedly achieved when 30 
pi of inoculum was used for each agar plate. Although some of the colonies were still close 
together with this density (around 500 colonies/per plate), individual colonies were obtained with 
relative ease in sufficient number without the risk of cross-contamination. Eventually, a total of 
17,900 E. coli colonies derived from the two cDNA libraries were randomly picked for Southern 
hybridisation, colony hybrdisations and dot blot hybridisation.
2.3.I.2. Colony blot hybridisations
Colony hybridisations were carried out for approximately 17,600 randomly picked bacterial 
colonies immobilised on 40 nylon membranes. The membranes were probed with [a-^^P] 
labelled cDNAs derived from the same muscle type and stage of development as that used for 
the library construction. Each nylon membrane had 440 bacterial colonies transferred to it. 
Figure 2:9 shows estimates of porcine longissimus dorsi muscle mRNAs extracted for probe 
labelling using agarose gel containing ethidium bromide. Figure 2:10 shows two representative 
autoradiographs with various hybridisation signals. Intense signals represented cDNA clones that 
were derived from highly expressed genes, while faint signals represented cDNA clones from 
weakly expressed genes. Intermediate signals represented cDNA clones from moderately 
expressed genes. The absence of a signal could be due to a weakly expressed clone or absence of 
cDNA insert. According to its location on the paper grid, each spot on the autoradiographs was 
able to be traced to the corresponding bacterial colony on the LB-kanamycin agar plate in 
Bio Assay square dish. Results of the colony hybridisations confirmed the presence of 
recombinant cDNAs in the transformed E. coli strain XLOLR bacterial colonies. Furthermore, 
the strong, moderate and weak expression profiles of porcine skeletal muscle genes were 
revealed on autoradiograph films in the fbnn of hybridisation signals of randomly picked 
colonies. The images of hybridsation signals reflected the similarity of mRNA abundance 
between the two skeletal muscles cDNA libraries used in this study. The results of colony 
hybridisations made it feasible to perform the following colony selection step, and more 
importantly, allowed the constmction of the microarray to proceed.
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2.3.1.3. Clone selection
Selection of the transformed E. coli strain XLOLR bacterial colonies from the LB-kanamycin 
agar BioAssay square dishes for microarray assembly was based on the signal intensity on 
autoradiograph films of the colony hybridisations. To attempt to assemble a cDNA microarray 
with a wide range of different cDNA clones, priority of colony selection was given to colonies 
with weak to moderate signals while colonies with strong signals were largely avoided. On 
average, about a quarter of the colonies on each LB-kanamycin agar BioAssay square dishes 
were selected/picked for the microarray assembly. A total of 5,500 colonies were 
selected/picked, of which 3,500 colonies derived fi.*om the 3-day-old porcine neonatal skeletal 
muscle library and 2,000 colonies derived from the 50-day-old porcine foetal skeletal muscle 
library.
2.3.1.4. Plasmid DNA extraction
The 5,500 selected bacterial colonies were inoculated individually into a total of fifty-seven 96- 
well flat-bottom blocks containing LB-kanamycin broth. Five thousand five hundred individual 
plasmid DNAs were obtained fiom their corresponding bacterial cultures. The average 
concentration of 20 eluted plasmid DNAs, which were randomly chosen, was 80 ng/pl as 
determined by spectrophotometry. In order to ensure the largest reliability of the constructed 
microarray, the presence of cDNA inserts in the pBK-CMV vector was evaluated by restriction 
enzyme digestion and agarose gel electrophoresis as part of the quality control outlined in Figure 
2:2. Sample gels from the evaluation are given in Figure 2:11. The inserts ranged in size from 
100 bp to 4 kb, predicted according to the known molecular weight standard (1 kb DNA ladder). 
The majority of the digestion samples produced two bands. The vector without insert would be 
the larger (4518 bp) of the two, and the insert the smaller. Some digestion samples of the 
recombinant plasmids produced thi*ee bands: two insert bands and one vector band. This may 
indicate that there was a restriction enzyme recognition site (i?coR I site or Xho I site) within 
each of these cDNA inserts. Of the total number of clones evaluated, about 10% were clones that 
did not show insert band on 0.8% agarose gel. This could be due to absence of cDNA insert in 
the pBK-CMV vector, or containing cDNA inserts of small size that was difficult to detect using 
0.8% agarose gel.
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2.3.1.5. PCR and purification of PCR products in 96-well plate format
All PCR amplification were performed in 96-well plate format, using T7 and T3 primers, on the 
plasmid DNAs extracted from the transformed and selected E. coli colonies. When evaluated by 
agarose gel electrophoresis for half of the 5,500 PCR products as part of the quality control 
outlined in Figure 2:2, the presence of the amplified cDNA fragments was found in all the PCR 
products evaluated. Purification of all PCR products was performed in 96-well plate format. The 
concentrations of 20 eluted purified PCR products, which were randomly selected, ranged from 
0.054 pg/pl to 0.271 pg/pl with the average concentration of 0.137 pg/pl. When evaluated by 
agarose gel electrophoresis for half of the 5,500 PCR purification products as part of the quality 
control outlined in Figure 2:2, the presence of the amplified and purified cDNA fr agments was 
found in all the PCR purification products evaluated. A sample gel from the evaluation is given 
in Figure 2:12. The presence of double bands in some of the purified PCR products (e.g., Lanes 4 
and 5 in Fig. 2:12) could be due to non-specific priming. The purified PCR products were 
divided into two identical sets of 96-well plates ready to be spotted onto Coming® CMT- 
GAPS™ Coated slides. Figure 2:13 shows three types of stock plates kept at -20°C for the 
construction of porcine skeletal muscle cDNA microarray and clone tracking.
2.3.1.6. Priiiting microarray slides
Printing of microarray slides was canied out in the PIC/Sygen Laboratory, Department of 
Pathology, Cambridge University. Purified, PCR amplified cDNA fragments were transferred 
fr'om fifty-seven 96-well plates (Platel-Plate57) to fifteen 384-well plates (QB1-QB15). An 
additional 384-well plate (QB16) of Cy3 labelled landing lights, Cy5 labelled landing lights and 
printing buffer was included for the printing process. Table 2:11 shows the link between the 384- 
well stock plates, the 96-well stock plates and the two porcine cDNA libraries. All printed 
materials were transfeiTed and spotted onto glass slides by robots from these sixteen 384-well 
plates. The microarray printed on each glass slide was arranged in 48 squares organised in 4 
meta-rows and 12 meta-columns (Fig. 2:14). Each square was composed of 256 individual 
printed spots arranged as 16 rows and 16 columns (Figure 2:15). Therefore, a total of 12288 
spots including landing lights and printing buffer were printed on each slide. Every single spot 
was printed in duplicate. Each printed spot and its con-esponding duplicate were located in the
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Table 2:11 The link between 384-well plates, 96-well plates and the two porcine cDNA libraries
384-weIl plates 96-well plates cDNA
_______ Library
Q B l contains whole plates of : Plate 1 & Plate 2 & Plate 3 & Plate 4 3-day-old 
pig
QB2 contains whole plates of : Plate 5 & Plate 6 & Plate 7 & Plate 8 3-day-old 
pig
QB3 contains whole plates of : Plate 9 & Plate 10 & Plate 11 & Platel2 3-day-old
pig
QB4 contains whole plates of : Plate 13 & Plate 14 & Plate! 5 & Plate! 6 3-day-old 
pig
QB5 contains whole plates of : Plate 17 & Plate 18 & Plate!9 & Plate20 3-day-old 
pig
QB6 contains whole plates of : Plate 21 & Plate 22 & Plate23 & Plate24 3-day-old 
pig
QB7 contains whole plates of : Plate 25 & Plate 26 & Plate27 & Plate28 50-day-old
foetus
QB8 contains whole plates of : Plate 29 & Plate 30 & PlateSl & Plate32 50-day-old
foetus
QB9 contains whole plates of : Plate 33 & Plate 34 & Plate35 & Plate36 50-day-old
foetus
QB 10 contains whole plates of : Plate 37 & Plate 38 & Plate39 & Plate40 50-day-old
foetus
Q B ll contains whole plates of : Plate 41 & Plate 42 & Plate43 & Plate44 50-day-old
foetus
QB12 contains whole plates of : Plate 45 & Plate 46 & Plate47 & Plate48 50-day-old
foetus
QB 13 contains whole plates of : Plate 49 & Plate 50 & PlateSl & Plate52 50-day-0 Id 
foetus
QB 14 contains whole plates of : Plate 53 & Plate 54 & Plate 55 & Plate56 50-day-old
foetus
QB 15 contains whole plates of : Plate 57
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Figure 2:13 Three types of stock plates kept at -20°C for the construction of porcine 
skeletal muscle cDNA microarray and clone tracking
Type-1
Selected plasmid clones in Main portion
96-well microtitre plates.
k— / If
PCR 
amplification 
in 96-well 
plate format
Tvpe-2PCR 
purifîcation 
in 96-well 
plate format
Purified, PCR-amplified cDNA 
fragments in 96-well microtitre 
plates.
freezer
Main portion
Tvpe-3
Purified, PCR-amplified cDNA 
fragment in 384-well microtitre 
plates for microarray printing
Main portion
Microarray printing
78
Figure 2:14 The 48 printed squares of a hybridised microarray slide
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Figure 2:15 Printing format for each square (16 spots x 16 spots) on the microarray slide
Top half 
row-1 to row 8
Bottom half 
row-9 to row-16 
(identical to top 
half)
A single square on the 
microarray slide
Rows Columns
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
9
10 
11
12
13
14
15
16
Each square of the microarray printing format containing 256 spots (16 spots x 16 spots).
The yellow section represents spots printed in the top half of each square. The blue section 
represents spots printed in the bottom half of each square, which is the duplicate of the spots in 
the yellow (top half) section.
80
same square. For each of the 48 squares, the spots located from row 9 to row 16 were orderly 
repeats of spots in rows 1 to 8 in the same square (Figures 2:14 and 2:15). All 48 squares were 
printed in the same format by using a preset computer programme for controlling the aiTaying 
robot (also called arrayer). Fifry-seven Coming® CMT-GAPS™ Coated slides were initially 
printed. All slides were stored for future use under the conditions specified in the Materials and 
Methods (see section 2.2.2.11. of this chapter). The quality of the printed porcine skeletal 
muscle cDNA microarray slides was monitored by both single-colour (Cy3) microaiTay 
hybridisation and dual-colour (Cy3 and Cy5) micro array hybridisation in the quality monitoring 
process (see sections 2.2.2.12.7. and 2.2.2.12.8. of this chapter).
2.3.1.7. Clone accounting
2.3.1.7.1. Clone identification system fo r microarray slides
The location of each printed spot was identified through the meta-row, meta-column, row and 
column of the spot on the microarray slide constructed in this study (Figs. 2:14 and 2:15). Every 
printed clone was given a unique gene name (Fig. 2:16). A total of 6144 different gene names 
labelled as “KC 1” to “KC 6144” were used.
2.3.1.7.2. Clone identification system fo r stock plates
All 96-well and 384-well stock plates were kept at -20°C in a freezer. The 96-well stock plates 
were of two types: plasmid DNA plates and PCR purification product plates. PCR purification 
products were transferred fr'om 96-well plates to 384-well plates prior to printing. All plates 
were labelled sequentially. Each cDNA clone was given a unique “KC” number. Each cDNA 
spot on the microarray slide and its duplicate spot located in the same square but different row 
had an identical and unique “KC” number. The location of each cDNA clone on the 96-well 
stock plate was identified as “P”, which was followed by the plate category, plate number, row, 
and column. The location of each clone on the 384-well stock plate was identified as “QB”, 
which was followed by the plate category, plate number, row, and column. Every cDNA clone 
printed on the microarray slide could be traced to all types of stock plates. An Excel file was set 
up for all the printed spots to link together the clone location in 96-well stock plates and in 384- 
well stock plates (Fig 2:17). Each cDNA clones used for the micro array construction could be
81
Figure 2:16 An example of gene naming and plate identity system of cDNA clones
Gene name Meta-Row Meta-Column Row Column Spot Location
KCl 1 1 1 1 1,1,1,1KCl 1 1 9 1 1,1,9,1KC16 1 1 1 16 1,1,1,16KC16 1 1 9 16 1,1,9,16
KCl 28 1 1 8 16 1,1,8,16
KCl 28 1 1 16 16 1,1,16,16
KCl 29 1 2 1 1 1,2,1,1KC129 1 2 9 1 1,2,9,1
KC6144 12 4 8 16 12,4,8,16
KC6144 12 4 16 16 12,4,16,16
Meta-Row Meta-Column Row Column
KC16
KC128
KC16
KCl
KC128
(Plate identity system on 96-well Plates)
PQl A 01
(Plate identity system on 384-well Plate)
Plate Plate Plate Plate Plate Platerow column row column
number number number number number number
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Figure 2:17 A sample of the Excel file established for tracking each gene name back to 
the location of a plasmid clone or a cDNA insert in stock plates
Image
Meta-Row
Image
Meta-Column
Image
Row
Image
Column
Identity on 
384-well 
Plates
Identity on 
96-well 
Plates
12 4 16 16 QB14J12 P54_E06
12 4 15 16 QB12J12 P46_E06
12 4 14 16 QB10J12 P38_E06
12 4 13 16 QB8J12 P30_E06
12 4 12 16 QB6J12 P22_E06
12 4 11 16 QB4J12 P14_E06
12 4 10 16 QB2J12 P06_E06
12 4 9 16 Landlights Cy3 Landlights
12 4 8 16 QB14J12 P54_E06
12 4 7 16 QB12J12 P46_E06
12 4 6 16 QB10J12 P38_E06
12 4 5 16 QB8J12 P30_E06
12 4 4 16 QB6J12 P22_E06
12 4 3 16 QB4J12 P14_E06
12 4 2 16 QB2J12 P06_E06
12 3 7 2 QB14_B12 P55_A06
12 3 6 2 QB12_B12 P47_A06
12 3 5 2 QB10_B12 P39_A06
12 3 4 2 QB8_B12 P31_A06
12 3 3 2 QB6_B12 P23_A06
12 3 2 2 QB4_B12 P15_A06
12 3 1 2 QB2_B12 P07_A06
12 2 16 15 QB14_012 P54_H06
12 2 15 15 QB12_012 P46_H06
12 2 14 15 QB10_O12 P38_H06
12 2 13 15 QB8_012 P30_H06
12 2 12 15 QB6_012 P22_H06
12 2 11 15 QB4_012 P14_H06
12 2 10 15 QB2_012 P06_H06
12 1 8 9 QB15_H12 P57_H12
12 1 7 9 QB13_H12 P51_D06
12 1 6 9 QB11_H12 P43_D06
12 1 5 9 QB9_H12 P35_D06
12 1 4 9 QB7_H12 P27_D06
12 1 3 9 QB5_H12 P19_D06
12 1 2 9 QB3_H12 P11_D06
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Figure 2:18 Microarray clone tracking system
Sequencing 
of the cDNA fragment 
from 5’ end with T3 
primer
List of differentially 
expressed genes
Microarray 
data analysis
Find the Plasmid DNA 
containing cDNA insert
Location of the plasmid clone 
containing cDNA insert on 96- 
well microtitre plate kept 
at -20°C
Excel file for tracing each gene 
name back to the location of a 
plasmid clone or a cDNA insert 
in stock plates
Location of the purified, PCR- 
amplified cDNA fragment on 96- 
well and 384-well microtitre plates 
which were kept at -20°C for 
microarray printing
84
tracked fi'om its spot location on the microaiTay slide back to its con'esponding DNA materials 
in the stock plates (Tables 2:11; Figures 2:13, 2:16 and 2:18).
2.3.2. QUALITY CONTROLS
2.3.2.1, Southern blot hybridisation
As part of the quality control outlined in Figure 2:2, Southern blot hybridisation was performed 
for the purpose of identifying the expression patterns of different types of niRNA transcripts 
(e.g., weakly, moderately and highly expressed niRNAs) in total mRNAs of porcine skeletal 
muscle, and therefore, providing the theoretical basis for the subsequent selection of clones 
according to the colony hybridisation results. In order to carry out Southern blot hybridisation, 
91 unselected plasmid clones, derived fi'om the 3-day-old porcine cDNA library, were first 
subjected to restriction enzyme digestion with EcoR. I and Xho I, followed by agarose gel 
electrophoresis. A sample gel is given in Figure 2:19. All the digested plasmid DNAs produced 
cDNA insert bands on 0.8% agarose gel. These cDNA fragments were transfened to nylon 
membranes and hybridised to the [a-^^P] labelled cDNA probe derived from 3-day-old porcine 
neonatal skeletal muscle. On the agarose gels for examining the digested plasmid clones (Fig. 
2:19), a signal band, between 4072 bp and 5090 bp in size, was visible in each sample lane. It 
was likely that these bands represented the pBK-CMV plasmid vector, which should be of 4518 
bp. All vector bands produced signals on the autoradiogiaph films of the Southern blot 
hybridisation. This could be due to non-specific hybridisation. The 1 kb DNA ladder, which 
bands were visible on the agarose gels (Fig. 2:19), did not produce signals on the autoradiograph 
films of Southern hybridisation (Fig. 2:20). On the autoradiograph films of Southern 
hybridisation, the majority of cDNA inserts produced clear signal bands. However, some cDNA 
inserts, which did not produce distinct band (e.g.. Lanes 10 and 20 in Fig. 2:20) when a short 
exposure (e.g., 23 hours) was used at -70 °C for the autoradiograph films (Fig. 2:21), became 
readily seen when a longer exposure (e.g., 41 hours) was used at -70 °C for the autoradiograph 
films (Fig 2:21). The signal intensities of cDNA inserts on the autoradiograph films of Southern 
blot hybridisation were grouped into 3 categories: intense, intermediate and weak signals. 
cDNAs producing intense, inteimediate and weak hybridisation signals represented the highly,
85
moderately and weakly expressed mRNA transcripts, respectively. Two sample autoradiograph 
films of the Southern blot hybridisation are shown in Figure 2:20. Intense hybridisation signals 
were produced by 33 cDNA clones, which comprised 36.3% of the 91 cDNA clones evaluated. 
Intermediate hybridisation signals were produced by 26 cDNA clones, which comprised 28.6% 
of the 91 cDNA clones evaluated. Weak hybridisation signals were produced by 32 cDNA 
clones, which comprise the 35.2% of 91 cDNA clones evaluated (Table 2:12). The expression 
patterns of different types of cDNA clones demonstrated by Southern blot hybridisation was 
similar to that demonstrated by colony blot hybridisations (Section 2.3.1.2. of this chapter).
Table 2:12 Results of Southern blot hybridisation
Signal intensity of cDNA insert on 
autoradiograph films Number of plasmids
Relative abundance 
(percentage)
Intense 33 36.3%
Intermediate 26 28.6%
Weak 32 35.2%
Total 91 100%
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2.3.2.2. Sequencing of plasmid DNAs derived from selected clones
One hundred and forty cDNA fiagments from the 3-day-old porcine cDNA library were 
sequenced to evaluate the range of genes present in the selected clones. The putative identity of 
each clone is listed in Table 2:13. Description of putative identity was based on the nucleotide 
sequence database provided by NCBI Standard nucleotide-nucleotide BLAST service. The 
GeneBank accession number, homology, function and property of each gene were also described 
in Table 2:13. The sequencing result confirmed the presence of a wide range of different genes 
represented by the selected clones for microarray incorporation.
Among the 140 selected cDNA clones detected by random sequencing, 65 cDNA clones 
appeared only once and represented 65 different genes, the majority of which were involved in 
various cell signalling pathways [e.g., IGF-2 (for Insulin-like Growth Factor 2), MAP3K7 (for 
Mitogen-Activated Protein Kinase Kinase Kinase 7), PTK9L (for Protein Tyi'osine Kinase-9 
like), GPS2 (for G Protein Pathway Suppressor 2), CDK2 (for Cyclin-Dependent Kinase 2), 
CKMT2 (for Creatine Kinase Mitochondrial 2)]. In Table 2:13, there were 18 duplicate clones 
representing 9 genes, which included ribosomal protein L7a, ribosomal protein S5, laminin 
receptor 1, cytoclmome c oxidase subunit Vib, myosin binding protein H, cardiac alpha 
tropomyosin, troponin I, sarcolipin, and heat shock protein. These 9 genes were found twice, each 
by sequencing. There were four identical clones representing enolase 3 gene, whilst another four 
identical clones were found to represent skeletal alpha actin gene. There were five identical 
clones found to represent mitochondrion partial genome. Among the 140 cDNA clones, 11 clones 
were pBK-CMV plasmid vectors without cDNA insert; 15 clones were unknown cDNA 
sequences without clear open reading fiame; 18 clones were unknown cDNA sequences with 
clear open reading frame that had very low homology to any information of the nucleotide 
databases provided by the NCBI Standard nucleotide-nucleotide BLAST seiwices. In summary, 
sequencing analysis of the 140 cDNA clones gave the results of a wide range of genes 
representing a wide range of different gene transcripts for the microaiTay incorporation.
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Table 2:13 Sequencing o f plasmid DNAs derived from the selected colonies
Closest putative identity 
and length of fragment 
in base pairs
GeneBank 
accession # Homology # of clone
Functions and 
properties
Human ribosomal protein L4 (RPL4) 
mRNA, Length =1445 bp
BC005817 310/331 (93%) 1 Protein synthesis
Human ribosomal protein L6 (RPL6) 
mRNA, Length = 925 bp
XM_012260 237/260 (91%) 1 Protein synthesis
Human ribosomal protein L7a 
(RPL7A) mRNA, Length = 885 bp
XM_015622 299/334 (89%) 
208/228 (91%) 2
Protein synthesis
Bovine ribosomal protein S28-like 
protein mRNA, partial cds, 
Length= 203 bp
AF307320 72/79 (91%) 1 Protein synthesis
Bovine ribosomal protein S2 mRNA, 
partial cds, Length = 918 bp
AF013215 567/663 (85%) 1 Protein synthesis
Human ribosomal protein S5 (RPS5) 
mRNA, Length = 706 bp
XM_009371 356/386 (92%) 2 Protein synthesis
Human ribosomal protein L23 
(RPL23) mRNA, Length = 474 bp
XM_015407 382/418 (91%) 1 Protein synthesis
Macaca fascicularis (Monkey) 
ribosomal protein S11 (RPS11) 
mRNA, Length = 557 bp
AB093675 448/484 (92%) 1 Protein synthesis
Human laminin receptor 1 (ribosomal 
protein SA, 67kD) mRNA, (LAMRl), 
Length =1045 bp
BC010418
NM_174379
629/684(91%) 
692/759 (91%) 2
Mediates the effects 
laminin
Bovine C0X6A mRNA for 
cytochrome c oxidase subunit Via, 
Length = 344 bp
X56857 284/309 (91%) 1 The enzyme cytochrome c oxidase 
is a transmembrane 
protein found in the 
mitochondrion.
Bovine mRNA for cytochrome c 
oxidase subunit VIb (AED), 
Length = 359 bp
X15112 259/274 (94%) 
243/259 (93%) 2
Cytochrome c oxidase 
is a ti’ansmembrane 
protein found in the 
mitochondrion.
Porcine lactate dehydrogenase-A 
(LDH-A) mRNA, Length =1668 bp
U07178 492/495 (99%) 1 LDH-A catalyses the conversion of L- 
lactate and NAD to 
pyruvate and NADH 
in the final step of
91
anaerobic glycolysis.
Porcine mitochondrion, partial 
genome, Length = 15978 bp
AF304200
AF304202
612/636 (96%) 
316/316(100%) 
385/400 (96%) 
191/192 (99%) 
457/463 (98%)
5 Mitochondrion partial genome
Porcine mRNA for myosin heavy 
chain 2b, Length=5929 bp
AB025261 229/230(99%) 1 Myofilamentcomponent
Porcine myosin light chain (MLC-1) 
mRNA, Length = 859 bp
X94689 601/614 (97%) 1 Myofilament
component
Myosin binding protein H (MYBPH) 
mRNA, Length = 1772 bp
NM 004997 
XM_001686
676/744 (90%) 
250/288 (86%) 2
Binds to myosin; may 
be involved in 
interaction with thick 
myofilaments in the a- 
band.
Porcine skeletal alpha actin gene, 
Length = 5157 bp
Ü16368 254/256 (99%) 
312/314(99%) 
254/256 (99%) 
297/299 (99%)
4 Myofilament
component
Human capping protein (actin 
filament) muscle Z-line, alpha 2 
(CAPZA2) mRNA, Length = 918 bp
XM_004969 427/450 (94%) 1 Myofilamentcomponent
Human cardiac muscle alpha actin 
mRNA, Length=1549 hp
BC009978 269/290 (92%) 1 Myofilament
component
Porcine mRNA for cardiac alpha 
tropomyosin. Length = 1207 bp
X66274 799/800 (99%) 
499/503 (99%) 2
Myofilament
component
Porcine partial mRNA for type III 
collagen (coBal gene),
Length = 287 bp
AJ289758 75/87 (86%) 1 Connective tissue
Porcine mRNA for sarcolipin, 
Length = 324 bp
Z98820 315/324 (97%) 
276/285 (96%) 2 Sarcolipin is an integi'al membrane protein. 
Sarcolipin regulates the 
sarcoplasmic reticulum 
Ca-ATPase in fast- 
twitch skeletal muscle.
Domestic rabbit mRNA for myosin 
light chain 2 (MLC2), type I, 
Length=645 bp
X54042 498/548 (90%) 1 Myofilament
component
Human actinin, alpha 2 (ACTN2), 
mRNA, Length = 4161 bp
XM_002047 267/288 (92%) 1 Actin-binding protein.lt 
is localised to skeletal 
muscle Z-disc and helps
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anchor myofibrillar 
actin filaments.
Domestic rabbit mRNA for troponin I, 
Length = 701 bp
X14190 352/398 (88%) 
502/548 (91%) 2
Myofilament
component
Dog triadin mRNA, 
Length = 2349 bp
AF165916 544/583 (93%) 1 Sarcoplasmic 
reticulum glycoprotein
Human NAC alpha mRNA (Naca 
muscle-specific factor),
Length = 829 bp
AY034001 526/555 (94%) 1 Muscle-specific ti'anscriptional factor
Human aldolase A, fmctose- 
bisphosphate (ALDOA), mRNA, 
Length = 1461 bp
XM_008117 386/417 (92%) 1 Striated muscle 
contraction; fructose 
metabolism
Human triosephosphate isomerase 
(TIM), mRNA, Length = 1225 bp
XM_208215 93/109 (85%) 1 TIM is an important enzyme in the 
glycolytic pathway
Human isopentenyl-diphosphate 
delta isomerase (IDIl), mRNA, 
Length = 1807 bp
NM_004508 194/227 (85%) 1 hitramolecular 
oxidoreductases 
ti ansposing C=C 
bonds; converts 
isopentenyl diphosphate 
to dimethylallyl 
diphosphate
Human heterogeneous nuclear 
ribonucleoprotein L (HNRPL), 
mRNA, Length = 2033 bp
NM_001533 83/87 (95%) 1 This protein is a 
component of the 
heterogenous nuclear 
ribonucleoprotein 
complexes, which 
provide substrate for 
the processing events 
that pre-mRNAs 
undergo before 
becoming functional, 
ti anslatable mRNAs in 
the cytoplasm.
Domestic sheep glycogen 
myophosphorylase, mRNA, 
Length = 2869 bp
AF001899 422/455 (92%) 1 This enzyme is needed for the breakdown of 
glycogen.
Human phosphorylase kinase, 
gamma 1 (muscle) (PHKGl), 
mRNA, Length = 1377 bp
NM_006213 293/324 (90%) 1 Phosphoiylase kinase is a regulatory enzyme of 
glycogen metabolism
Human enolase 3, (beta, muscle) 
(EN03), mRNA, Length = 1389 bp
XM 008524 
BCO17249
497/550 (90%) 
339/370 (91%) 
352/384 (91%)
4 Glycolytic enzyme
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LIM and cysteine-rich domains 1 
(LMCDl), mRNA,Length = 1724 bp
XM_003181
423/474 (89%) 
379/416(91%) 1 LIM protein is 
transcription factor
Human apolipoprotein B mRNA 
editing enzyme, catalytic 
polypeptide-like 2 (AP0BEC2), 
mRNA, Length = 1164 bp
NM_006789 83/93 (89%) 1 Glycolysis
Porcine mRNA for insulin-like- 
growth factor 2 (IGF-2),
Length = 1225 bp
X56094 694/709 (97%) 1 Cell signalling
Human HLA class III region 
containing N0TCH4 gene, partial 
sequence, homeobox PBX2 (HPBX) 
gene, receptor for advanced 
glycosylation end products (RAGE) 
gene, complete cds, and 6 
unidentified cds. Length = 62944 bp
U89336 157/183 (85%) 1 Cell signalling
House mouse integral membrane 
glycoprotein (Img), mRNA, 
Length = 4822 bp
NM_008377 100/124 (80%) 1 An integral component 
of a membrane
Domestic rabbit elongation factor 1 
A2 (EEFlA-2), mRNA,
Length = 1749 bp
AF035178 316/328 (96%) 1 Eukaryotic translation
(1) Human integi'al membrane 
protein 2B (ITM2B), mRNA, 
Length = 1844 bp
(2) Human putative transmembrane 
protein E3-16, mRNA,
Length = 1896 hp
(1)XM_012311
(2)AF136973
314/341 (92%) 
314/341 (92%)
1
An integral component 
of a membrane
(1) Human laminin, gamma 1 
(foimerly LAMB2) (LAMCl), 
mRNA, Length = 7923 bp
(2) Porcine mRNA for heat shock 
protein 70, Length= 2518 bp
(3) Porcine heat shock protein 72 
mRNA, Length = 1461 bp
(1)NM_002293
(2)X68213
(3)M29506
470/501(93%)
19/19(100%)
19/19(100%)
2 Heat shock proteins 
are induced when a 
cell undergoes 
environmental stresses
(1) Human tripartite motif protein 
TRIM5 isoform alpha,beta,gamma 
,delta,epsilon (TRIMS) mRNA, 
complete cds; alternatively spliced
(2) Human stimulated trans-acting 
factor (50 kDa) (STAF50), mRNA, 
Length = 2809 bp
(1)AF220025-
AF220029
(2)XM_015243
184/223 (82%) 
76/83 (91%)
1
TRIM proteins share a 
common function: by 
means of homo- 
multimerisation they 
identify specific cell 
compartments.
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Human diacylglycerol kinase 3 
(DAGK3) gene, exon 10, 
Length = 418 hp
AF020931 22/23 (95%) 1 Transcription factor
Human presenilin 1 (Alzheimer 
disease 3; apoptosis) (PSENl), 
mRNA, Length = 2764 bp
XM007441 287/329 (87%) 1 The encoded protein is predicted to be an 
integi'al membrane 
protein
Human kelch-like protein C3IP1 
(C3IP1), mRNA, Length = 2013 bp
XM_010659 373/404 (92%) 1 Protein-proteininteraction
Porcine mRNA for heparin-binding 
epidermal growth factor-like protein, 
Length = 627 bp
Y15731 425/437 (97%) 1 Cell signalling
Human ankyrin 1, erythrocytic 
(ANKl), mRNA, Length = 1179 bp
XM_011727 364/408 (89%) 1 Attach integral membrane proteins to 
cytoskeletal elements
(1) Human upregulated by 1,25- 
dihydroxyvitamin D-3 (VDUPl), 
mRNA, Length = 2688 bp
(2) Mouse thioredoxin interacting 
factor (Vdupl) gene,
Length = 5529 bp
(1)XM_002093
(2)AF282825
152/162 (93%) 
152/167 (91%)
1
Stress response gene, 
which could have a 
unique role in 
epidermis regulating 
the conversion of 
postmitotic cells to 
differentiating ones.
Lynx lynx (wild feline) H I9 RNA 
gene, partial cds. Length = 879 bp
AF190056 166/195 (85%) 1 Not clear
Human cyclin-dependent kinase 2 
(CDK2), mRNA, Length = 1297 bp
NM„001798 182/198 (91%) 1 Cell signalling; 
Transcription factor
Human creatine kinase, 
mitochondrial 2 (sarcomeric) 
(CKMT2), mRNA,Length = 1585 bp
XM_011329 405/459 (88%) 1 Transcription factor
Human seven transmembrane 
domain protein mRNA, 
Length = 878 bp
BC001118 476/514 (92%) 1 Cell signalling
(1) Porcine adenine nucleotide 
translocator 1 (ANTI) gene, exons 2 
and 3, partial cds, Length = 1042 bp
(2) Bovine ADP/ATP translocase T1 
mRNA, Length = 1194 bp
(1)AF055633
(2)M24102 
& J02845
145/145(100%) 
322/335 (96%) 1
Adenine nucleotide 
ti-anslocase (ANT) is 
responsible for the 
stoichiometric exchange 
of ATP and ADP across 
the inner mitochondrial 
membrane.
Human apoptosis inhibitory protein 5, XM_208445 235/287 (81%) 1 Inhibit apoptosis
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mRNA, Length = 3665 bp
Human mitogen-activated protein 
kinase kinase kinase 7 (MAP3K7), 
mRNA, Length = 2769 bp
XM_004499 348/371 (93%) 1 MAP3K7 is involved 
in INK signal 
transduction pathway.
Human zinc finger protein 259, 
mRNA, Length = 1199 bp
XM_018293 452/501 (90%) 1 Transcription factor
Human protein tyrosine kinase 9-like 
(A6-related protein) (PTK9L), 
mRNA, Length = 1574 bp
XM_003237 395/434 (91%) 1 Transcription factor
Human G protein pathway suppressor 
2 (GPS2), mRNA, Length = 1189 bp
NM 004489 530/576 (92%) 1 G protein pathway 
suppressor
(1) Human long form transcription 
factor C-MAF (c-maf proto­
oncogene) mRNA, complete cds. 
Length = 2145 bp
(2) Human v-maf
musculo aponeurotic fibrosarcoma 
(avian) oncogene homolog (MAF), 
mRNA, Length = 2145 bp
(1)AF055377
(2)NM_005360
279/287 (97%) 
279/287 (97%)
1 Oncogene
Porcine glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), mRNA, 
Length = 1419 bp
AFO17079 318/330 (96%) 1 Mammalian GAPDH is involved in membrane 
fusion, microtubule 
bundling,
phosphotransferase 
activity, nuclear RNA 
export, prostate cancer 
progression, 
programmed neuronal 
cell death, DNA 
replication, and DNA 
repair.
Domestic rabbit pyruvate kinase 
mRNA, partial cds,
Length = 1593 bp
U44751 342/374 (91%) 1 Pyruvate kinase is an enzyme that helps in 
the conversion of 
glucose to energy 
when there is not 
adequate oxygen.
(1) Human calmodulin 1 
(phosphorylase kinase, delta) 
(CALMl) mRNA, Length = 1525 bp
(2) Human, calmodulin 2 
(phosphorylase kinase, delta), mRNA, 
Length= 1058 hp
(1)XM 00738 
5
(2)BC000454
302/326 (92%) 
301/326 (92%)
1 Transcription factor
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Porcine gene for skeletal muscle 
ryanodine receptor (RyRl), 
Length = 29699 bp
X69465 184/199 (92%) 1 The ryanodine 
receptor is the channel 
responsible for the 
release of calcium 
from the sarcoplasmic 
reticulum in muscle 
cells.
(1) Porcine rotavirus mRNA for 
RGD-containing collagen associated 
protein, Length = 2819 bp
(2) Human transforming growth 
factor, beta-induced, 68kDa 
(TGFBI), mRNA, Length = 2691 bp
(1)D55717
(2)
NM_00G358
484/501 (96%) 
97/112(86%)
1
(1) Porcine rotavirus 
mRNA
(2) transcription factor
Bovine low molecular mass 
ubiquinone-binding protein mRNA, 
Length = 681 bp
L06665 301/332 (90%) 1 Ubiquinone-binding
protein
House mouse casein kinase 2 beta 
subunit (gMCK2) gene, partial cds.
AF109719 100% 1 Transcription factor
House mouse adult male kidney 
cDNA, RIKEN full-length enriched 
library, clone:0610010G04, full 
insert sequence, Length = 993 bp
AR002470 184/214 (85%) 1 Not clear
Human mRNA for KIAA0353 gene, 
partial cds. Length = 6651 bp
AB002351 297/367 (80%) 1 The protein encoded by this gene is an 
intermediate filament 
family member, which 
fonns a linkage between 
desmin and the 
extracellular matrix, and 
provides an important 
sti'uctural support in 
muscle.
Human CGI-92 protein (L0C51117), 
mRNA, Length= 1548 bp
NM_016035 320/363 (88%) 1 Ubiquinone 
biosynthesis protein
Human upregulated by 1,25- 
dihydroxyvitamin D-3 (VDUPl), 
mRNA, Length = 2704 bp
NM_006472 387/420 (92%) 1 An stress response 
gene
Human, clone MGC: 2198, mRNA, 
Length = 657 bp
BC000587 221/259(85%) 1 Not clear
Human myomesin (M-protein) 2 
(MY0M2) mRNA,Length = 4921 bp
XM_005198 159/180 (88%) 1 165 kDa titin- 
associated protein
Human C9orH0 protein (C9orfl0: XM_011758 435/487 (89%) 1 Not clear
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chromosome 9 open reading frame 10) 
mRNA, Length = 3331 bp
Human hypothetical protein 
HSPC152 (HSPC152), mRNA, 
Length = 612 hp
NM_016404 302/356 (84%) 1 Not clear
(1) Bovine BAP 1 mRNA,
Length = 1367
(2) Human APEX nuclease,
clone MGC:4057 IMAGE:2823545, 
mRNA, Length = 1450 bp
(1) X56685
(2) BCO 19291
832/917 (90%) 
733/821 (89%) 1
Human APEX 
nuclease is a 
multifunctional DNA 
repair enzyme.
House mouse mRNA for hypothetical 
protein (ORFl) clone Telethonin 
(Italy_B41)_Strait03708_FL626, 
Length=905 bp
AJ277212 128/143 (89%) 1 Not clear
cDNA sequences (with clear open 
reading flame) that had very low 
homology to any infoimation of the 
nucleotide databases provided by the 
NCBI Standard nucleotide- 
nucleotide BLAST seiwices.
None Not Match 18 Not clear
cDNA sequences (without clear open 
reading frame) that had very low 
homology to any information of the 
nucleotide databases provided by the 
NCBI Standard nucleotide- 
nucleotide BLAST services
None Not Match 15 Not clear
Shuttle expression vector 
pBK-CMV, Length = 4518 bp 
(Plasmid DNA without insert)
U37573 100% homology 11 pBK-CMV plasmid vector
“cds” is abbreviated from “coding sequence”; “bp” is abbreviated from “base pairs’
2.3.2.3. Dot blot hybridisation
The efficiency of the clone selection was assessed by dot blot hybridisation, which was 
perfoimed to compare 96 plasmid DNAs extracted from the selected colonies with 96 plasmid 
DNAs extracted from the unselected colonies. All cDNA inserts in the plasmids for dot blot
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hybridisation were derived from the 3-day-old porcine cDNA library. On the autoradiograph 
films of the dot blot hybridisation, much less number of intense signals (dark spots) appeared in 
the hybridisation image of selected clones than in the hybridisation image of unselected clones 
(Fig. 2:22). These intense signals (dark spots) represented cDNA inserts converted from highly 
expressed mRNA transcripts. The reduction in the number of intense signals in the hybridisation 
image of selected clones indicated that the clone selection method had substantially reduced 
cDNAs representing highly expressed genes and consequently increased the number of cDNAs 
representing weakly and moderately expressed genes.
2.3.2.4. Microarray hybridisation using Cy3 labelled T7 primer target
Effectiveness of the microarray printing process was evaluated hy microarray hybridisation with 
the Cy3 labelled T7 primer target. The fluorescent image of every single hybridised microarray 
cDNA spot, which was obtained by scanning the hybridised microarray slide, was round, clear 
and bright (image not shown). The signal intensities of all hybridised cDNA spots printed on the 
microarray slide were similar. This image indicated that all the printed cDNA fragments, which 
had previously been amplified using T7 and T3 primers, hybridised successfully with the Cy3 
labelled T7 primer. The result of this single-colour (Cy3) microaiTay hybridisation confimied 
that all the cDNA fragments obtained for microanay incorporation were effectively printed and 
immobilised onto the surface of the Corning CMT-GAFS*^  ^Coated slides.
2.3.2.5. Dual-colour microarray hybridisatiou
Following microarray printing, one of the completed microarray slides was evaluated by 
cohybridisation of Cy3 labelled cDNA target derived fiom 91-day-old porcine foetal longissimus 
dorsi muscle and Cy5 labelled cDNA target derived from porcine kidney. The scanned image 
was processed using ImaGene'*’’^  v4.2 (BioDiscovery) computational software to show the two 
colour (red and gi'een) fluorescent image (Fig. 2:23). Microarray cDNA spots, which hybridised 
with both Cy3 labelled targets and Cy5 labelled targets, were yellow or orange in colour. The 
result of this dual-colour (Cy3 and Cy5) microarray hybridisation showed that the cDNA 
microarray constmcted in this study was appropriate for simultaneous hybridisation with the 
mixture of Cy3 labelled and Cy5 labelled targets.
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2.4. DISCUSSION
2.4.1. CONSTRUCTION OF THE PORCINE SKELETAL MUSCLE cDNA 
MICROARRAY
All ordinary array design starts with identification of genes to be arrayed. Selecting the right 
genes and clones to represent these genes is crucial to successful use of in-house designed 
microaiTays. In most cases, sequence infonnation of gene collections for array assembly is 
obtained bom public, proprietary or subscription databases such as human division of UniGene, 
primate division of GeneBank, etc. Most cDNA microarrays are developed based on DNA 
fragments with known sequence information. However, at the initial array design stage of this 
study, sufficient sequence information on porcine skeletal muscle was not available. It was not 
possible to build an oligonucleotide microanay or a cDNA microarray by adopting conventional 
approaches. To resolve the problem of lack of necessary sequence information, this study sought 
to develop a cDNA microarray, the establishment of which was completely based on the 
selection of unknown cDNA fragments derived fr'om either prenatal or postnatal porcine skeletal 
muscle cDNA libraries. The two cDNA libraries were chosen for use because understanding 
alterations of expression patterns of thousands of genes in different developmental stages is 
critical for enliancing cun*ent knowledge of molecular mechanisms involved in skeletal muscle 
development, ageing, regeneration and degeneration, which remain elusive at this time, hr this 
study, sequencing all the unknown cDNA fragments to be arrayed was deemed impractical 
because the necessary efforts would have been too long and the cost too high. The non- 
nomialised cDNA libraries used in this study for micro array assembly posed the problem of 
clone redundancy. Colony hybridisations and the clone selection effectively reduced this 
problem to a large extent. To date, gene identities of a large number of these arrayed clones have 
already been obtained by sequencing.
First-hand experience has been gained fi'om this study to enable improvements on the methods 
used for creating the porcine skeletal muscle cDNA microanay. For example, the clone tracking 
system included in the microarray construction process had not been established until the 
microaiTay printing was finished. Owing to lack of practical experience, the importance of 
building a clone tracking system at a much earlier stage had not been fully realised when the 
sequencing efforts had been made as quality assurance for identifying 140 cDNA inserts, which
1 0 2
were later used for the microaiTay incorporation. The clone tracking system was not established 
for the 140 cDNA fragments. Consequently, it is impossible to correlate the sequence 
information on the 140 DNA fragments with spot locations on the completed porcine cDNA 
micro array. One other experience was also gained during the colony hybridisation and clone 
selection process for the microarray assembly. The porcine cDNA fi'agments, ranging from 
approximately lOObp to 3kb, were labelled with [a-^^P] using random primers and used as 
radioactive probes subjected to colony hybridisation for clone selection based on signal 
intensities on autoradiograph films. cDNA to be labelled was first denatured and then mixed with 
oligonucleotides of random sequence in the presence of [a-^^P] labelled nucleotide(s) and DNA 
polymerase. These “random oligos” annealed to complementary random sites on the DNA and 
serve as primers for DNA synthesis during which [a-^^P] label was incoiporated. More [a-^^P] 
label was incorporated into longer cDNA fragments than into shorter cDNA fragments. 
Therefore, when a long cDNA fragment and a short cDNA fragment, which had similar gene 
expression levels, were hybridised with their complementary cDNA fragments labelled with [a- 
^^P], stronger signals were seen for the longer cDNA fragments on autoradiogiaph films, whilst 
weaker hybridisation signals were obtained for the shorter cDNA fragments. As colony selection 
was based on signal intensities, some cDNA fragments representing lowly expressed genes must 
have been left out by the colony selection process. Because of the nature of the colony selection 
process, this phenomenon is deemed unavoidable. The results obtained during this study were 
similar to those described in a published literature which showed that, in human adult skeletal 
muscle, the abundance of weakly expressed genes accounts for 63.5% of the total genes, while 
moderately expressed and highly expressed genes account for 27.4% and 9.1% of the total genes 
respectively (Boiloluzzi et al., 2000).
Apart from the experimental knowledge established, different versions of the micro array 
construction process could have been adopted for a similar outcome. In order to increase the 
frequency of occurrence of rare cDNA clones while decreasing the percentage of abundant 
cDNAs in the two porcine skeletal muscle cDNA libraries, subtraction normalisation by 
suppression PCR, or normalisation without subtraction, which is based on re-association kinetics 
can be alternative methods of colony selection (Rink et al, 2002;Patanjali et al, 1991;Soares et 
al, 1994). The approach of subtraction nonnalisation by suppression PCR (also called 
subtractive suppression hybridisation) depends on hybridisation selection with genomic DNA so 
that the relative abimdance of cDNAs would be proportional to the abundance of genes
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complementary to that cDNA in genomic DNA (Byers et ah, 2000;von Stein, 2001). However, 
this method was deemed less suitable for microan'ay clone selection because of its potential to 
exclude lowly expressed non-muscle specific clones. The re-association reaction kinetics 
approach, which is by reassociation of single-stranded library plasmids at relatively low Cot 
[initial concentration of DNA (mol of nucleotide per litre) x time (sec)] to remove highly 
expressed clones, depends on the obseiwation that if cDNA reamiealing follows second-order 
kinetics, rarer species will aimeal less rapidly and the remaining single-stranded fraction of 
cDNA will become progressively more nonnalised during the course of the hybridisation.
2.4.2. DIVERSITY AND REDUNDANCY OF CLONES INCORPORATED 
IN THE PORCINE SKELETAL MUSCLE cDNA MICRO ARRAY
The approach of colony selection based on mRNA relative abundance, although laborious, has 
the capability of reducing the repetition of colonies representing highly expressed genes for 
microarray incoiporation. Sequencing of 140 plasmid DNAs derived from the selected colonies 
contributed to the assurance that the colony selection was appropriate for obtaining diverse 
cDNA fragments, which represented a broad range of different genes. These genes, including 
both the skeletal-muscle-specific gene transcripts and transcripts expressed in other tissues. 
Although the redundancy in the constructed novel microan*ay was diminished by eliminating 
multiple cDNA clones belonging to the same transcript, repetition of some genes (e.g. porcine 
skeletal alpha actin gene, porcine beta-globin gene) was evident in the sequencing results 
presented in Table 2:14.
2.4.3. IMPORTANCE AND NECESSITY OF THE QUALITY ASSURANCE 
PROCESS
The fahrication of microarray in this study included two processes: the main construction process 
and the associated quality assurance process. Due to practical limitation, the main construction 
process was set up with the aim of incoiporating 5,000 to 6,000 cDNAs in the microarray. 
Ideally, this desired number of cDNAs is expected to represent 5,000 to 6,000 different genes, so 
that the microaiTay can be highly representative. However, because no sequence information was 
available on any cDNA insert derived from the two muscle libraries that were used for the
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construction, it was unlikely to avoid the presence of some repeat cDNAs in the microaiTay. The 
efficiency of colony selection detected through dot blot hybridisation for quality assurance has 
contributed in part to the success of this construction project. Although the quality assurance 
steps including restriction enzyme digestion and/or agarose gel electrophoresis were not always 
included in other construction protocols, it was conducted resolutely in this study on 8,250 
samples from thi'ee stages (plasmid DNA extractions, PCR reactions and PCR purifications) to 
monitor the presence of cDNAs in order to complete the micro array of a high quality. Once the 
cDNAs were printed on slides, hybridisation detection with the Cy3 labelled T7 primer target 
was used to monitor the printing process. The two-colour (Cy3 and Cy5) microarray 
hybridisation was used as a first evaluation on the functionality of the micro array.
2.4.4. ADVANTAGES AND WEAKNESSES OF THE MICRO ARRAY 
CONSTRUCTED IN THIS STUDY
The porcine skeletal muscle cDNA microarray fabricated in-house in this study is the first of its 
kind. This microarray, in common with many other cDNA microarrays obtained commercially, 
has a most important advantage of accurately measuring changes in expression levels of a large 
number of mRNA transcripts in tissues or cells. A major advantage of the de novo constructed 
microaiTay is the possession of potential full-length cDNA clones, whose inserts were 
unidirectionally cloned into a CMV-promoter driven expression plasmid (pBK-CMV vector). 
These clones could be readily used for downstream expression studies. Another advantage of this 
microarray is the good maintenance and accurate curation of extensive clone stocks for 
microaiTay fabrication and gene identification. The clone sets were categorised as concentrated 
plasmid DNA, diluted plasmid for DNA synthesis by PCR, and purified PCR products. Clones 
classified into different category were differently labelled whilst all sets of stocks were kept in 
microtitre plates at -20°C with unique identity for each sample. This system makes it possible to 
trace the locations of immobilised cDNA on microarray slides back to the correct plasmids or 
purified PCR products, in microtitre plate. Gene identification could be double-checked with 
different category of stocks to avoid any possible mix-ups. The clone stocks for the micro array 
construction can potentially provide several hundred fabricated slides that would be sufficient for 
various downstream works in skeletal muscle research.
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A possible disadvantage of the constructed porcine micro array, at least at the beginning, is the 
lack of knowledge of the sequence identity of each clone. However, there is, at present, 
insufficient sequence infonnation on faim animals to design a comprehensive oligonucleotide- 
based micro array. As the sequence identity of each clone is largely unknown, it is not known for 
certain how representative the porcine skeletal muscle cDNA micro array is. On the one hand, 
considering that there might be fewer than 30,000 human genomic DNAs (Venter et al., 2001), 
and assuming that 50% of all genes are transcriptionally active at one time in a given tissue 
(Bortoluzzi et al., 2000), it is possible that around 20% of the genes that are expressed in skeletal 
muscle are found on the constructed micro anay (Pietu et ah, 1999; Venter et al., 2001). On the 
other hand, a group of 4080 human skeletal muscle genes, which included both skeletal muscle- 
specific genes and genes expressed in skeletal muscle as well as in other tissues, was found to 
conespond to 80% of the total number of genes expressed in skeletal muscle as reported so far in 
Unigene (including foetal muscle and rhabdomyosarcoma) (Bortoluzzi et ah, 2000). Hence the 
constructed microanay in this project may represent substantially more than 20% of all genes 
expressed in porcine muscle.
2.4.5. POTENTIAL IMPROVEMENTS TO THE MICRO ARRAY 
CONSTRUCTED IN THIS STUDY
Future investigations into gene expression patterns will require microarrays with cDNA 
collections covering most if not all genes expressed in porcine skeletal muscles. In order to 
improve the in-house constructed novel microaiTay for future studies, more recombinant clones, 
containing weakly and moderately expressed cDNAs, can be selected to expand the range of 
different genes represented in the micro array. Continuing effort is being made to identify, by 
sequencing analysis, all the cDNA fragments incoiporated in the current microarray. Moreover, 
genes derived from other developmentally distinct porcine skeletal muscle cDNA libraries (e.g. 
porcine foetus younger than 50 days, and old pigs) can also be included in this microarray.
2.4.6. POTENTIAL APPLICATIONS OF THE MICRO ARRAY AND ITS 
ASSOCIATED CLONE STOCKS
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The porcine cDNA microarray constructed de novo in this study has a wide range of potential 
applications in both industrial and academic research. Industrial research, in which the porcine 
microan'ay can be used, includes meat quality contiol for food production, animal selection for 
breeding, and the effects of nutrition on the amount and type of fat in meat. For example, the 
porcine micro array can be used to characterise expression levels of known and unknown genes 
that associate with particular muscle quality traits, such that specific type of animals can be 
selected based on levels of gene expression. Comprehensive gene expression analysis with the 
porcine microarray can potentially provide valuable information about various biological 
processes, such as alterations in skeletal muscle stmcture and function as consequences of 
different stimuli that modify skeletal muscle contractile activity, changes in gene expression 
under different metabolic status (e.g., different hormone treatment; different type of nutrition), 
differences at the molecular level between normal and diseased skeletal muscle tissues, and 
among patients. The transcriptional signalling pathways and the differential gene expression 
evens involved in these processes can be further recognised using the porcine microaiTay. 
Potential utilisation of the porcine microanay also includes the development and validation of 
new dmgs for treatment of skeletal muscle diseases, the identification of drug targets by profiling 
gene expression of diseased skeletal muscle, and examination of drug side effects on skeletal 
muscle (e.g. drug toxicity). Therefore, with the porcine skeletal muscle cDNA micro array, the 
response of a large percentage of the skeletal muscle genome to exercise training, inactivity, and 
dmg treatment is expected to be further characterised.
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CHAPTER THREE
DIFFERENTIAL GENE EXPRESSION 
IN RED AND WHITE 
PORCINE SKELETAL MUSCLES
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3.1. INTRODUCTION
Skeletal muscle is composed of heterogeneous fibre types that vary in contraction velocity, 
endurance capability, and metabolic enzyme profile. Skeletal muscle also displays a remarkable 
ability to adapt at the gene level to alter its structure in response to the demand placed on muscle. 
Two extremes of skeletal muscle phenotype are the red, oxidative, slow twitch muscle, usually 
employed in a postural role, and the white, glycolytic, fast twitch muscle, which generally has a 
locomotive role (Pette and Staron, 1990;Schiaffino and Reggiani, 1996). The physiological 
differences between red and white muscle have been reviewed in chapter one. The molecular 
mechanisms underlying these differences have so far not been fully discovered. Understanding 
the molecular processes that regulate skeletal muscles fibre-type is of agricultural and medical 
importance, hi agiiculture, for example, because skeletal muscle fibre characteristics are key 
determinants of meat quality, molecular insights into factors that affect pig muscle traits are 
necessary for developments to improve meat quality and production (Essén-Gustavsson, 
1993;Karlsson et al., 1999). In medicine, for example, the metabolic profile of red and white 
muscle may show the development and progi'ession of cluonic disease, hidividuals with a higher 
percentage of red fibres are less likely to have chronic metabolic syndromes, such as insulin 
resistance (Hickey et al., 1995; Kiiketos et al, 1996), glucose intolerance (Toft et al, 1998), type 
2 diabetes (Nyholm et al, 1997), obesity (Helge et al, 1999; Kiiketos et a l, 1997; Storlien et al, 
1996), and a blood lipid profile associated with an increased risk of cardiovascular disease 
(Tikkanen et al, 1991). The ability to study gene expression differences with DNA microarrays 
may enable researchers to determine those genes responsible for the diversity of muscle fibre 
composition. The main purpose of the study of red and white muscle microarray analysis was to 
detect the effectiveness of the novel porcine skeletal muscle cDNA micro array for high 
throughput gene expression profiling. The study aims to develop a gene expression profile of 
white and red muscles in pigs to gain a better understanding of gene regulation that underlies the 
differences between muscle fibre types.
3.2. MATERIALS AND METHODS
3.2.1. MATERIALS
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3.2.1.1. Porcine tissues
The red and white muscle microarray differential gene expression analysis was carried out using 
the psoas muscle, which was red muscle, and the longissimus dorsi (LD) muscle, which was 
white muscle, of a 22-week-old Berkshire pig named pig 130. Previous study demonstrated that 
over 90% of psoas muscle fibres were red muscle fibres (da Costa et al., 2002;da Costa et al., 
2003), whilst over 90% of longissimus dorsi muscle fibres were white muscle fibres (da Costa et 
al., 2002;da Costa et al., 2003). Psoas muscles and longissimus dorsi muscles taken from another 
thi'ee 22-week-old Berkshire pigs (pig 1, pig 2, and pig 3) were used in real-time quantitative 
reverse transcription polymerase chain reaction (RT-PCR) for validation of expression levels of 
specific genes, which were identified as differentially expressed in the microaiTay analysis. 
These four pigs (pig 130, pig 1, pig 2, pig 3) were intact males reared under identical husbandry 
and feeding conditions. These pigs were individually fed (20% protein, 14 megajoules/digestible 
energy/kg with 1.14% lysine) twice a day at 90% of the predicted adlib feed intake based on 
body weight. Bach type of muscle was sampled from the same anatomical sites of each animal 
within 30 minutes of slaughter, frozen in liquid nitrogen, and stored at -80°C until further 
processing (da Costa et ah, 2002;da Costa et al., 2003). In addition, eight different porcine 
tissues including psoas muscle, longissimus dorsi muscle, heart, brain, uterus, kidney, liver and 
spleen were taken from of a 7-weeks-old commercial hybrid pig (pig 4) h om a local fann. These 
eight different porcine tissues were used in real-time quantitative RT-PCR for examination of 
expression levels of specific genes in these tissues.
3.2.1.2. Commercial kits, reagents and software
Most of the commercial kits and reagents used in this study are detailed in Tahle 3:1. Other 
materials used have been listed in chapter two, or are described under “Methods” below. 
Commercial software used in this study is detailed in Table 3:2. The ImaGene'^'^ version 4.2 
software (BioDiscovery) was used for automating the process of measuring and visualising gene 
expression level in microarray image analysis. The GeneSpring'^'^ version 4.2 software (Silicon 
Genetics) was used for performing statistics and ratio operations in micro array data mining. The 
ABI PRISM' '^^ Primer Express version 1.5 software (Applied Biosystems) was used for 
designing primers and probes used in real-time quantitative RT-PCR.
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Table 3:1 Commercial kits and reagents
Commercial kit and chemical reagent Use of the kit
Dynabeads® mRNA DIRECT™ kit 
(Dynal LTD)
mRNA extraction from skeletal muscle tissues or 
cells
CyScribe First-Strand cDNA labelling kit 
(Amersham Pharmacia Biotech)
Synthesis and cyanine dye labelling of single­
stranded cDNA
Micro Bio-Spin® Chromatography Columns 
(BIO-RAD Laboratories)
Purification of nucleic acids and proteins (In this 
study, these columns were used during the 
calcineurin cellular activity assay.)
AutoSeq G-50 columns 
(Amersham Phannacia Biotech)
Purification of cyanine dye labelled target cDNAs 
prepared for microarray hybridisation.
GHB-200 2x microarray hybridisation 
buffer (Genpak)
Microarray hybridisation.
TaqMan® Universal PCR Master Mix 
(Applied Biosystems, Roche)
Real-time quantitative RT-PCR amplification.
ABI Prism BigDye Terminator v3.0 
Cycle Sequencing Reaction Kit 
(Applied Biosystems)
Sequencing PCR.
Perfoima® DTR (Dye Tenninator Removal) 
Gel Filtration Cartridge
Removing dye terminators, dNTPs, and other low 
molecular weight materials fr om sequencing 
reactions before loading PCR products onto ABI 
PRISM™ 3100 Genetic Analyser for sequencing.
Table 3:2 Software used in micro array expression analysis and real-time quantitative RT-PCR
Software Use of software Manufacturer
hnaGene'^'^ 
version 4.2
For automating the process of measuring 
and visualising gene expression level in 
microan-ay image analysis
BioDiscovery, Inc.
GeneSpring"^^ 
version 4.2
For performing statistics and ratio 
operations in microanay data mining
Silicon Genetics
ABI PRISM' '^^ Primer 
Express version 1.5
For designing primers and probes used in 
real-time quantitative RT-PCR
Perkin Elmer, 
Applied Biosystems
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3.2.2. METHODS
The experimental design (Figures 3:1 and 3:2) of this study was to use mRNAs from skeletal 
muscle tissues to generate fluorescent dye labelled cDNA samples (termed targets), which were 
subsequently hybridised to the cDNA sequences (termed probes) of the porcine cDNA 
microanay. The hybridisation images were processed, and the data was normalised and 
analysed.
3.2.2.I. Preparation of target cDNA samples for microarray hybridisation
3.2.2.LL First strand cDNA synthesis and fluorescent dye labelling
All skeletal muscle samples used for isolation of mRNA were frozen in liquid nitrogen. Red 
muscle {psoas muscle) and white muscle {longissimus dorsi muscle) mRNAs were extracted 
separately from pigl30 using Dynabeads® mRNA DIRECT™ kit (Figures 3:1 and 3:3). The 
mRNA extraction was as described in chapter two (section 2.2.2.2.2.). At the beginning of each 
mRNA extraction, 50 mg frozen skeletal muscle tissue was weighed, homogenised and used for 
the extraction. At the final stage of each mRNA extraction, 21 pi of 10 mM Tris-HCl (pH 7.5) 
was used to elute the mRNA from the Dynabeads® oligo (dT)2s. Concentration of the 21 pi 
mRNAs from each extraction reaction was estimated to be about 20-25 ng/pl by comparing 1 pi 
extracted mRNA with 1 pi 50 ng/pl 1 kb ladder DNA on agarose gel containing ethidium 
bromide (Fig. 3:3). Single-stranded cDNA synthesis and target labelling were performed on red 
and white muscle mRNAs using a CyScribe First-Strand cDNA labelling kit (Amersham 
Pharmacia Biotech). To anneal the oligo(dT) and random nonamer primers to muscle mRNA, 9 
pi (about 180-225 ng) muscle mRNA, 1 pi random nonamers and 1 pi anchored oligo(dT) were 
added into a sterile ribonucleases-free 1.5 pi micro centrifuge tube, and mixed gently by pipetting 
up and down. The mixture was incubated at 70°C for 5 minutes in a water bath (Grant 
Instruments Ltd), and then left at room temperature for 10 minutes to allow random nonamer 
primers to amieal to the mRNA template. The mixture was then centrifuged for 30 seconds using 
a Heraeus Biofuge Pico microcentrifuge. Following annealing step, 4 pi CyScript buffer (5x 
concentration), 2 pi 0.1 M dithiothreitol (DTT), 1 pi dCTP CyDye-labelled nucleotide, 1 pi 
nucleotide mix and 1 pi CyScript reverse transcriptase were added to the annealed
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Figure 3:1 Steps taken for the red and white muscle microan*ay hyhridisation
The hybridised microarray slides 
were scanned using an 
Affymetrix 428^^ Array Scanner
Extraction of red muscle mRNA Extraction of white muscle mRNA
Red muscle (psoas muscle) White muscle (longissimus dorsi 
muscle)
22-weeks-old pig 130 (Berkshire breed)
Purified, single-stranded, 
red muscle cDNAs were labelled 
with fluorescent CyDye
Purified, single-stranded, white 
muscle cDNAs were labelled with 
fluorescent CyDye
Cy3 labelled red muscle cDNA and Cy5 labelled white muscle cDNA 
(or CyS labelled red muscle cDNA and Cy3 labelled white muscle cDNA) 
were mixed to form target mixture
The replicated, dye-swap paired target mixtures were 
hybridised to seven porcine skeletal muscle cDNA 
microarray slides
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Figure 3:2 Procedures for microarray image processing, data mining and validation
Two data files 
(Cy3 file and Cy5 
file) obtained from 
each slide
Seven hybridised microarray 
slides were scanned using an 
Affymetrix 428^”^ Array Scanner
Data obtained from 
image qnantification
Data obtained 
from 
data analysis
Validation of data 
obtained from 
microarray
Sequencing data
List of genes 
identified
Sequencing analysis 
using ABI PRISM™ 3100 Genetic Analyser
Image processing and quantification 
using ImaGene™ version 4.2 software
Data analysis 
using GeneSpring™ version 4.2 software
Real-time quantitative RT-PCR 
using ABI PRISM™ 7700 sequence detector
Standard nucieotide-nucleotide 
BLAST [blastn] searches
j
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template mRNA in the 1.5 ml microcentrifiige tube which was placed on ice. The final volume 
of the cDNA synthesis reaction was 20 pi. The reaction components were mixed by vortexing, 
then centrifuged for 30 seconds, and followed by incubation at 42°C for 1.5 hours in a water 
bath.
3.2,2.1.2. Target cDNA Purification
It was necessary to remove unincorporated mRNAs from the synthesised cDNAs by purification 
to promote hybridisation of target cDNAs to immobilised microan*ay probes whilst minimising 
hybridisation with complementary mRNAs. Removal of unincorporated cyanine dye labelled 
nucleotides (e.g. primers) was necessary for minimising hybridisation background and 
improving detection sensitivity of targets of low abundance, hi order to purify target cDNAs, 
mRNA was degraded into short oligomers. The short oligomers and unincoiporated nucleotides 
were then removed by spin column cliromatogiaphy. To degrade mRNA into short oligomers, 2 
pi of 2.5 M NaOH was added into each 20 pi labelling reaction, mixed by vortexing, centrifuged 
for 30 seconds, and then incubated at 37°C for 15 minutes. In order to neutralise all components 
of the mRNA degradation reaction, 10 pi of 2 M HEPES free acid was added to each reaction 
solution, mixed by vortexing, and then centrifuged for 30 seconds. At this stage, 32 pi solution 
was obtained for each target cDNA labelled with cyanine dye. Following centrifugation, 
AutoSeq G-50 columns (Amersham Phannacia Biotech) containing Sephadex G-50 DNA gi'ade 
F were used to remove nucleotides and short oligomers from the cyanine dye labelled single­
stranded target cDNAs. The resin in each AutoSeq G-50 column was re-suspended by vortexing 
gently. The cap of each column was loosened a quarter of a turn, and the bottom closure of each 
column was snapped off. The columns, which had been placed in a 1.5 ml screw-cap 
microcentrifuge tube for support, were centrifuged at 2000 xg for 1 minute. Following 
centrifugation, each AutoSeq G-50 column was placed in a new 1.5 ml microcentrifiige tube and 
used immediately for target purification to avoid drying of the matrix. The 32 pi solution of 
target cDNAs was applied slowly to the centre of angled surface of the compacted resin bed in 
each AutoSeq G-50 column. The columns were then centrifuged for 1 minute at 2000x g. The 
purified cDNAs were collected at the bottom of the 1.5 ml microcentrifiige tubes. A final volume 
of 32 pi was obtained for each purified target cDNAs.
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3.2.2.1.3. Dye-swap pairing
Following purification, dye-swap pairing was performed for the cyanine dye labelled target 
cDNAs. Sixteen microlitres of Cy3 labelled psoas muscle cDNAs and 16 pi of Cy5 labelled 
longissimus dorsi muscle cDNAs were mixed with 1.0 pi (S.Opg/pl) of poly (dA) 
oligonucleotide (27-7836, Amersham). The mixture was heated at 95°C for 2 minutes, and then 
mixed with 33 pi of 2x hybridisation buffer (GHB-200, Genpak) to obtain a final volume of 66 
pi. The same procedure was carried out for pairing Cy5 labelled psoas muscle cDNAs and Cy3 
labelled longissimus dorsi muscle cDNAs. The dyes, Cy3 and Cy5 are frequently paired because 
they are widely separated in their excitation and emission spectra, allowing highly discriminating 
optical filtration during microarray image capture. Most cDNA microarray experiments show 
systematic differences in the red and green fluorescent intensities, namely, overall cDNA spots 
on a micro array exhibit higher fluorescent intensity when incorporated with one dye or the other, 
regardless of the target sample under study. The red-green bias is due to differences between the 
labelling efficiencies and scanning properties of the two fluorescent dyes (Cy3 and Cy5). In this 
study, it was anticipated that the replicated dye-swap pairing method adopted by this study 
would help to reduce systematic colour bias of fluorescent dyes.
3.2.2.2. Microarray hybridisations
Prior to pre-hybridisation, microarray cDNA fi'agments immobilised on glass slides were 
denatured at 95°C for 2 minutes by immersing the micro array slides in heated distilled water. 
Pre-hybridisation was then perfoiined at 65°C for 20 minutes in a plastic 2-slide holder 
containing 15 ml of 3x SSC (sodium chloride and sodium citrate), 2% bovine serum albumin 
(B4287, Sigma) and 0.1% SDS. After a brief rinse in distilled water at room temperature, the 
slides were dehydrated in absolute ethanol and centrifriged at 100x g for 2 minutes. At this stage, 
the microarray slides were ready to be used for microarray hybridisations. With the red and 
white muscle fluorescent-dye-tagged cDNA targets, which were not quantified, seven replicate 
microaiTay hybridisations were completed, with the dye assignments reversed in thi’ee of them. 
Each microaiTay slide was layered with 33 pi of hybridisation mixture, then covered with a 22 
mm X 64 mm BDH cover glass to exclude air bubbles, and placed in a hybridisation chamber 
(Aii’aylt hybridisation cassette AHC-1). Although 1-2 pg target mRNA was used for each 
cyanine dye labelling reaction (section 3.2.2.1.1. of this chapter), only 0.5-1 pg target mRNA
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was needed for each microarray slide. The hybridisation reaction was incubated in a dry 
incubator at 45°C for 24 hours. Following incubation, the microarray slides were washed gently 
to remove as much as possible the unbound and non-specifically bound target cDNAs. The slides 
were washed once in a 300 ml of solution containing Ix SSC and 0.2% SDS for 10 minutes at 
45°C, twice in 300 ml of solution containing 0.2x SSC and 0.2% SDS for 10 minutes at 45°C, 
and twice in a 300 ml of solution containing O.lx SSC for 10 minutes at 37°C. The microaiTay 
slides were then dried by centrifugation at lOOx g for 2 minutes and ready for micro array image 
capture.
3.2.2.3. Microarray image capture and quantification
On each hybridised microarray slide, the signal intensity of each spot is proportional to the 
number of dye molecules, and hence the number of probes hybridised with the airay (Byers et 
al., 2000). To obtain information about gene expression levels following hybridisation, each 
hybridised microarray slides were scanned using a MWG Affymetrix 428™ Array Scaimer to 
facilitate measurement of molecular binding events on the array and generate a quantitative two- 
dimensional fluorescence image of hybridisation intensity. This scaimer was a eonfocai laser 
microscope with a flying head, i.e, the objective lens scans over the slide. The resulting 
fluorescence was measured after excitation with two different wavelengths (532 and 635nm) 
corresponding to the dyes used (Bowtell, 1999). The hybridisation intensity information was 
captured digitally and imported to hnaGene'^^ version 4.2 software to extract biological 
information by adding GenelD files, generating grid, and quantifying dyes. Once the image 
processing was completed, the quantified image data were saved/stored automatically in text 
files, which were subsequently imported to GeneSpring™ version 4.2 software to perform data 
analysis.
3.2.2.4. Microarray data analysis
MicroaiTay data analysis, including data normalisation, ratio operation and statistical analysis, 
was conducted using GeneSpring’^ ’^  version 4.2 computer software. The purpose of micro array 
data normalisation was to adjust for any bias which arose from variation in the microanay 
teclmology rather than from biological differences between the target samples or the printed
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probes. It was necessary to normalise the microarray signal intensities before any subsequent 
analysis was carried out (Cui and Churchill, 2003).
In this study, three normalisation steps (per spot, intensity-dependent, and per chip/slide) were 
performed in data mining to achieve data normalisation at gene level (to standardise expression 
levels between genes) and at chip level (to standardise expression values between aiTays). In per 
spot normalisation, after background subtraction, the fluorescent intensity (e.g. Cy3) of each 
clone was divided by its control or reference channel intensity (e.g. Cy5). Values of the control 
channel that fell below 10 were adjusted to 10 prior to taking the ratio between signal and control 
value. Intensity-dependent normalisation, often called non-linear or Localised Weighted 
Regression (LOWESS) normalisation, was applied in this study to correct artefacts caused by 
differential dye incorporation and inconsistency of fluorescence dye intensities. Per chip 
noimalisation was used to take into account intensity variation across the entire slide, by dividing 
the signal strength of a clone on a slide by the percentile signal of all of the measurements 
taken hom the same slide. Chip-wide variations in signal intensity could be due to inconsistent 
washing, inconsistent sample preparation, or microfluidics imperfections. Additionally, the 
GeneSpring Global Error Model, based on the replicate measurement samples of all genes on the 
microarray was applied to estimate differences between medians, the standard errors among the 
different clones, and the extreme tails of the distribution of differences. Differences among 
muscles in expression were standardised for different clones by dividing the difference between 
muscle medians by the square root of the common variance. The Global Error Model is a way to 
estimate the precision/variability of gene expression measurement by combining measurement 
variation and sample-to-sample variation. Measurement variation is the lowest level of 
difference between the expression measurement of a gene on a single chip and the true value that 
would be achieved by a perfect measurement. Sample-to-sample variation, which represents 
biological or sampling variability, is the variation between results of replicate micro array 
hybridisations which are carried out in a same condition (Smyth et ah, 2003;Lee et ah, 2002).
To identify genes that were more highly expressed in the psoas than in the longissimus dorsi, 
clones with normalised psoas/longissimus dorsi ratio of 2.0 or more, and with one-sample t-test 
p-values not more than 0.05 were selected for sequencing. Likewise, clones with a normalised 
psoasllongissimus dorsi ratio of 0.7 or less, and with one-sample t-test p-values not more than 
0.05 were selected for sequencing to identify genes that were more highly expressed in the 
longissimus dorsi than in the psoas, hi the red and white muscle microanay analysis, "Filter
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Genes Analysis tools" of GeneSpring version 4.2 was applied to search for genes that were 
differentially expressed. Genes were filtered by setting normalised psoasllongissimus dorsi ratio 
of 2.0 as minimum fold change to be met, whilst nonnalised psoasllongissimus dorsi ratio of 0.7 
the maximum one. To examine the expression levels of genes in the two phenotypical distinct 
muscles, the "Scatter Plot view" of GeneSpring version 4.2 was applied to represent the 
experiment values plotted against the control values.
3.2.2.5. Sequence analysis to clone identification
Following micro array data analysis, cycle sequencing reaction was performed for each cDNA 
template (see Table 3:5 and 3:6) using the ABI PRISM® BigDye'*’’^  Terminators v3.0 Cycle 
Sequencing Reaction kit (Applied Biosystems), which provided AmpliTaq DNA polymerase, 5x 
sequencing buffer and FS Hi-Di formamide. In a 0.2 ml microcentrifiige tube, 6 pi plasmid DNA 
(about 500 ng), 6 pi sterile ddH20, 4 pi Big Dye (containing AmpliTaq DNA polymerase), 2 pi 
of 5x sequencing buffer, and 2 pi 1.6 pmol/pl primer mixture containing T7 and T3 primers, 
were mixed. The cycle sequencing reaction was perfoimed for 25 cycles. In each cycle, the 
reaction was first incubated at 96 °C for 10 seconds, then at 50 °C for 10 seconds and finally at 
60 °C for 4 minutes. Performa® DTR Gel Filtration Cartridges (EDGE Biosystems) were used 
for purifieation of the cyele sequencing reaction products. Each purified cycle sequencing 
product was resuspended with 25 pi FS Hi-Di formamide. Twenty micro litres of each 
resuspended sample were used for sequencing and loaded onto the ABI PRISM® 3100 Genetic 
Analyser (Applied Biosystems). Sequencing data was collected by using the 3100 Data 
Collection Software version 1.1 (Applied Biosystems). All data obtained from the sequencing 
step was subjected to BLAST (standard nucieotide-nucleotide Basic Local Alignment Search 
Tool) searches for gene identification based on the similarity between the sequences obtained in 
this study with the sequences provided by the database. Sequence information and BLAST 
search results were made available through this web-accessible database 
(http://www.nebi.nlm.nih.gov/BLAST/).
3.2.2.6. Validation of gene expression by real-time quantitative RT-PCR
As microarray data does not provide an absolute measure of gene expression, post-analysis 
validation of microarray gene expression data using real-time quantitative RT-PCR is critical for
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confirming biological significance of specific gene results. Continuous, real-time, fluorescence 
detection of amplification products allows accurate calculation of the quantity of template 
initially present in a sample. During the exponential phase (also called extension phase) of 
amplification, there is a highly reproducible relationship between the initial amount of template 
present in the reaction, and the number of cycles required before a significant increase in 
fluorescence signal is observed. First, the position of the cycle tlueshold line must be defined on 
a graph of “Fluorescence versus Threshold cycle number". The cycle threshold [C(t)] line is 
often positioned at a point where the fluorescent signals surpass background noise and begin to 
increase. The thi'eshold cycle for an individual sample is then defined as the cycle at which the 
sample’s fluorescence trace crosses the cycle thi'eshold line. By including quantitation standards 
with varying initial amounts of template in the run, a standard curve of “Log quantity versus 
Thi'eshold cycle number” can be plotted. The quantity of initial template in unknown samples 
can then be calculated by applying the sample’s threshold cycle to the standard curve. The higher 
the initial amount of target template in real-time RT-PCR process, the fewer cycles required 
before significant fluorescence signal is detected, and the sooner the accumulated product is 
detected. In this study, an arbitrary cycle threshold line was chosen, placed above the baseline 
and within the exponential phase of PCR. The tlueshold cycle value was calculated for each 
reaction by determining the point at which fluorescence generated exceeded this chosen cycle 
tlueshold line/limit. The threshold cycle value was reported as the cycle number at this point 
(Bustin, 2000;Chuaqui et al., 2002).
3.2.2.6.I. Designing primers and probes for real-time quantitative RT-PCR
In real-time quantitative RT-PCR, three oligonucleotides (a forward primer, a reverse primer, 
and a Taqman probe) are used. TaqMan probes (also called hydrolysis probes) are non­
extendible fluorogenic probes, which are designed to anneal to an internal region of a PCR 
product. Each Taqman probe is dual-labelled with a fluorescent reporter dye F AM (6- 
carboxyfluorescein) at 5' end and a quencher dye TAMRA (6-carboxy-tetramethyl-rhodamin) at 
3' end of the sequence. When a Taqman probe is in its free form, the fluorescence of reporter dye 
is absorbed by quencher dye, and prevented from emission. Once Taqman probe aimeal to PCR 
template, the 5' exonuclease activity of Taq polymerase cleave the Taqman probe and separate 
reporter and quencher dye. Reporter dye starts to emit fluorescence which increases in each cycle 
proportional to the quantity of PCR product present. This process occurs every cycle and does 
not interfere with the exponential accumulation of PCR products. TaqMan probe only emit a
1 2 1
fluorescent signal upon cleavage of this prohe by Taq polymerase during exponential phase of 
PCR reaction. Initial amount of mRNA in cDNA template can be quantified by recording 
increase in TaqMan probe fluorescence emission at each PCR cycle, which indicates PCR 
product accumulation. In this study, all primers and TaqMan probes for real-time quantitative 
RT-PCR were designed using the ABI PRISM™ Primer Express software version 1.5 (Perkin 
Elmer Applied Bio systems) (Tables 3:3).
Table 3:3 Primers and TaqMan probes for real-time quantitative RT-PCR
Gene Tm Sequence 5’->3’
58.2°C Primer Sense: CCA GCA CCA TGA AGA TCA AGA TC
porcine 58.0°C Primer Antisense: ACA TCT GCT GGA AGG TGG ACA
(3-actin 63.0°C TaqMan
Probe
Sense: 5' FAM - CCC CTC CCG AGC GCA AGT ACT CC 
- 3' TAMRA
57.5°C Primer Sense: AGG CTC GGG CTC ACT TGA A
GAPDH 57.8°C Primer Antusense: TGC CCA TCA CAA ACA TGG G
62.0°C TaqMan
Probe
Sense: 5’ FAM - AGC CAA AAG GGT CAT CAT CTC 
TGC CC - 3’ TAMRA
59.0°C Primer Sense: CAC TTT AAG TAG TTG TCT GCC TTG AG
MyHC Ilb 58.0°C Primer Antisense: GGC AGC AGG GCA CTA GAT GT
63.OX TaqMan
Probe
Sense: 5’ FAM - TGC CAC CGT CTT CAT CTG GTA 
ACA TAA GAG G - 3 ’ TAMRA
57.3X Primer Sense: GCC AGC AAT GTG CAG AAG AA
bin-1 59.4X Primer Antisense: CAT CTG CCT TCC CCA GTT TC
63.OX TaqMan
Probe
Antisense: 5’ FAM - CCT TCT CCT GCG CGC GAG TGA 
G -3’TAMRA
54.0X Primer Sense: TTT TTT CCA TTC CCT GGT TGA
novel gene 59.4X Primer Antisense: AGG GAC CCT GTA AGC CAA CA
kc2725 64.0X TaqMan
Probe
Sense: 5' FAM - CCA GTC TGG TGG CCT AGT CAT 
GCC C - 3' TAMRA
The choice of probe sequences was made prior to that of primers. All TaqMan probes were 
systhesised by Transgenomic/Cmachem Limited at 100 pmol/pl, and primers by MWG. All 
TaqMan probes were designed to have more cytosines than guanines. The total number of
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guanines and cytosines in each probe was 30-80%. Guanine was avoided at 5' end of all probes 
because a guanine adjacent to reporter dye would have suppressed reporter fluorescence even 
after cleavage. Runs of consecutive identical nucleotides (especially guanine) in all probes were 
avoided. The primers were designed to be 15-30 bases in length. In order to avoid non-specific 
priming due to relative instability of the 3' end of primers, the total number of guanines and 
cytosines in the last five nucleotides at 3' end of all primers was designed not to exceed three. In 
real-time quantitative PCR, ideal length of template sequences are 50-150 bases because PCR 
with shorter template sequences is more efficient and more tolerant of reaction conditions, and 
gives more consistent results. In this study, maximum length of all template sequences was 
designed not to exceed 200 base pairs (bp). In order to avoid false-positive results due to 
amplification of contaminating genomic DNA in the cDNA preparation, primers were designed 
to span exon-exon junctions to avoid the amplification of genomic DNA (Bustin, 2000).
3.2.2,6,2. Selected genesy target templates and endogenous housekeeping gene for normalisation
Real-time quantitative RT-PCR was perfoimed for four selected genes [GAPDH (for 
glyceraldehyde-3-phosphate-dehydrogenase), MyHC Ilb, bin-1 (for box-dependent MYC- 
interacting protein-1) and novel gene kc2725] for validation of gene expression levels in psoas 
and longissimus dorsi muscles derived from four pigs (pig 1, pig 2, pig 3 and pig 4). A reference 
cDNA panel, comprising eight different tissue templates {longissimus dorsi muscle, psoas 
muscle, heart, brain, utems, liver, spleen and kidney) of a 7-week-old pig (pig 4) was used to 
evaluate the quantitative distribution of two selected genes (bin-1 and novel gene kc2725) in 
different tissue templates.
In real-time quantitative RT-PCR, for an ideal quantification, the stail amount of mRNA should 
be the same for all target templates. Normalisation with an endogenous housekeeping gene helps 
to minimise the effects of variations in initial amount of target templates input into real-time RT- 
PCR reaction. An ideal 'housekeeping' gene should be expressed at constant level among 
different tissues of an organism, at all stages of development, and should not be affected by the 
experimental treatment. The most common genes used as a housekeeping gene are [3-actin, 18S 
rRNA (ribosomal RNA) and HPRT (hypoxanthine guanine phosphoribosyl tranferase) (Bustin et 
al., 2000; Rajeevan et al., 2001). Choosing the ideal housekeeping gene for each real-time 
quantitative RT-PCR experiment is very important to ensure the credibility and reproducibility 
of the results. (3-actin is a highly conserved protein ubiquitously expressed in all eukaryotic cells
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as a component of the cytoskeleton and as a mediator of internal cell motility. In this study, in 
order to compare relative gene expression of a same gene between samples, mRNA of P-actin 
was quantified as a standard control to normalise results in real-time quantitative RT-PCR.
3.2.2.6.3. Real-time quantitative RT-PCR
Real-time quantitative RT-PCR was performed in this study using relative standard cuiwe 
method of quantification (da Costa et a l, 2002). In the relative standard cuiwe method, 
comparisons of relative expressions are only made between samples of the same gene, and it is 
considered not appropriate to compare expression levels between two different genes. The 
components of each reaction mixture prepared for real-time quantitative RT-PCR are described 
in Table 3:4. Microamp Optical 96-well reaction plates (Applied Biosystems) were used for 
preparation of the reaction mixtures. The amplification of each reaction was perfoimed in a ABI 
PRISM™ 7700 sequence detector (Perkin Elmer, Applied Biosystems) containing a built-in 
theimal cycler with 96-well positions, and monitored by the sequence detection system version 
1.7 software (Perkin Elmer, Applied Bio systems). The real-time RT-PCR reaction mixture was 
first incubated at 50°C for 2 minutes, and then denatured at 95°C for 10 minutes. After 
dénaturation, 40 cycles of the amplification were performed for each target template with each 
cycle started at 95°C for 15 seconds and followed by incubation for one minute at 60°C.
Table 3:4 Reaction mixture prepared for Real-time quantitative RT-PCR
Reaction content Volumn
cDNA template derived from skeletal muscle tissue 5.0 pi
Probe (5 pmol/pl) (Cruchem) 1.0 pi
TaqMan™ Universal PCR Master Mix (Applied Biosystems) 12.5 pi
W4502 sterile double distilled H2O for molecular biology (Sigma) 1.5 pi
Sense primer (900 nM) (MWG) 2.5 pi
Antisense primer (900 nM) (MWG) 2.5 pi
Total volume for each reaction 25.0 pi
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3.3. RESULTS
3.3.1. RED AND WHITE MUSCLE MICROARRAY ANALYSIS
To evaluate the performance of the porcine skeletal muscle cDNA microarray, a profiling 
experiment was conducted to determine the differential expression of genes between red {psoas) 
and white {longissimus dorsi) muscle. Replicated, dual-colour hybridisations (e.g., Fig. 3:4) were 
performed on seven identical porcine cDNA microarray slides. The expression profile of all 
clones represented on the microarray after hybridisation can be visualised as an Imagene scatter 
plot. In the Imagene scatterplot images (e.g.. Fig. 3:5) that plotted the expression of each clone in 
the psoas muscle against the expression of the same clone in the longissimus dorsi muscle, each 
point is the urmormalised value from only one slide, hi the GeneSpring scatterplot image (Fig. 
3:6) that plotted the median expression of each clone in the psoas muscle against the median 
expression of the same clone in the longissimus dorsi muscle, each point is the median of 14 
nonnalised values (2 replicates per slide, 7 slides per muscle). Most points cluster around the 
middle line indicating similar levels of expression in both muscles. There were, however, a 
number of clones falling substantially below the middle line, indicating consistently lower levels 
of expression in the psoas compared with the longissimus dorsi muscle. Low signal readings for 
both dyes may indicate the absence of a cDNA insert. About 12% of the printed clones were 
found to fall below 50 arbitrary units for both dyes (according to GeneSpring analysis) and were 
considered to be without cDNA inserts. This value was consistent with the earlier estimate of 
insertless clones in the cDNA libraries.
3.3.1.1. Genes more highly expressed in psoas red muscle
A normalised psoasllongissimus dorsi ratio of 2.0 or more (P<0.05) was used as data mining 
selection criterion to identify genes that were more highly expressed in psoas than in longissimus 
dorsi muscle. This ratio represents the top 5% of differences in expression. Seventy clones 
meeting this criterion were sequenced. The sequences were compared with database sequences 
by BLAST searching. Table 3:5 is a summary of these genes identified. All the listed genes are
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.TMFigure 3:4 Imagene' 
processed image of red-white 
muscle microarray 
hybridisation
Psoas muscle target was labelled with the red 
colour Cy3
Longissimus dorsi muscle target was labelled 
with the green colour Cy5
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Figure 3:5 Imagene'^ 
scatterplot demonstrating 
differential gene expression in 
red and white muscles
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T able 3:5 Genes more highly expressed in psoas red muscle than in longissimus dorsi (LD) white
muscle
Gene PsoasILD Homology # o f
clones
Accession #
Mitochondrial Origin
16S ribosomal RNA 2.07 97%(P) 12 AY011178
12S ribosomal RNA 2.18 100%(P) 7 AY012145
28S ribosomal RNA 2.67 99%(BR) 1 VO 1270
Ribosomal protein S29 4.14 94%(B) 1 U66372
Ribosomal protein L23 30.05 92%(H) 1 NM_000978
Cytochrome oxidase subunit I 2.03 86%(B) 2 AF490529
Cytoclii'ome oxidase subunit III 2.28 81%(SA) 1 AF030272
Cytoclirome oxidase subunit Vic 27.97 88%(H) 1 NM_004374
Cytochrome oxidase subunit VIb 2.51 96%(B) 1 X15112
NADH dehydrogenase subunit 2 2.51 77%(SW) 1 AF414121
NADH dehydrogenase subunit 3 2.58 82%(B) 7 AY052631
NADH dehydrogenase subunit 6 2.15 81%(B) 4 AF416451
NADH dehydrogenase subunit B15 2.34 87%(B) 1 X64898
ATP synthase protein 6 2.1 96%(P) 2 AF190B13
ATP synthase protein 8 2.17 100%(P) 1 AF039170
ATP synthase protein 9 20.55 96%(H) 1 NM_001689
tRNA 3.87 97%(P) 2 AF304202
Adenine nucleotide translocator SLC25A6 
Non-Mitochondrial Origin
2.05 92%(H) 1 XM__114724
Non-Mitochondrial and sarcomeric/structural
Ankyrin 1 2.23 93%(H) 1 XM_016774
Tubulin alpha 1 2.68 94%(H) 1 AF14147
Non-Mitochondrial and non-sarcomeric
Pituitary tumor-transforming 1 interacting protein 
(tr)
2.98 84%(H) 1 BC031097
Par-6 partitioning defective 6 homolog gamma 
(tr)
30.36 92%(HM) 1 XM_129044
TAFII140, a novel TAP component (TATA- 
binding protein associated factors) (tr)
2.16 94%(H) 1 AJ292190
STAR transcriptional activator (tr) 2.15 88%(H) 1 NM_003442
Prefoldin subunit 6 (KE2 protein) (tl) 2.65 85%(HM) 1 M65255
EH domain-binding protein, Epsin (s) 2.23 93%(H) NM„013333
Beta-catenin (s) 2.18 100%(P) 1 AB046171
Casein kinase 2, alpha 1 polypeptide (s) 6.47 87%(H) 1 NM_001895
Small muscle protein (smpx) (s) 7.34 88%(H) 1 BC005948
Tyi'osine kinase 9-like (A6-related protein) (s) 2.04 90%(H) 1 BCO16452
Fructose-1,6-biphosphatase (m) 25.07 92%(DR) 1 AJ272520
Testis intracellular mediator protein (PEAS) 
(kc3978) (u)
2.12 88%(H) 1 BC021546
Hypothetical protein (FLJ12666) (kc5959) (u) 2.23 93%(H) 1 NM_024595
Unknown small protein (kcl564) (u) 3.93 94%(H) 1 BC005398
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Unknown clone (kc2725), homologous to 3' 
untranslated region (UTR) of RNA binding 
protein SI (u)
Unknown clone (kc542), homologous to 3' UTR 
of enhancer of rudimentary (u)
Unknown clone (kc797), homologous to Homo 
sapiens clone KIAA0513 (u)
Unknown clones (kc2668, kc522, kc2469) (u)
2.57
2.07
13.21
3
90%(H)
81%(H)
81%(H)
XM_028847
U66871 
NM 014732
Possible involvement: (tr), transcriptional; (tl), translational; (s), signalling; (m), metabolic; (u), 
unknown. Accession # refers to porcine gene or close homologue: (P) -  Porcine, (H) = Human, 
(HM) = House mouse, (DR) = Demestic rabbit, (SA) = Shaggy antelope, (SW) = Sperm whale, 
(BR) = Brown rat, (B) = Bovine.
categorised into two groups: mitochondrial origin and non-mitochondrial origin. The non- 
mitochondrial origin category is divided into sarcomeric/structure genes and non-sarcomeric 
genes. Sixty seven percent of the clones (47 out of 70) sequenced were genes of mitochondrial 
origin. Of these several were featured more than once on the microarray, namely genes encoding 
16S ribosomal RNA, 12S ribosomal RNA, and NADH dehydrogenase subunits 3 and 6. One of 
the well established distinguishing features of red muscle is its relatively high oxidative 
phosphorylation capacity, reflected by an abundance of mitochondria in red muscles. It is 
therefore not surprising that the mitochondrial genome was well represented in the identified 
population of differentially expressed clones in the psoas red muscle. Thirty percent of the 
clones (21 out of 70) did not show any homology with known mitochondrial or sarcomeric genes 
in the database. These clones were categorised as non-mitochondrial and non-sarcomeric genes. 
The function of 9 of these clones was completely unknown. The 9 clones included kc3978, 
kc5959, kcl564, kc2725, kc797, kc542, kc2668, kc522 and kc2469 (Table3:5). Of the 21 genes 
in the non-mitochondrial and non-sracomeric category, one gene encoded for fructose-1,6- 
biphosphatase, an enzyme that is necessary for muscle gluconeogenesis. The function of the 
remaining 11 clones, which represented 10 different genes, was involved with aspects of 
transcription, translation or signal transduction, but their functions in skeletal muscle have not 
been characterised. These 10 genes encoded 10 different proteins including pituitary tumor- 
transfoi*ming 1 interacting protein, par-6 partitioning defective 6 homolog gamma, TATA- 
binding protein associated factor, STAF transcriptional activator, prefoldin subunit 6, EH 
domain-binding protein, beta-catenin, alpha 1 polypeptide of casein kinase 2, small muscle
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protein and tyi'osine kinase 9-like A6-related protein. Of these 10 different genes, three genes, 
which encoded alpha 1 polypeptide of casein kinase 2, small muscle protein and tyiosine kinase 
9-like A6-related protein, were members of the casein kinase 2 signalling pathway. The al 
subunit of casein kinase 2 (CK2) is one half of the holoenzyme (Blanquet, 2000;Faust and 
Montenarh, 2000). The small muscle protein (smpx) is encoded by a recently discovered X- 
linked stretch response gene (Kemp et ah, 2001). The tyi'osine kinase A6-related protein binds 
ATP and actin, and interacts with protein kinase C zeta (Rohwer et ah, 1999). Although the 
function of the latter two proteins is not known, both were shown to be targets of CK2 
phosphorylation. The normalised psoas/longissimus dorsi ratios of five genes listed in Table 3:5 
were above 20. The proteins encoded by these five genes were ribosomal protein L23, 
cytochrome oxidase subunit Vic, ATP synthase protein 9, par-6 partitioning defective 6 homolog 
gamma, and fructose-1,6-biphosphatase. The uncharacteristic high psoas/longissimns dorsi ratio 
could be due to low signal intensities or high levels of noise, which could lead to the occurrence 
of the false positive.
3.3.1.2. Genes more highly expressed in longissimus dorsi white muscle
When the data mining criteria of a normalised psoasllongissimus dorsi ratio of 0.5 or less 
(P<0.05), equivalent to longissimus dorsi/psoas ratio of 2.0 or more (P<0.05), was applied, only 
10 significant clones were detected. When the selection criteria were relaxed, clones with a 
normalised psoasllongissimus dorsi ratio of 0.7 or less (P<0.05), which represented the most 
extreme 5% of clones were identified. Forty-five clones were sequenced and examined for 
homology by BLAST searching. Table 3:6 lists the genes that were more highly expressed in the 
longissimus dorsi than in the psoas. All the listed genes are categorised into two groups: 
mitochondrial origin and non-mitochondrial origin. The non-mitochondrial origin are divided 
into sarcomeric/stmcture and non-sarcomeric. Only 4 out of 45 clones listed in Table 3:6 were of 
mitochondrial origin, and they were different hom those expressed more abundantly in the 
psoas. Fast isofoiins of sarcomeric structural proteins (myosin heavy chains [MyHCs] Ila, fix, 
Ilb, myosin regulatory light chain 2, a-actinin 3, fast troponin C, and fast troponin T3) were well 
represented amongst the sequenced clones identified to be more highly expressed in longissimus 
dorsi muscle. Sarcomeric/structural genes made up nearly half of the total clones (22 out of 45) 
listed in Table 3:6. The other highly represented gimip of genes on the list (11 out of 45 clones) 
were involved in anaerobic glycolysis, such as glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), SERCA, phosphoglycerate kinase, phosphoglucomutase, muscle glycogen
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Table 3:6 Genes more highly expressed in longissimus dorsi (LD) white muscle than in psoas red
muscle
Gene LD/Psoas Homology # o f
clones
Accession #
Mitochondrial Origin
Ribosomal protein L35A 2.2 86%(H) 1 AK055653
Ribosomal protein L7a 1.85 90%(H) 1 BC005128
Ribosomal protein S23 1.91 88%(BR) 1 X77398
Ribosomal protein S12 
Non-Mitochondrial Origin
1.61 100%(P) 1 X79417
Non-Mitochondrial and sarcomeric /structural
Myosin heavy chain fast Ila 1.91 100%(P) 6 AB025260
Myosin heavy chain fast IIx 1.77 100%(P) 2 AB025262
Myosin heavy chain fast Ilb 1.88 97%(P) 2 AB025261
Myosin regulatory light chain 2 2.95 91%(H) 2 AF363061
Alpha actinin 3 1.47 93%(H) 2 M86407
S-nexilin 1.77 70%(H) 1 AK057954
Fast skeletal troponin C 1.67 94%(DR) 1 Y00760
Fast skeletal troponin T (TnT3) 1.7 93%(B) 3 AB085599
Alpha-1 skeletal actin (ACTAl) 1.53 93%(H) 2 BC012597
Alpha-2 smooth muscle actin (ACTA2) 1.62 96%(H) 1 BC017554
Non-Mitochondrial and non-sarcomeric
Sarcoplasmic/endoplasmic reticulum calcium 
ATPase 1 (SERCAl) (g)
1.54 98%(P) 3 AY027797
Aldolase A (g) 1.47 87%(H) 1 BCO 10660
Phosphoglycerate kinase (g) 1.48 88%(H) 1 V00572
Glyceraldehyde-3-phosphate dehydrogenase (g) 1.53 100%(P) 1 X94251
Muscle pyruvate kinase (PKM2) (g) 1.63 91%(H) 1 BC007952
Phosphoglucomutase isoform 2 (PGM) (g) 1.81 94%(DR) 1 M97664
Muscle glycogen phosphorylase (g) 1.65 92%(DR) 2 X04265
Adenylate kinase isozyme 1 (myokinase) (g) 1.51 87%(P) 1 E03007
Calsequestrin (c) 1.7 83%(DD) 2 J03766
Polyubiquitin (tl) 1.51 90%(DS) 1 AF038129
Bridging-integrator protein-1 (binl) (s) 2.17 85%(H) 1 AF001383
Myomegalin-like protein (kc) (u) 6.94 94%(H) 1 AB042557
Heat shock cognate protein (HSPA8) (kc) (tr) 1.77 93%(B) 1 X53827
Unknown clone (kc), homologous to Homo 
sapiens clone HSPCO40 (kc4590) (u)
2.08 86%(H) 1 BC000810
Unknown clone (kcl362), homologous to 3' UTR 
of Homo sapiens actin bundling protein (kc) (u)
1.99 77%(H) 1 U09873
Associated or possible role: (g), glycolysis; (c), contraction; (tr), transcription; (tl), translation; (s), 
signalling; (u), unknown. Accession # refers to porcine gene or close homologue: (P) = Porcine, 
(B) = Bovine, (H) = Human, (DR) = Demestic rabbit, (DS) = Domestic sheep, (BR) = Brown rat, 
(DD) = Domestic dog.
132
phosphorylase, aldolase, adenylate kinase, and muscle pyruvate kinase. White muscles comprise 
predominantly more fast-glycolytic fibres than red muscles. In this study, most of the 45 clones 
listed in Table 3:6 were either fast isoforms of structural genes, or enzymes connected with 
anaerobic glycolysis, and these findings were consistent with expectations. The function of two 
non-sarcomeric genes (kcl362, kc4590) was completely unknown. A few candidate regulatory 
genes (binl, polyubiquitin, myomegalin-like, calsequestrin, and HSPA8) were also found. Of 
particular interest is the tumour suppressor gene binl (Sakamuro et âl., 1996;Tsutsui et al., 1997; 
Wechsler-Reya et al., 1998), which has recently been shown to play a role in C2C12 myoblast 
differentiation (Wechsler-Reya et al., 1998). Myomegalin-like gene, which predominantly 
expressed in heart, is also expressed in skeletal muscle. Although precise function of the 
myomegalin-like gene is still unknown, it could play a role in heart development (Soejima et al., 
2001). Calsequestrin, which was identified as more highly expressed in longissimus dorsi white 
muscle than in psoas red muscle, is the major Ca^^-binding protein in the sarcoplasmic 
reticulum. Polyubiquitin is ATP-dependent selective degradation of cellular proteins. Heat shock 
proteins are transcription factors, the main function which is to control the accurate folding and 
translocation of polypeptides at different cellular compartments (Maitra et al., 2002).
Therefore, the use of the newly assembled porcine skeletal muscle cDNA micro array to study 
differential expression of muscle genes between red and white muscles had generated two 
distinct lists of differentially expressed genes (Tables 3:5 and 3:6). The microaiTay results 
correctly exemplified genes that are known to be more highly expressed in only one muscle type. 
With highly expressed genes, such as mitochondrial genes and structural genes, there were 
detectable levels of redundancies (repeats) on the micro array. Reassuringly, in the presence of 
redundancies, no gene was found to be present on both lists. Crucially, this work has identified a 
number of candidate regulatory genes, which may play key roles in determining muscle 
phenotype.
3.3.2. VALIDATION OF GENE EXPRESSION BY REAL-TIME RT-PCR
To assess the validity of the micro array approach to identify differentally expressed genes, 
quantitative real-time RT-PCR (TaqMan) was performed on four representative clones (GAPDH, 
MyHC Ilb, bin 1 and a novel gene kc2725), each normalised to (3-actin. Bin 1 was identified by
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microarray analysis as being more highly expressed in the longissimus dorsi than in the psoas 
(Fig. 3:7). However, this pattern of gene expression was found in only 3 (pig 1, 3, and 4) out of 4 
pigs. In pig 2, there was no significant difference in bin 1 expression between longissimus dorsi 
and psoas (Fig. 3:7). Bin 1 was previously found to be ubiquitously expressed by Northern 
analysis (Sakamuro, et al, 1996;Tsutsui, et al, 1997). hi this study, quantitative real-time RT- 
PCR showed that bin 1 expression was between 1 to 2 orders of magnitude greater in the heart 
and brain than in skeletal muscle. Bin 1 also demonstrated low expression levels in the uterus, 
liver, spleen and kidney (Fig. 3:8). A novel gene kc2725 of unknown function, found by 
microarray analysis to be more highly expressed in the psoas than in the longissimus dorsi, was 
individually quantified in 4 pigs (pig 1, 2, 3, and 4) (Fig. 3:9). All pigs (pig 1, 2, 3, and 4) gave 
the same pattern of expression (Fig. 3:9) as that detected on the microanay. hiterestingly, 
expression of kc2725 was ubiquitous and was much more abundant in other tissues (e.g., brain, 
uterus, liver, spleen, kidney) than that in skeletal muscle {psoas and longissimus dorsi) (Fig. 
3:10). However, the expression of a gene from the same muscle can vary between similar 
individuals (Figures 3:7, 3:9). In line with functional expectations, previous quantitative work 
performed has shown that the mRNA expression of GAPDH and MyHC Ilb was higher in the 
psoas than in the longissimus dorsi within individual animals (da Costa et al, 2002). In this 
study, the relative levels of GAPDH and MyHC Ilb of pooled total cDNA samples from four 
pigs (pig 1, 2, 3, and 4) were measured (Fig 3:11). The results showed that the differential 
mRNA expression of GAPDH and MyHC Ilb was sufficiently consistent between the 
longissimus dorsi and psoas muscles to be detected in the pooled cDNAs. Therefore, in this 
study, TaqMan real-time quantitative PCR, performed on the selected representative genes 
(GAPDH, MyHC Ilb, bin 1, a novel gene kc2725), not only demonstrated the functional integrity 
of the newly constructed porcine skeletal muscle cDNA microarray in the appropriate 
identification of differentially expressed genes between red and white muscles, but also 
highlighted the existence of variation in muscle gene expression among similar individuals.
134
.5 vs
^  . £ f1 3  a
1 5
 ^ o
g  J
s - 1
«  sl iCi vs 
o  C3
S  §SI
o> .SSu
3
•2f> J
b
O)■q.
COD)■q.
CNO)■q.
05"a.
.— 4
lO If ) '«t If ) CO If ) CN If ) T— If )o TT CD CO O <N O CD CDo O CD CD CD CD CD CD CD Oo O CD CD CD CD CD CD CD CDo CD O CD CD CD CD CD CD CD
CD CD CD CD CD O CD CD CD CDO CD CD CD CD
u|)oe-e)eq o$ pesiieuijou 
|9A9| uojssejdxe euaB aApeiej i uig
0)nE
3C
O)
'q .
0 )
o
CO
3
E
CD
COCD
O
QL□
0)
o
CO
:3
2
* §
CO
3
5
CO
. 2
O )
co
- J□
135
ÆDX)
^  TT 
g  W  
%  On
t  5i len tw
S  "Ok . g)
» - Ë%
g0>(DD
>
T 3
0^
g%
“  sC>k UUo
O ng
S  Ï  
%  %  
^  gflj (w
S = 3
&£• pN
k
\ B
%
4 ? -
\
\ hh
<p
%.< '
\ ,
S '
\ '>
\
% K '
%
V
% %>
%
co ro co co co co co co Tfo o o o o o o o O
u!j lù LÙ u!j lA u!j u!j LÙ lÙo o O o o o o o oin q in o If) o lO q o
N" Tf co co csi c\i T-‘ iri
iOo
0)
3(A(g'3
Q)C
OCL
w.%9
u j)3 e - e ; e q  o ;  p a s i |e iu J o u  
|0A 0| u o j s s 0 jd x 0  0 U 06  0 A j;e |0 j i N ig
136
f t
ü  u— s
0  f
1  ®%u  0>11
B  s0^ %  
&£ Q  %%
. 2  ^  
i l
n  ^r -
f SV
G \
"§
S
o>kSttJD J i• PN
b
%» /% o
%
co
g)Q .
0)
E3C
.5>Q.
.g)Q .
Tj- lOo o O o o o
LU LU LU LU LU LUO LO O lO o O
CO Csj c\i - r T-" LO
OO+
LUO
<Z>
CO3
Ecocoo
£X□
_0)"oco
E
E
■§co:3
•gco.E
O )co
u!$oe-e$aq o; pasiieuuou |aA@| 
uoissajdxe aua6 @Ape|0 j g z i Z ^ ^
137
a
%  .2 f  
■ 3  a ,l |
e SII
a
"  ki3>
S% %
IDD
>
CQ
uif)( Sr -
nu
pi^
f i
V  kocu
'We
®  k  
•  •
«  "Oi t
% 4
%
% . H 4
V
%
c*
r
\
\ ,
\4 /
<&%
%
\
% t>
%
% .
% ,%
CN CN CN CN CO CO CO CO0 0 0 0 0 0 0 0
LÙ u !j u !j  u !j u !j u !j u !j LÙ0 0 0 0 0 0 0 0CD Tf CN CD 0 0 q 0T-^ 0 0 CD CN
O
2oo
%
Q)
Q)C
oÛ.
%
9
ujpe-e)9q 03 pasneaijou 
|9A9| uojssejdxe aueB aAj;e|ai gziZ^^
138
c 3 > c q r ^ c q i q ' ^  c o c \ j - » - C 3c J o o o o c J o o o
S |8 A9 | V N ^ L U  8 A ! )B |8 y
139
3.4. DISCUSSION
The main experimental objective of the red and white muscle micro array gene expression 
analysis was to evaluate, under experimental conditions, the effectiveness of the in-house 
constructed porcine skeletal muscle cDNA microarray by profiling the expression patterns in 
porcine red and white muscles. Two predictable lists of differentially expressed genes were 
identified by the microarray analysis. Real-time quantitative RT-PCR results were obtained for 
validating expression levels of the genes selected from the two lists.
The microanay results validated the prior hypothesis of differential gene expression in red and 
white muscles, thus demonstrating the functional integrity of the newly constructed microarray. 
One of the well established distinguishing features of red muscle is its relatively high oxidative 
phosphorylation capacity, reflected by an abundance of mitochondria in red muscles. It is 
reassuring that genes from the mitochondrial genome were well represented in the red muscle 
pool of differentially expressed genes (Table 3:5). White muscles comprise predominantly more 
fast-glycolytic fibres than red muscles. The findings of this study were consistent with 
expectations, in that most of the 45 clones selected as more highly expressed in white muscle 
(Table 3:6) were either fast isoforms of structural genes, or enzymes connected with anaerobic 
glycolysis. With highly expressed genes, such as mitochondrial genes and structural genes, there 
were detectable levels of redundancies (repeats) on the microarray. However, in the presence of 
redundancies, no gene was found to be present on both lists. Differentially expressed clones 
originating from both the foetal and neonatal libraries were found in comparable proportion. A 
previous report comparing red and white murine skeletal muscles on generic commercial 
oligonucleotide microarray (Affymetrix GeneChips), which comprised the equivalent of 3,000 
different genes, yielded a differential list of 49 known genes (Campbell et al., 2001). In this 
study, the results of known differentially expressed genes were comparable in both number and 
in the different types of genes found. One problem underlying the analysis of micro array data is 
the large number of comparisons required, which can produce false positive results. This study 
compared the expression of clones in psoas and longissimus dorsi muscle as the median of 14 
comparisons (each microarray clone was printed twice on each slide and 7 slides were used), and 
restricted fuither analysis to the clones demonstrating the most consistent and extreme 
differences. Therefore, the majority of the clones identified in this study are likely to represent 
real differences between muscles. However, any specific gene assignment should be regarded as
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provisional until it can be confirmed in an independent study, such as another microarray or in 
another assay such as quantitative PCR.
The interpretation of microan'ay results can be complicated. Firstly, members of the same gene 
family could cross-hybridise to the same spots on the microarray. Interpretation of differential 
expression of individual isoforms should therefore be made with caution. In the case of MyHC 
genes, a plausible interpretation is that fast MyHC mRNA isofoims (Ila, IIx and Ilb) were more 
abundant in the longissimus dorsi than in the psoas. However, it has previously been found by 
quantitative real time RT-PCR that in at least 4 out of 6 pigs, of the same sex, age and breed as 
the one used in the microarray hybridisation, MyHC Ila and IIx were, in fact, more highly 
expressed in the psoas than in the longissimus dorsi (da Costa et al., 2002). The 3 fast MyHC 
isoforms found in Table 3:6 might have been the result of cross hybridisation by the relatively 
large amounts of MyHC Ilb specific probe generated from the longissimus dorsi muscle. 
Secondly, in comparing the profiles of two noimal physiological states, such as red and white 
muscles, large variation in nomiai gene expression between individual pigs could present a 
major problem. This variation is mainly attributed to genetic differences that exist between 
individual pigs; even pigs of the same breed are not genetically the same. The use of pooled 
porcine mRNA samples could inadvertently increase the genetic variation within each 
experimental group of animals. Therefore, in the context of porcine red-white muscle micro array 
analysis, there may be no advantage in pooling mRNAs, derived from the same muscle of 
several pigs. On the other hand, the use of different muscles fr om the same pig could minimise 
the effects of environmental variation, which could exist between individuals. Unlike the use of 
inbred strains of mice, there is little control over the genetic and metabolic variations that could 
exist between individual pigs. The use of inbred lines in laboratory rodents largely eliminates the 
problem of genetic variation between individuals of the same line. Hence, the use of labelled 
cDNA from pooled inbred individuals would enhance experimental reliability without increasing 
genetic variation. However, inbred pig strains are not widely available and limited to a few lines 
of mini-pigs. Whether the microarray probes were derived from an individual or pooled from a 
group of individuals, extensive validation, such as by quantitative PCR or Northern analysis, is 
necessary to demonstrate that the differential expression of a gene identified on a microanay is 
consistent in a wider context.
One important objective of this red and white muscle experiment was to identify a list of 
candidate regulatory genes that could be involved in determining muscle phenotype, which
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includes parameters connected to hypertrophy, differentiation and isofonu-specific expression. 
Indeed, a shortlist of known and unknown candidate regulatory genes was identified. Most of the 
10 unknown genes listed as differentially expressed were found with major open-reading frames, 
suggesting that they code for protein products. Known candidate regulatory genes in the present 
context are genes with putative identities based on homology comparison. However, with the 
possible exception of binl, their functional roles in skeletal muscle are largely unclear. Of the 
known candidate regulatory genes, CK2 a l  subunit, smpx, and tyrosine kinase A6-related gene 
were particularly interesting. They were found to be more highly expressed in red muscle and are 
connected to the casein kinase 2 signalling pathway. CK2 is a protein serine/tlireonine kinase 
that has been implicated in cell growth and proliferation (Guerra and Issinger, 1999;Tawfic et al., 
2001; Blanquet, 2000) CK2-mediated phosphorylation of Myf-5, a member of a family of 
myogenic transcription factors, was reported to be required for Myf-5 activity (Winter et al., 
1997). Presently, contribution of the CK2 signalling pathway to skeletal muscle function is not 
known. Its role in muscle phenotype determination deseiwes evaluation. The gene for heat shock 
70kD protein 8 (HSPA8) seemed to be upregulated in white muscle. Heat shock proteins are 
considered to be molecular chaperones and indicators of cellular stress (Liu and Steinacker, 
2001). The same gene was found to be up-regulated in human hypertrophic cardiomyopathy 
(Lim et al., 2001). It is not clear if this finding was related to cellular stress of myopathy or 
muscle hypertrophy. Investigations into the function of any candidate gene will need to involve 
gain-0f-function and loss-of-function analysis, such as via in vitro transfection studies, using 
muscle cell lines and primary porcine muscle cells. The results of differential gene expression in 
red and white muscles exemplify the power of microarray analysis in generating a desirable but 
substantial list of candidate genes. Its sheer number poses a logistical dilemma for downstream 
work. The challenge to any investigator is to pick the correct clones to demonstrate their 
functional significance to the phenotype in question.
Two important questions were considered when evaluating the red-white muscle microarray 
expression data. The first question was whether the constructed micro array was functional. The 
second one was whether the microanay results fundamentally described the molecular 
mechanisms underlying the differences between red and white muscle. The gene expression 
validation by performing quantitative real-time RT-PCR is not taken as a quality measure of the 
overall microarray, but as a necessary confirmation of specific gene results. For some of the 
genes examined in the real-time quantitative RT-PCR in this study, there were significant
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quantitative differences, if not contradiction, between the array- and the real-time RT-PCR-based 
data. Similar observations were also described in other published literature, which argued that 
genes identified by DNA arrays with a two to fourfold difference in expression should not be 
accepted as true or false without validation with real-time RT-PCR (Rajeevan et al., 
2001a;Rajeevan et al., 2001b;Taniguchi et al., 2001). It has been suggested by the anay 
community that technical questions regarding the differences in accuracy and sensitivity between 
microarray- and real-time RT-PCR-based methods, and the cost and effect involved in caiTying 
out follow-up studies on a large scale have yet to be thoroughly addressed. Furthermore, 
obtaining accurate expression measurements involves more than just post-analysis verification of 
results using an independent laboratory approach. Introduction of artefacts is possible at any time 
during the array experiment, and so each component of the procedure must be carefully 
considered.
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CHAPTER FOUR
MICRO ARRAY PROFILING OF 
lONOMYCEV REGULATED GENES
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4.1. INTRODUCTION
Calcineurin-dependent signalling mechanisms have been characterised extensively in the 
activation of cytokine gene expression in T and B lymphocytes responding to stimuli that elevate 
intracellular free calcium concentration ([Ca^ "^ ];). Binding of calcium to a calmodulin-calcineurin 
complex stimulates serine/threonine phosphatase activity of calcineurin, the major substrates of 
which are nuclear factor of activated T cells (NFAT) transcription factors. Dephosphorylation of 
NFATs by calcineurin promotes their translocation from the cytoplasm to the nucleus, where 
they bind a cognate nucleotide recognition sequence and stimulate transcription of target genes 
(Crabtree, 1999). Although calcineurin and several NFAT isofonns are abundant in skeletal 
muscles, target genes that respond to this pathway in skeletal myocytes have not been fully 
identified previously. Calcineurin activity, tightly regulated by [Ca^^]i, responds preferentially to 
substained, low-amplitude elevations of [Ca^’’]]. The divalent calcium cation Ca^ "^  is used as a 
major signalling molecule during cell signal transduction to regulate energy output, cellular 
metabolism, and phenotype. Calcium signals in the cell are generated and highly regulated by 
ion influx thi'ough voltage- and ligand-gated Ca^'^-permeable ion channels that allow a low 
resting concentration of Ca^  ^ in the cytosol of the cell, release from internal stores, and 
sequestration by Ca^ "^  pumps and exchangers. This enables extracellular signals from honnones 
and gi'owth factors to be transduced as [Ca^ "^ ]/ spikes that are amplitude and frequency encoded 
(Goldring et al., 2002; Hawke and Garry, 2001; Wada et al., 2002). lonomycin, which has been 
widely used as a tool to investigate the role of intracellular calcium in cells, has high affinity for 
calcium, and facilitates the sustained entry of extracellular calcium across biological and 
artificial membranes by a carrier-type mechanism. Treatment for cells with ionomycin leads to a 
rise in [Ca^ "^ ]i that allow binding of calcium to the calmodulin-calcineurin complex thereby 
resulting in the activation of calcineurin. Skeletal muscle satellite cells are undifferentiated 
mono-nucleate myoblasts, with the capacity to divide extensively and fuse with one another. One 
objective in this chapter is to further evaluate the effectiveness of the porcine skeletal muscle 
cDNA microarray by profiling differential gene expression in skeletal muscle myocytes treated 
with ionomycin or vehicle (dimethyl sulphoxide). This study also aims at identifying 
transcriptional mediators and target genes related to signalling mechanisms that involve calcium 
and calcineurin (Rao et al. 1997; Olson and Williams, 2000a; Olson and Williams, 2000b).
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4.2. MATERIALS AND METHODS
4.2.1. TARGET PREPARATION FOR MICROARRAY HYBRIDISATION
4.2.1.1. Primary cell culture and ionomycin treatment
The flow diagram in Figure 4:1 shows the methods used in microaiTay gene expression analysis 
in this study. In order to obtain skeletal muscle myocytes, a 4-weeks-old Large White cross pig 
from a local farm was used. Longissimus dorsi muscles were removed from the pig, and washed 
in PBS DULBECCO’S [without (w/o)/lacking calcium, magnesium and sodium bicarbonate] 
(Gibco' '^^, Invitrogen Corporation) in a 50 ml Falcon tube (Becton Dickinson). The muscle 
tissues were transferred to a 140 mm sterile Sterilin petri dish (Bibby Sterilin Ltd) in a BioMAT 
class II microbiological safety cabinet (Medical Air Technology Ltd), and finely dissected using 
sterile Swann-Morton® disposable scalpels. About 5 ml of the finely minced muscle tissue was 
transferred to a new 50 ml Falcon tube. Filter-sterilised dispase 1.4 U/ml (Sigma) in PBS 
DULBECCO’S was added to the minced muscle to obtain a final volume of 50 ml. The mixture 
of the minced muscle and dispase was incubated at 37 °C for two hours, during which the 
mixture was shaken fairly vigorously every few minutes. Following incubation, the mixture was 
centrifuged at lOOx g at room temperature for 5 minutes to pellet tissue debris. Debris was 
removed, and the supernatant was transferred to a new 50 ml Falcon tube using a sterile 
disposable plastic pipette. Dulbecco's modified Eagle's medium (DMEM) with glutamax-1 (with 
sodium pyruvate, 4500 mg/1 glucose and pyridoxine) (GIBCO™, Invitrogen Corporation), 
supplemented with 15% [volume/volume (v/v)] heat inactivated foetal bovine serum (Sigma- 
Aldrich), 50 mg/L penicillin (Invitrogen), 100 mg/L streptomycin (Invitrogen) and 10 pg/ml 
ciproxin (Bayer), was added to the supernatant to obtain a final volume of 50 ml, followed by 
centrifugation at 400x g at room temperature for 5 minutes to pellet cells. Following 
centrifugation, the supernatant was decanted, and the cell pellet was washed with 20 ml DMEM 
with supplements. The suspension was centrifuged at 400x g for 5 minutes at room temperature 
to re-pellet cells. Following centrifugation, the supernatant was decanted and the cell pellet was 
re-suspended in 10 ml DMEM with supplements. The re-suspended cells were filtered using 
sterile lOO-pm nylon cell strainers (Becton Dickinson) into a new 50 ml Falcon tube.
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Figure 4:1 Flow diagram showing methods used for microarray gene expression analysis in this
study
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Culturing skeletal muscle satellite cells
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Harvest ionomycin treated myocytes Harvest untreated myocytes
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Fifty of sterile Costar'' 162 cm^ non-pyro genic, polystyrene cell culture flasks (Costar ", Corning 
Incorporated) were used for the primary cell culture. One microlitre of the filtrate was transfeiTed 
into each of the fifty cell culture flasks. Fifteen microlitres of DMEM, supplemented with 15% 
(v/v) heat inactivated foetal bovine serum (Sigma-Aldrich), 50 mg/L penicillin (Invitrogen), 100 
mg/L streptomycin (Invitrogen) and 10 pg/ml ciproxin (Bayer), was added to the filtrate in each 
flask. Some cells were plated onto ten chamber glass slides for fixation and morphological 
analysis and desmin detection. The satellite cells cultured in each 162 cm^ flask was maintained 
for 48 hours at 37 °C with 5% CO2 in air in a humidified HERA cell incubator (Heraeus). During 
the culturing process, cells were examined using a Leitz “Labovert FS” trinocular inverted 
microscope (Leitz). Following incubation, the medium in each flask was discarded. One 
millilitre of Trypsin-EDTA (Ix) in HESS w/o Ca and Mg w/EDTA.4NA (GIBCO™, hivitrogen 
Coiporation) was added to cells in each flask, incubated at 37“C with 5% CO2 in air in the 
humidified cell incubator for 5 minutes, and then transferred into a new 50 ml Falcon tube, 
followed by centrifugation at 120Qx g for 5minutes. Cell pellets were re-suspended with 40 ml 
fresh DMEM with supplements, and transferred into new 162 cm^ flasks. The cells were 
maintained at 37°C with 5% CO2 in air in the humidified cell incubator for another 120 hours (5 
days), during which the medium was replaced every two days. Following five days of 
incubation, the cells in each flask became about 80-90% confluent. DMEM containing foetal 
bovine serum in each flask was discarded, and 25 ml of DMEM containing 2% (v/v) heat 
inactivated horse serum (Sigma-Aldrich), 50 mg/L penicillin, 100 mg/L streptomycin and 10 
pg/ml ciproxin were then added to cells. Cells were maintained at 37°C with 5% CO2 in air in 
the humidified cell incubator for 96 hours (4 days) for differentiation, during which the medium 
was replaced every two days (Kubis et al., 1997).
After 96 hours of incubation, the medium was removed, and the cells were maintained in 25 ml 
fresh DMEM with supplements in the absence or presence of ionomycin calcium salt (Sigma- 
Aldrich). Ionomycin calcium salt was initially dissolved in dimethyl sulphoxide (DMSO) and 
sterilised using a sterile 0.25 pm filter (Nalgene) to give 1 mM stock solutions. Fifty microlitres 
of ImM ionomycin stock solution were diluted with 25 ml DMEM (with supplements) to obtain 
a final concentration of 2 pM. DMEM (with supplements) containing 2 pM ionomycin calcium 
salt was added to the myocytes cultured in twenty-five 162 cm  ^ flaks. The myocytes cultured in 
the remaining twenty-five 162 cm^ flasks were treated with a vehicle (DMSO) in the absence of 
ionomycin treatment, serving as a control. DMSO alone had no effect on cultured myocytes at
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the concentrations used (0.001-0.05 % v/v) (Scott et al., 1997; Sun et al., 1998). Both cell groups 
were maintained at 37°C with 5% CO2 in air in the humidified cell incubator for 48 hours prior 
to harvest.
4.2.1.2. Detection of desmin expression in the cultured cells
4.2.1.2.1. Cell culture on glass slides and methanol/acetone fixation fo r  adherent cells
Skeletal muscle satellite cells were also cultured on Lab-Tek® II chamber glass slides (Nalge 
Nunc International). Materials and methods used for the cell culture on chamber glass slides 
were the same as that described for the cell culture in 162 cm^ flasks (section 4.2.1.1. of this 
chapter). Following cell culture, the medium was discarded, the glass slides with cells adherent 
on one side of them were immersed in 1:1 ice-cold methanol:acetone incubated at -20°C in a 
freezer for 10 minutes. The glass slides were then removed fr'om the -20°C freezer, air-dried at 
room temperature and then subjected to immunohistochemical staining for desmin.
4.2.1.2.2. Immunohistochemical staining o f  the cultured cells
The glass slides with fixed cells on one side were placed in a metal rack and immersed briefly in 
ddH20. The glass slides were then placed for 30 minutes in 100 ml methanol containing 0.5% 
H2O2, and washed briefly in Tris-buffered Tween. About 1 ml of 1% rabbit serum solution was 
applied to the cells, and then incubated at room temperature for 30 minutes. Following 
incubation, 1:500 diluted monoclonal mouse anti-desmin antibody (mouse Ig concentration was 
160 mg/L; total protein concentration was 26 g/L) (DAKO), which reacts with inteimediate 
filament protein desmin in skeletal muscle myocytes, was applied to the cells on the glass slides. 
The cells were incubated at room temperature for 2 hours and then washed with Tris-buffered 
Tween for three times with 5 minutes for each time. About 1 ml of 1:200 diluted rabbit anti­
mouse biotinylated antibody was applied to the cells on the glass slides. The cells were incubated 
for 45 minutes and then washed with Tris-buffered Tween for tlnee times with 5 minutes each 
time. About 1 ml of SteptAB Complex/HRP (Dako) was applied to the cells on the glass slides. 
The cells were incubated for one hour and then washed with Tris-buffered Tween for three 
times, each time for 5 minutes. A solution of 3,3 diaminobenzidine was applied to the cells on 
the glass slides, which were examined under the light microscope. The cells were then washed in
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ddH20 to terminate the reaction. The cells on glass slides were placed in Gills Haematoxylin for 
30 seconds, then washed in ddH20. The cells on glass slides were immersed briefly (about 3 
dips) in 1% acid alcohol, and then washed in ddH20. The cells on glass slides were immersed in 
STWS for staining nuclear, and then washed in ddH20. The glass slides were placed in 
methylated spirits, then in absolute alcohol, and finally in citroclear solution. Permanent 
mountant was then applied to the cells on glass slides.
4.2.I.3. Calcinuerin cellular phosphatase activity assay
4.2,1.3.1. Harvesting skeletal muscle myocytes
Myocytes, cultured in 162 cm^ flasks and treated with ionomycin or control vehicle, were 
haiwested separately. Before cell harvesting, the myocytes of both category were examined under 
light microscope to confirm that the cells were about 80-90% confluent. Medium was removed 
from each flask and discarded. The cells were washed with 20 ml TBS (Tris-buffered saline) (see 
Appendix) for three times, then scraped off the flasks using a disposable sterile cell scraper 
(Coming Incorporated) and maintained in TBS on wet ice. Trypsin and PBS were not used in the 
cell harvesting process in this study because trypsin and PBS contain phosphate, which would 
have affected the result of the calcineurin cellular phosphatase assay. The cells maintained in 
TBS were centrifuged using a Heraeus Sorvall Legend RT centrifuge at 1200x g for 5 minutes to 
pellet cells. The cell pellets were re-suspend with 20 ml fresh TBS. The re-suspended cells were 
transferred to 2 ml sterile micro centrifuge tubes followed by centrifugation at 1200x g for 5 
minutes to pellet cells. The cell pellets were immediately placed on wet ice, then on dry ice, and 
finally stored in a -80°C jfreezer. At this stage, the frozen cell pellets were ready for both the 
assay of calcineurin cellular phophatase activity and the preparation of microanay target 
mRNAs. lonomycin-treated cells, which were harvested from five 162 cm^ flasks, and vehicle 
(DMSO)-treated cells, which were harvested from five 162 cm  ^ flasks, were both subjected to 
the assay for calcineurin cellular phosphatase activity. lonomycin-treated cells, which were 
haiwested from twenty 162 cm  ^ flasks, and vehicle (DMSO)-treated cells, which were harvested 
fi'om twenty 162 cm^ flasks, were used to prepare of microarray target mRNAs.
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4.2.13.2. Preparation o f skeletal muscle myocyte extracts
To determine the effect of ionomycin treatment on the cells cultured in this study, cellular 
calcineurin phosphatase activity in the cell extracts was measured using CALBIOCHEM® 
Calcineurin Cellular Activity Assay Kit (Catalogue No. 207007) (Calbiochem-Novabiochem 
Coiporation). Components of this kit included protease inhibitor cocktail tablets, lysis buffer, 
Green™ reagent, 2x assay buffer, and RII phosphopeptide (full list of components is to be found 
in the manual of the CALBIOCHEM® Calcineurin Cellular Activity Assay Kit). RII 
phosphopeptide is the most efficient peptide substrate known for calcineurin. Calcineurin 
phosphatase activity was measured spectrometrically by detecting fi'ee-phosphate released from 
the calcineurin specific RII phosphopeptide.
The cell pellets, previously harvested using TBS, were removed fiom -80°C and maintained on 
dry ice. The protease inhibitor cocktail tablet was added to the lysis buffer (50 niM Tris, 1 mM 
DTT, 100 pM EDTA, 100 pM EGTA, 0.2% NP-40, pH 7.5) immediately before use, and mixed 
by vortexing (1 protease inhibitor cocktail tablet per 10 ml lysis buffer). Fifty microlitres of lysis 
buffer containing protease inhibitors were added to each cell pellet and mixed by pipetting up 
and down. The mixture was transferred to ultracentrifuge tubes, followed by centrifugation at 
100,000 xg for an hour at 4°C using the TL-100 ultracentrifuge (Beckman). After centrifugation, 
the debris discarded, the supernatant, which was about 50 pi in each tube, was saved as cell 
extracts and transferred to sterile 1.5 ml microcentrifuge tubes labelled as “HSS” (high speed 
supernatant). The quantity of protein in the cell extracts used for each assay was measured by 
comparing with a protein standard curve (see section 4,2.1.43. of this chapter).The HSS 
supernatant (cell extracts) was immediately assayed.
4.2.1.3.3. Removal offree phosphate from cell extracts
A Micro Bio-Spin® Chromatography Column (BIO-RAD Laboratories) was used to remove 
excess fine phosphate and unincorporated nucleotides in the high speed supernatant (HSS). 
Micro Bio-Spin® Clii’omatography Columns were inverted sharply several times to re-suspend 
the settled gel and remove any bubbles. The tip of the column was snapped off and the column 
was placed in a 2 ml microcentrifuge tube. The top cap of the column was removed to allow the 
excess packing buffer to drain by gravity to the top of the gel bed. The drained buffer was
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discarded and the column was placed back into the 2 ml tube. The Micro Bio-Spin® 
Chromatography Columns was centrifuged for 2 minutes at room temperature in a Heraeus 
Biofuge Pico centrifuge at 3,500 rpm [1,000 x (g)] to remove the remaining packing buffer that 
was later discarded. The column was then placed in a clean 1.5 ml microcentrifuge tube. The 
HSS supernatant, which was not less than 20 |ul was applied directly to the centre of the column. 
After loading sample, the column was centrifuged at room temprature in a Heraeus Biofuge Pico 
centrifuge at for 4 minutes at 3,500 rpm [1,000 x(g)]. Following centrifugation, the column was 
discarded and the flow through, which was the purified cell extracts, was stored on wet ice for 
further use. The column retained molecules smaller than the column’s exclusion limit. The 
effective removal of phosphate/nucleotides from the cell extracts was then tested qualitatively by 
adding 100 fil GREEN'’^  ^ reagent to 1 |ul cell extract and a separate sample of 1 p.1 of distilled 
H2O. The GREEN'^’^  reagent is a highly sensitive phosphate detection solution. Free phosphate 
and unincoi-porated nucleotides, which are slowly hydrolysed to release free phosphate in the 
presence of the GREEN"^^ reagent, is detected visually as a change in colour from yellow to 
green. If no phosphate/nucleotides were present, both samples should remain yellow in colour 
over a time period of 30 minutes at room temperature. The development of a visible green colour 
indicates phosphate contamination, which must be eliminated from the samples before 
proceeding further. The cell extract flow-tlirough of the column, which was desalted cell lysate 
material, was collected in the 1.5 ml microcentrifuge tube and frozen on dry ice. About 5 pi 
purified cell extract was transferred into a new 1.5 ml micro centrifuge tube, to be used for 
measuring protein concentration.
4.2.1.3.4, Protein quantification
Eight hundred microlitres of ddH20 were added to each of twelve plastic cuvettes labelled 
“cuvette X2 1” to “cuvette 1^ 9 12”. Bovine serum albumin (BSA) stock solution (1 mg/ml) was 
removed from -20°C and thawed at room temperature. In order to obtain a series dilution of the 
BSA stock solution, 2, 4, 6, 8, 10, 12, 14, 16, and 18 pi of 1 mg/ml BSA stock solution were 
added respectively to cuvettes Jfe 2, X2 3, Jfs 4, 5, JMs 6, X2 7, JN2 8, hTa 9, and JV2 10. Cuvette Rb
1 contained distilled H2O blank. Five micro litres of purified cell extracts from the vehicle 
(DMSO) treated myocytes were added to cuvette Rbl l .  Five microlitres of purified cell extracts 
from the ionomycin treated myocytes were added to cuvette JXb 12. Protein Assay Dye Reagent 
Concentrate containing phosphoric acid methanol (Bio-Rad) was diluted in a 50 ml Falcon tube
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by mixing 12 ml ddH^O and 3 ml Bio-Rad Protein Assay Dye Reagent Concentrate. One 
millilitre of the four-times diluted protein assay dye was added to each of the eleven plastic 
cuvettes containing ddHgO and the protein samples (BSA or cell extracts). The protein content in 
each plastic cuvette was measured using a Beckman DU® 640 spectrophotometer (Beckman 
Coulter, Inc.) at 595 nm absorbance wavelength. The protein concentration standard cuiwe was 
thus obtained, and the amount of protein used for calcineurin phosphatase activity assay was 
quantified by comparing with the protein standard curve.
4.2.1.3.5. GREEN^^ phosphatase assay
In order to prepare reagents for the Green™ Phosphatase Assay, all components of the 
CALBIOCHEM® Calcineurin Cellular Activity Assay Kit were thawed and held on ice, except 
for the GREEN''^^ reagent, which was kept at room temperature. Twenty microlitres of 
calmodulin was added to 980 pi 2x assay buffer. The RII phosphopeptide substrate was 
reconstituted with distilled H2O to 750 pM (1.64 mg/ml) by adding 305 pi ddH20 to a vial 
containing 0.5 mg RII phosphopeptide (10 pi 1.64 mg/ml RII phosphopeptide were needed per 
assay well).
In order to prepare phosphate standard curve sample wells, 1:1 serial dilutions of phosphate 
standard plus a distilled H2O blank were prepared. Dilutions of 80 pM, 40 pM, 20 pM, 10 pM, 5 
pM, 2.5 pM, and 1.25 pM corresponding to 2 nmol, 1 nmol, 0.5 nmol, 0.25 nmol, 0.125 mnol, 
0.063 nmol, and 0.031 nmol PO4 were obtained according to the following procedures: (1) fifty 
microlitres of 80 pM phosphate standard were added to well # 1 of a 96-well microtitre plate. (2) 
twenty-five microlitres of distilled H2O were added to wells # 2-8 of the microtitre plate. (3) 
Twenty-five microlitres of 80 pM phosphate standard were removed from well # 1 and added to 
well # 2, in which the solution was mixed thoroughly. This process was repeated for wells # 3-7. 
Finally, 25 pi of the solution in well # 7 was removed and discarded. Well # 8 contained distilled 
H2O blank. Twenty-five microlitres of 2x assay buffer were added to each of wells # 1-8, which 
were used for obtaining the phosphate standard curve. The final volume in each well was 50 pi.
In order to carry out calcineurin total phosphatase activity assay, backgi*ound wells that did not 
contain substrate were used as a control for background phosphate/interfering substances. The 
backgi'ound wells were set up by adding 20 pi distilled H2O and 25 pi 2x assay buffer with
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calmodulin to each well. The calcineurin total phosphatase activity assay wells used for detecting 
calcineurin total phosphatase activity in each cell extract sample, were set up by adding 10 pi 
dH20 and 25 pi 2x assay buffer with calmodulin to each well. Ten microlitres of phosphopeptide 
substrate were added to each well of the purified high speed supernatant (HSS) except for the 
background control. No substrate was added to the phosphate standard curve samples. The 
micro titer plate was equilibrated to reaction temperature (37°C) for 10 minutes. To initiate the 
calcineurin assay, 5 pi cell extract was added to each of the appropriate wells. The microtitre 
plate was incubated at 37°C for 30 minutes. After incubation, the reactions were terminated, by 
adding 100 pi GREEN™ reagent to each sample including those used for obtaining the 
phosphate standard cuiwe. The colour was allowed to develop for 20-30 minutes, Absorbance 
was read for the plate on the microplate reader at 650 nm wavelength, and then data analysis was 
performed.
4.2.I.4. Preparation of cyanine dye labelled cDNA targets for microarray hybridisations
Messenger RNAs were extracted from ionomycin-treated and control vehicle-treated myocytes, 
respectively (Fig. 4:2). Materials and methods used for mRNA extraction, single-strand cDNA 
systhesis, and cyanine dye labelling were the same as those described in Chapter Two and 
Chapter Three.
4.2.2. MICROARRAY HYBRIDISATION AND SEQUENCING ANALYSIS
Materials and methods used for microarray hybridisations and the following image capture, 
image quantification, data mining, sequencing analysis and BLAST searches were the same as 
that described in Chapter Three.
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4.3. RESULTS
4.3.1. DESMIN EXPRESSION IN THE CULTURED CELLS
In order to detect presence of desmin in the cells isolated from porcine skeletal muscle, 80-90% 
confluent cells cultured on chamber glass slides were subjected to monoclonal mouse anti- 
desmin antibody. About 80-90% of the entire mononucleated cells in porcine cell cultures on 
chamber glass slides were desmin-positive, suggesting that desmin was synthesised in 
proliferating porcine satellite cells (Fig. 4:3). The presence of desmin was used as a marker for 
identifying skeletal muscle satellite cells. Porcine fibroblasts were desmin-negative. Application 
of desmin staining to porcine satellite cell growth assay indicated that porcine satellite cells 
cultured in this study were contaminated with porcine fibroblasts at a level that was 
approximately 15-20% in mature cultures. Desmin is a muscle cytoskeletal protein whose gene 
belongs to the family of intermediate filament proteins (Lazarides and Hubbard, 1976; Small and 
Sobieszek, 1977; Geisler and Weber, 1982). Desmin is one of the first muscle-specific proteins 
to be detected in the mammalian embryo and it is expressed before titin, skeletal muscle actin, 
myosin heavy chains and nebulin (Hill et al., 1986; Fürst et al., 1989; Babai et al., 1990). Levels 
of desmin expression in skeletal muscle remain high throughout emhryogenesis and in early 
postnatal life. More than 20 genes are known to be coordinately induced during skeletal 
myogenic differentiation (Caravatti et al., 1982; Gunning et al., 1987). The expression of the 
desmin gene differs from most of these genes, which share the property of being repressed in 
proliferating undifferentiated myoblasts and of being concomitantly expressed with myoblasts 
fusion. In contrast, desmin expression is initiated in replicating myoblasts and accumulates to a 
high level as muscle cells differentiate (Pieper et al., 1987; Kaufman and Foster, 1988; Li and 
Paulin, 1991).
4.3.2. CALCINEURIN TOTAL PHOSPHATASE ACTIVITY IN SKELETAL 
MUSCLE MYOCYTES
The assay for detecting calcineurin total phosphatase activity in the ionomycin-treated or control 
vehicle (DMSO)-treated myocytes was performed. The calcineurin total phosphatase activity in 
the ionomycin-treated myocytes (1 nmol phosphate per pg of cell extract protein) was 
approximately 1.4 times higher than that in the control vehicle-treated myocytes (0.7 nmol
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phosphate per pg of cell extract protein) (Fig. 4:4), suggesting that calcineurin activity was up- 
regulated in the myocytes subjected to ionomycin treatment.
4.3.3. MICROARRAY IMAGE PROCESSING AND DATA ANALYSIS
Eight dual-coloured array replicates were obtained. Figure 4:5 shows a representative partial 
hybridised microarray image and hnaGene'^'^ scatter plot. Gene Spring™ scatterplots profiling 
gene expression patterns in the ionomycin-treated and control vehicle-treated cell groups were 
obtained by conducting data normalisation and statistical analysis using the GeneSpring^"^ 
software. GeneSpring'^'^ scatterplots in Figure 4:6 show separate expression profiles of 
ionomycin-activated and ionomycin-repressed genes. Figure 4:6 is a derivation of Figure 4:7. 
Figure 4:7 shows a GeneSpring™ scatterplot profiling expression of total genes including both 
ionomycin-activated and ionomycin-repressed genes.
4.3.4. DIFFERENTIALLY EXPRESSED GENES
4.3.4.I. Genes more highly expressed in the myocytes treated with ionomycin
When the data mining criteria of ionomycin-treated/vehicle-treated ratio of 2.0 or more (P<0.05), 
were applied, 68 clones passed the restriction and were detected. They were sequenced and 
BLAST searches were performed. Table 4:1 is a summary of the genes identified as more highly 
expressed in the ionomycin treated myocyte group. Of sixty-eight clones characterised, fourteen 
clones (cytochrome oxidase subunit 1) were of mitochondrial origin; nineteen genes encoded 
skeletal muscle alpha actin; one gene encoded cardiac alpha actin; nine genes encoded skeletal 
muscle tropomyosin genes; seven genes encoded cardiac tropomyosin. Other genes such as CD95 
(Fas, APO-l)-associated tyrosine phosphatase non-receptor type 13 (PTPN13), polyubiquitin, 
myotonic dystrophy protein kinase (DMPK) gene, caldesmon 1 (CALDl), muscle cofilin 2, fascin 
(FSCN), ID3 and fibromodulin (FMOD) were also found in the list of ionomycin-activated genes. 
Mitochondrial cytochrome oxidase subunit 1 is responsible for aerobic respiration. Polyubiquitin 
is a protein related to ATP-dependent selective degradation of cellular proteins. Myotonic 
dystrophy protein kinase (DMPK) is responsible for myotonic dystrophy. Various iso forms of
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Table 4:1 Genes that were at least two-fold (P<0.05) more highly expressed in the ionoinycin-
Closest Putative Identity Ionomycin-treated 
/Vehicle-treated
Homology # of 
Clone
Accession #
Cytochrome oxidase subunit 1 2.36 100% (P) 14 AF030277
NADH dehydrogenase subunit 2.66 97% (H) 1 AF493542 J
Skeletal muscle alpha actin 2.79 93% (H) 19 XM 001869
Cardiac alpha actin (Actcl) 2.83 91% (M) 4 NM 009608 :
Fibromodulin(FMOD) 3.16 95% (B) 2 X16485 :-1
Myosin regulatory light chain 2.32 91% (B) 1 AF513721 --1
F-actin binding protein nexilin 3.21 92% (H) 2 NM 144573
Cardiac alpha tropomyosin 2.67 98% (P) 7 X66274
Skeletal muscle tropomyosin 2.74 92% (H) 9 M75165
Fascin homolog 2 (FSCN2), actin- 
bundling protein
2.65 95% (H) 1 NM_012418
Caldesmon 1 (CALDl) 2.24 96% (H) 1 XM 058059
Cofilin 2 (muscle) mRNA 3.01 96% (H) 1 BC022876
Protein tyrosine phosphatase, non­
receptor type 13 (PTPN13)
2.98 86% (H) 1 NM 006264
ID3 protein (ID3 gene) 2.04 93% (D) 1 AJ271644 ■
Dystrophia myotonica-protein kinase 
(DMPK)
2.87 83% (H) 1 XM 027572
MYB binding protein, niRNA 2.19 94% (H) 1 NM 014520
Polyubiquitin 2.51 97% (P) 1 M18159
Unknown clones, homologous to 
Homo sapiens chromosome 14 DNA 
sequence B AC R-137H15 of library 
RPCI-11
2.11 87% (H) 1 AL135998
Accession # refers to porcine gene or close homologue: (P) = 
(M) = House mouse, (D) = Domestic dog.
Porcine, (B) = Bovine, (H) = Human,
DMPK have been reported in skeletal and cardiac muscles. The functional role of DMPK, which 
has so far not been fully understood, may play an important role in the modulation of the Ca^”^ 
homeostasis in skeletal muscle cells. Caldesmon (CALDl) is an actin- and myosin-binding 
protein implicated in the regulation of actin-myosin interactions, possibly acting as a bridge 
between myosin and actin filaments in smooth muscles and non-muscle tissues. Although some 
studies reported that caldesmon was not expressed in skeletal muscle or heart (Wang & Yang, 
2000; Mani et al, 1992; Ishikawa et al, 1992), caldesmon gene was found in this study to be up- 
regulated in the ionomycin-treated skeletal muscle myocytes. Cofilins are actin-binding proteins 
and regulate actin assembly. Cofilin 2 (CFL2) is a skeletal muscle actin-modulating protein, 
which plays an important role in noimal muscle function and muscle regeneration (Thirion et ah,
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2001). Fascin (FSCN) is an actin-crosslinking protein in the core actin bundles of cell-surface 
spikes and projections that are implicated in cell motility. Fascin is also a tumor marker with 
potential diagnostic and therapeutic implications for pancreatic carcinoma (Jawhari et ah, 2003; 
Maitra et ah, 2002). Fibromodulin (FMOD) is a collagen binding protein and a key regulator of 
tendon strength (Hedbom and Heinegard, 1989). FMOD regulates the assembly of collagens into 
higher-order fibrils in connective tissues and thus aids fibril maturation (Jepsen et ah, 2002). The 
detection of FMOD in this study could be due to the inclusion of fibroblasts in the primary cell 
culture when isolating skeletal muscle samples from the pigs. The helix-loop-helix (HLFI) motif- 
containing transcription inhibitor ID3 (for Inliibitor of Differentiation-3) inhibits the binding of 
E2A-containing protein complexes to muscle creatine kinase E-box enhancer. ID3 has been 
shown to be highly expressed in proliferating myoblasts but down regulated when myoblasts are 
induced to differentiate (Yeh and Lim, 2000). Moreover, overexpression of ID3 has been shown 
to inhibit skeletal muscle differentiation program and repress muscle-specific gene expression 
(Yeh and Lim, 2000; Jen et ah, 1992). Enforced expression of ID3 has been found to be a strong 
inducer of apoptosis in serum-deprived fibroblast cells (Norton and Atherton, 1998).
4.3.4.2. Genes more highly expressed in the myocytes treated with vehicle (DMSO)
When the data mining criteria of vehicle-treated/ionomycin-treated ratio of 2.0 or more (P<0.05), 
equivalent to ionomycin-treated /vehicle-treated ratio of 0.5 or less (P<0.05), was applied, 12 
clones passed the restriction. They were sequenced and BLAST searches were perfoimed. Table 
4:2 is a suimnary of the genes identified more highly expressed in skeletal muscle myocytes 
treated with control vehicle (DMSO). Of twelve clones characterised, seven cytochrome oxidase 
genes were of mitochondrial origin, four genes encoded ribosomal proteins, and one gene 
encoded SI00 calcium binding protein AlO (also called annexin II light chain or calpactin light 
chain). S I00 proteins are a family of calcium binding proteins that function to transmit calcium- 
dependent cell regulatory signals. S I00 proteins have no intrinsic enzyme activity but bind in a 
calcium-dependent manner to target proteins to modulate target protein function.
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Table 4:2 Genes that were at least two-fold (P<0.05) more highly expressed in the vehicle-
treated myocytes than in the ionomycin-treated myocytes
Closest Putative Identity Vehicle-treated 
/Ionomycin treated
Homology # of 
Clone
Accession #
Cytoclirome oxidase subunit 1 2.43 99% (P) 7 AF304202
Ribosomal protein S15a 2.17 92% (H) 1 BC030569
Ribosomal protein S3 2.62 91% (H) 1 BC034149
Ribosomal protein S23 (RPS23) 2.81 93% (H) 1 NM 001025
Ribosomal protein S2 2.09 91% (B) 1 AF013215
SI00 calcium binding protein AlO 
(SIOOAIO) [annexin II ligand, 
calpactin I, light polypeptide (pi 1)]
2.69 94% (H) 1 XM 001468
Accession # refers to porcine gene or close homologue: (S) 
Bovine.
Porcine, (H) = Human, (B)
4.4. DISCUSSION
The primary goal of this study was to further assess the effectiveness of the constructed porcine 
skeletal muscle cDNA microarray for high throughput gene expression profiling. The micro array 
experiment described in this chapter focused on identifying genes that were differentially 
expressed in skeletal muscle myocytes in the presence or absence of ionomycin. Results from the 
eight replicated microarray hybridisations demonstrated that the porcine cDNA microanay was 
able to generate a list of genes that were at least 2-fold more highly expressed in the ionomycin- 
treated myocytes.
According to previous published information, treatment for cells with ionomycin led to a rise in 
intracellular free calcium concentration ([Ca^’^ ji) that allowed binding of calcium to the 
calmodulin-calcineurin complex thereby resulting in the activation of calcineurin (Rao et al., 
1997). In this study, although the cellular phosphatase activity of calcineurin was up-regulated in 
the ionomycin-treated myocytes, neither calcineurin nor the targets of calcineurin phosphatase 
activity (e.g., NF-AT, MEF2) were found in the list of genes that were at least 2-fold more 
highly expressed in the ionomycin-treated myocytes. Calcineurin activity is essential for 
activation of the skeletal muscle differentiation program, which involves irreversible withdrawal 
of myoblasts from the cell cycle, fusion to form multinucleate myotubes, and transcriptional
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activation of muscle-specific genes (Berchtold et al., 2000;Delling et al., 2000;Friday et al., 
2000). In this study, however, no multinucleate myotubes were found by light microscopy in the 
primary cultures of satellite cells. It is obvious that in this study the porcine myoblasts did not 
fuse in either ionomycin-treated or control vehicle-treated primary cell cultures. Even the 
desmin-positive cells did not have the typical morphology of myoblasts expected to be spindle 
shaped. Therefore, culture requirements for the porcine skeletal muscle primary cultures require 
further work that is not possible to be included in this study, due to the restrictions on time limit 
towards the end of a three-year project. Also, desmin is not an ideal marker for skeletal muscle 
cells, because even the skeletal myoblasts are expected to synthesise low levels of more 
specialised myofibrillar proteins such as myosins, troponins and tropomyosin etc. DMSO is a 
well-known modulator of cell differentiation not only for muscle cells but also for non-muscle 
cells. For example, Blau and Epstein stated that 2% DMSO inliibits the fusion of myoblasts to 
form multinucleate myotubes. However, unlike skeletal muscle cells, DMSO is known to 
promote differentiation of HL60 cells. DMSO alone has no effect on cultured myocytes at the 
concentrations used (0.001-0.05 % v/v) (Scott et al., 1997; Sun et al., 1998). Although no fused 
myotubes were observed in the primary cell cultures in this study, it is unlikely that the lack of 
differentiation is related to the inliibition of differentiation by DMSO, because much lower 
(0.02% v/v) concentration of DMSO was used in this study. Therefore, DMSO (0.02% v/v) used 
in this study had no effect on the fusion of myoblasts. Ionomycin is a toxic chemical. Previous 
published studies showed that toxic chemicals that generated oxidative stress or induced a 
pathologic increase in cellular calcium levels could target Ca^ "^  signalling processes resulting in a 
prolonged elevation of [Ca^ "^ ],, depending on the degree of exposure (Trump and Berezesky, 
1996;Dypbukt et al, 1994;Rafffay and Cohen, 1997;Bonfoco et al, 1995). Elevated cytoplasmic 
Ca^  ^ levels can cause activation of certain proteases, lipases, and nucleases. Altered 
physiological properties of skeletal muscle, altered gene transcription and transformation of 
muscle fibres, necrosis, and apoptosis may be the consequences (Orrenius and Nicotera, 
1994;Berchtold et ah, 2000). In this study, the effect of prolonged (48 hours) ionomycin 
treatment on cultured myocytes was likely to be toxic. CD95 (Fas, APO-l)-associated tyiosine 
phosphatase non-receptor type 13 gene (PTPN13), also known as FAP-1 (Fas-associated 
phosphatase-1), was up-regulated by the ionomycin treatment (Table 4:1). The protein encoded 
by PTPN13/FAP-1 is a member of the protein tyrosine phosphatase family, which regulates a 
variety of cellular processes including cell growth and differentiation (Sato et ah, 1995). CD95 
(Fas, APO-1) is a cell surface receptor belonging to the tumor necrosis factor receptor 
superfamily (Inazawa J, 1996). Some published studies reported that tissues and cell lines
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resistant to CD95 (Fas, APO-1 )-mediated cytotoxicity/apoptosis strongly over-expressed 
PTPN13/FAP-1, which binds to CD95 (Fas, APO-1) and inhibited CD95 (Fas, APO-1 )-induced 
cytotoxicity/apoptosis and promotes cellular survival (Sato et ah, 1995;Westphal and Kalthoff, 
2003;Inazawa J, 1996;Yanagisawa et ah, 1997; Ivanov et ah, 2003). Other studies reported that 
PTPN13/FAP-1 triggered apoptosis in human breast cancer cells, and this effect was independent 
of CD95 (Fas, APO-1) but associated with an early inliibition of the IGF-1/PI3K/AKT pathway 
(Bompard et ah, 2002). Apoptosis is a form of programmed cell death occurring during 
organogenesis and organ remodelling and in adult life to modulate the immune system or to kill 
transformed and virally infected cells (Kerr et al, 1987;Kerr et al, 1972;Arends and Wyllie, 
1991). The mechanisms by which PTPN13/FAP-1 inhibits CD95 (Fas, APO-1 )-mediated cell 
death signalling, or triggers apoptosis remain unclear. In this study, the upregulation of 
PTPN13/FAP-1 in the ionomycin-treated myocytes could suggest that the skeletal muscle 
myocytes were resistant to the CD95 (Fas, APO-1 )-mediated apoptosis, or could suggest that 
PTPN13/FAP-1 triggered apoptosis in the ionomycin-treated myocytes. Cells undergoing 
apoptosis show well-defined morphologic and biochemical changes including cellular and 
nuclear slirinkage, condensation, margination and fragmentation of chromatin, changes in plasma 
membrane architecture, and intracellular proteolysis (Kerr et al, 1987; Kudin and Thompson, 
1997; Jacobson et al, 1997). However, in this study, when examined by light microscopy, no 
morphologic changes were found in the myocytes treated with ionomycin. Although this 
preliminary study showed that the constructed porcine cDNA microarray was able to generate a 
list of genes differentially expressed in the ionomycin-treated myocytes, the sum of the present 
data does not provide sufficient information on the involvement of the 
Ca^^/calmodulin/calcineurin signaling pathways in the ionomycin-treated myocytes.
To complement the study described in this chapter, the following experimental designs using the 
constructed porcine cDNA microarray can be adopted and carried out in the future. The skeletal 
muscle myocytes can be cultured in the presence or absence of 2 pM ionomycin, and the cells 
can be harvested at 0, 1, 2, 4, 8, 16, and 24 hours timepoints for microarray differential gene 
expression analysis. The immunosuppressive agents cyclosporin A (CsA) and tacrolimus 
(FK506) bind to intracellular immunophilin receptors, cyclophilin (CyP) and FK506 binding 
protein FKBP), respectively. The complexes of CsA-CyP and of FK506-FKBP both bind to and 
inhibit the activity of the calcium/calmodulin-dependent serine/threonine phosphatase 
calcineurin. Therefore, at each of the 5 timepoints (0, 1, 2, 4, 8, 16, and 24 hours) of ionomycin 
treatment, the transcriptional responses of ionomycin-treated myocytes can be characterised
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using the porcine cDNA microarray following stimulation in the absence or presence of 
cyclosporin A (CsA) or tacrolimus (FK506), hoping to identify target dependent upon 
calcineurin or specific targets of either CyP or FKBP inhibitable by one drug alone. Furtheimore, 
at each of the 5 timepoints (0, 1, 2, 4, 8, 16, and 24 hours) of ionomycin treatment, dose- 
dependent effect of ionomycin on skeletal muscle myocytes can also be characterised using the 
porcine cDNA micro array after treating the myocytes with 0, 0.25, 0.5, 1, and 4 pM ionomycin.
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CHAPTER FIVE
GENERAL DISCUSSION
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5.1 IMPORTANCE OF THE PORCINE cDNA MICRO ARRAY 
FOR PROFILING DIFFERENTIAL GENE EXPRESSION
The major achievement of this study was the completion of the novel porcine skeletal muscle 
cDNA microaiTay, which contained 5,500 cDNA fragments derived from both pre-natal and 
post-natal porcine skeletal muscle cDNA libraries. The entire process for creating the porcine 
cDNA micro array, which was composed of the construction process and the quality control 
process, was successful. The quality control process adopted by this study to ensure uniformity, 
accuracy and reliability of the microarray was considered to be necessary for achieving the 
porcine cDNA microarray of a high quality. The red and white muscle microarray gene 
expression analysis described in Chapter Tlrree optimised experimental conditions peculiar to the 
utilisation of this de novo created microaiTy (Figures 3:1 and 3:2), The fluorescent images of the 
microarray hybridisations and the subsequent data mining results uncovered substantial 
differences in gene expression between red and white muscle (Figures 3:4, 3:5 and 3:6) with a 
number of these identified, differentially expressed genes [e.g., genes of mitochondrial origin, 
genes for myosin heavy chain fast isoforms (Tables 3:5 and 3:6)] in either categories well- 
matched respectively with the physiological characteristics of the two types of the skeletal 
muscles. The red and white muscle microarray experiment demonstrated the usefulness and 
reliability of the porcine cDNA micro array by profiling high-throughput differential gene 
expression, which was in good agreement with prior knowledge of the systems under study 
(Pette and Staron, 1990;Schiaffmo and Reggiani, 1996). Expression patterns of four genes (bin 1, 
novel gene kc2725, MyHC Ilb and GAPDH) validated by real-time quantitative RT-PCR 
(Figures 3:7, 3:9 and 3:11) were well-matched respectively with their differential gene 
expression patterns identified by the red-white muscle micro array analysis. Thus, the 
effectiveness of the porcine cDNA microarray for profiling differential gene expression was 
confirmed. The experiment described in Chapter Four revealed the alterations in the transcript 
level of thousands of transcriptomes in the skeletal muscle myocytes treated with ionomycin, and 
uncovered a number of ionomycin-regulated genes [e.g., PTPN13, DMPK (Tables 4:1)]. This 
experiment further demonstrated that the porcine cDNA microan'ay is capable of profiling 
differential gene expression. In conclusion, the strengths of the study concerning the in-house 
construction and the subsequent utilisation of the porcine skeletal muscle cDNA microarray 
include: (1) the availability of a large number of cDNA fragments maintained in the form of 
plasmid inserts and in the form of PCR-amplified and purified free cDNA fragments, both of 
which have been maintained as frozen stocks; (2) the ability to print hundreds of the porcine
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skeletal muscle cDNA micro array slides; (3) the uniform morphology and high DNA 
concentration of the printed microanay spots/probes; (4) the clone tracking system established 
for the porcine cDNA micro array; (5) the hybridisation conditions optimised specifically for the 
use of the porcine cDNA microaiTay; (6) the high signal-to-noise ratio and good statistical 
reproducibility of the microarray hybridisation results obtained with the help of the software 
tools for image processing and data analysis.
The de novo constructed porcine skeletal muscle cDNA microarray has been proved to be a 
useful biological tool for detennining levels of gene expression. Instead of investigating the 
complexity of skeletal muscle biological effects by analysing single genes of putative importance 
one after the other, gene expression profiling using the de novo constructed porcine cDNA 
microarray facilitates an experimental approach where alterations in the transcript level of 
thousands of transcriptomes can be simultaneously detected in various biological contexts. 
Firstly, this allows one to find out which genes are involved in a biological event and, secondly, 
it permits detailed analysis of their action or interaction afterwards (Bai et al., 2003;da Costa et 
ah, 2004).
5.2 IMPORTANCE OF THE IDENTIFIED CLONES IN SKELETAL 
MUSCLE RESEARCH it
i lThe microarray analysis of red and white muscle, and the access to the microanay clone stocks,
' " iallowed a number of differentially expressed genes to be identified [e.g. genes for bin 1, HSPA8,
CK2 al subunit (Tables 3:5, 3:6)], the function of which had not previously been fully 
elucidated. These differentially expressed regulatory genes, which could be involved in muscle 
phenotype detennination, should be further investigated to define their roles in skeletal muscle.
For example, CK2 al subunit, smpx, and tyrosine kinase A6-related gene were found to be more 
highly expressed in red muscle and are connected to the casein kinase 2 signalling pathway, the 
contribution of which to skeletal muscle function is not known presently. It would also be 
important to define the role of the novel gene kc2725 in skeletal muscle in both physiological 
and pathological situations. PTPN13, which was identified in Chapter Four to be up-regulated in 
the ionomycin-treated skeletal muscle myocytes, regulates cell growth and differentiation, and is 
connected to CD95 (Fas, APO-1 )-mediated cytotoxicity/apoptosis (Sato et al., 1995; Westphal 
and Kalthoff, 2003;Inazawa J, 1996). However, the mechanisms by which PTPN13 inliibits
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CD95 (Fas, APO-1 )-mediated cell death signalling, or triggers apoptosis remain unclear. DMPK 
was also found to be up-regulated in the ionomycin-treated myocytes. DMPK, the functional role 
of which in skeletal muscle has not been fully understood, is connected to the modulation of the 
Ca^ "^  homeostasis in skeletal muscle cells (Benders et ah, 1997). In conclusion, the differentially 
expressed genes identified by this project may play pivotal roles in skeletal muscle biology, and 
therefore, deserve further evaluation.
5.3 FUTURE DIRECTION IN THE UTILISATION OF THE 
PORCINE cDNA MICROARRAY
High-thi'oughput gene expression analysis with the de novo constructed porcine skeletal muscle 
cDNA microarray could be able to provide in the future valuable information about molecular 
mechanisms of skeletal muscle physiological and pathological processes, tlirough potential 
experimental strategies (Yang and Speed, 2002;Churchill, 2002). These biological processes 
could be alterations in skeletal muscle structure and function as consequences of different stimuli 
that modify skeletal muscle contractile activity (e.g. low-intensity high-repetitive endurance 
exercise, high-intensity low-repetitive resistance training, environmental factors such as hypoxia, 
etc.), mechanisms of skeletal muscle development, gradual changes in skeletal muscle with 
ageing (Larsson and Ramamurthy, 2000;Hughes and Schiaffino, 1999), skeletal muscle 
degeneration, degree of progression or interruption of skeletal muscle regeneration, and 
differences at the molecular level between normal and diseased skeletal muscle tissues, and 
among patients. The transcriptional signalling pathways and the differential gene expression 
events involved in these processes could be further recognised using the porcine cDNA 
microarray. The porcine cDNA microarray could also be used to investigate molecular details of 
the complex interactions/cross-talk among different signalling pathways [e.g., the MRFs, 
ubiquitin ligase pathway, IGF-l/FI3K/AKTl/mTOR/p70S6K pathway, 
Ca^^/calmodulin/calcineurin pathway (see reviews in Chapter One)] which are involved in 
skeletal muscle developmental, physiological and pathological events. The porcine cDNA 
microarray could also be used in industrial research (e.g., livestock production, meat quality 
control) to improve the skeletal muscle phenotype of the pig (Klont et ah, 1998). Therefore, by 
using the porcine cDNA microanay, the response of a large percentage of the skeletal muscle 
genome to exercise training, inactivity, and drug treatment could be characterised; and the 
transcriptional events influenced by physiological and pathological processes could be identified
172
in the future. The novel porcine skeletal muscle cDNA microarray could also be used to evaluate 
high throughput gene expression in porcine models of human skeletal muscle diseases. 
Furthermore, the current porcine cDNA microarray could also be expanded by incoiporating 
more genes in this biological tool.
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APPENDIX
(Further Details of Materials and Methods)
173
Further details of materials and methods described in this thesis
40% Acrylamide
(for DNA sequencing)
Dissolve 380 g of acrylamide (DNA-sequencing gi'ade) and 
methylenebisacrylamide in a total volume of 600 ml of distilled H2O.
20 g of AW-
10% Ammonium persulfate
To 1 g of ammonium persulfate, add H2O to 10 ml. The solution may be stored for several 
weeks at 4°C.
Antibiotic solutions
Stock solutions of antibiotics dissolved in H2O should be sterilised by filtration through a 
0.22-micron filter. Antibiotics dissolved in ethanol do not need to be sterilised. Store solutions 
in light-tight containers.
Stock solution Working concentration
concentration storage stringent plasmids relaxed plasmids
Ampicillin 50 mg/ml in H2O -20°C 20 pg/ml 60 pg/ml
Kanamycin 10 mg/ml in H2O -20°C 10 pg/nil 50 pg/ml
Streptomycin 10 mg/ml in H2O -20°C 10 pg/ml 50 pg/ml
Tetracycline 5 mg/ml in ethanol -20°C 10 pg/ml 50 pg/ml
Denatured, fragmented salmon sperm DNA
Salmon sperm DNA (e.g., Sigma type III sodium salt) is dissolved in water at a concentration 
of 10 mg/ml. If necessary, the solution is stin'ed on a magnetic stirrer for 2-4 hours at room 
temperature to help the DNA to dissolve. The concentration of NaCl is adjusted to 0.1 M, and 
the solution is extracted once with phenol and once with phenol:chlorofonn. The aqueous 
phase is recovered, and the DNA is sheared by passing it 12 times rapidly through a 17-gauge 
hypodei*mic needle. The DNA is precipitated by adding 2 volumes of ice-cold ethanol. It is 
then recovered by centrifugation and redissolved at a concentration of 10 mg/ml in water. The 
OD260 of the solution is determined and the extract concentration of the DNA is calculated. 
The solution is then boild for 10 minutes and stored at -20°C in small aliquots. Just before 
use, the solution is heated for 5 minutes in a boiling-water bath and then chilled quickly in ice 
water. Denatured, fragmented salmon sperm DNA should be used at a concentration of 100 
pg/ml in prehybridisation solutions.
Denhardies reagent
Denhardt’s reagent is usually made up as a 50x stock solution, which is filtered and stored at 
-20°C. The stock solution is diluted ten-fold into prehybridisation buffer. 5Ox Denliardt’s 
reagent contains 5 g of Ficoll, 5 g of polyvinypyrrolidone, 5 g of bovine serum albumin 
(Fraction V), and H2O to 500 ml.
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1 M  Dithiothreitol (DTT)
Dissolve 3.09 g of DTT in 20 ml of 0.01 M sodium acetate (pH 5.2). Sterilise by filtration. 
Dispense into 1-ml aliquots and store at -20°C.
Denaturing buffer
(For transfer of DNA to nitrocellulose filters)
Per 10 litres
200 g NaOH 
876.6 g NaCl 
Denaturing buffer contains 1.5 M NaCl and 0.5 N NaOH
0.5 M  disodium ethylenediaminetetra-acetate (EDTA) (pH 8.0)
Add 186.1 g of disodium ethylenediaminetetra-acetate.2H2O to 800 ml of H2O. Stir vigorously 
on a magnetic stirrer. Adjust the pH to 8.0 with NaOH (~ 20 g of NaOH pellets). Dispense into 
aliquots and sterilise by autoclaving.
Ethidium bromide (10 mg/ml)
Add 1 g of ethidium bromide to 100 ml of H2O. Stir on a magnetic stirrer for several hours to 
ensure that the dye has dissolved. Wrap the container in aluminum foil or transfer the solution 
to a dark bottle and store at room temperature.
Ethidium bromide fluorescent quantitation o f  the amount o f  double-stranded DNA
Sometimes there is not sufficient DNA (< 250 ng/ml) to assay spectrophotometrically, or the 
DNA may be heavily contaminated with other substances that absorb ultraviolet irradiation 
and therefore impede accurate analysis. A rapid way to estimate the amount of DNA in such 
samples is to utilise the ultraviolet-induced fluorescence emitted by ethidium bromide 
molecules intercalated into the DNA. Because the amount of fluorescence is proportional to 
the total mass of DNA, the quantity of DNA in the sample can be estimated by comparing the 
fluorescent yield of the sample with that of a series of standards. As little as 1-5 ng of DNA 
can be detected by this method.
6xGel-loading buffer
0.25% bromophenol blue
0.25% xylene cyanol FF
40% (w/v) sucrose in water 
[In this study, 6xGel-loading buffer type III contained 3 ml glycerol, 7 ml water, 250 pg 
Xylene cyanole FF (sigma), and 250 pg bromophenol blue (Fisons Scientific Equipment)] 
Storage temperature for the 6xGel-loading buffer is 4°C. Gel-loading buffers serve three 
purposes: They increase the density of the sample, ensuring that the DNA drops evenly into 
the well; they add colour to the sample, thereby simplifying the loading process; and they 
contain dyes that, in an electric field, move toward the anode at predictable rates. 
Bromophenol blue migrates tlii’ough agarose gels approximately 2,2-fold faster than xylene
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cyanol FF, independent of the agarose concentration. Bromophenol blue migrates through 
agarose gels run in 0.5x TBE at approximately the same rate as linear double-stranded DNA 
300bp in length, whereas xylene cyanol FF migrates at approximately the same rate as linear 
double-stranded DNA 4 kb in length. These relationships are not significantly affected by the 
concentration of agarose in the gel over the range of 0.5% to 1.4%.
HEPES, free acid
[N-(2-Hydroxyethyl) piperazine N'-(2-ethanesulfonic acid)]
HEPES is a zwitterionic N-substituted aminosulfonic acid buffer, typically referred to as 
Good's buffer, useful in cell culture media formulations.
Luria-Bertani (LB) medium
Per litre:
To 950 ml of deionised H2O, add:
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCl 10 g
Shake until the solutions have dissolved. Adjust the pH to 7.0 with 5 N NaOH (~ 0.2 ml). 
Adjust the volume of the solution to 1 litre with deionised H2O. Sterilise by autoclaving for 20 
minutes at 15 Ib/sq. in. on liquid cycle.
LB medium containing agar
Prepare LB medium. Just before autoclaving, add:
bacto-agar 15 g/litre
Sterilise by autoclaving for 20 minutes at 15 Ib/sq. in. on liquid cycle. Allow the medium to 
cool to 50°C before adding thennolabile substances (e.g., antibiotics). Mix the medium by 
swirling. Plates can then be poured directly from the flask; allow about 30-35 ml of medium 
per 90-mm plate. In this study, all LB-agar plates used contained 50 pg/ml kanamycin (Sigma- 
Aldrich).
Lysis/Binding buffer
100 mM Tris-HCl, pH 7.5 
500 inM LiCl 
10 mM EDTA, pH 8.0 
1% LiDS 
5 mM dithiothreitol (DTT)
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SMNaCl
Dissolve 292.2 g of NaCl in 800 ml of H2O. Adjust the volume to 1 litre with H2O. Dispense 
into aliquots and sterilise by autoclaving.
Neutralisation buffer
(For transfer of DNA to nitrocellulose filters) 
IM Tris (pH 7.4)
1.5 M NaCl
Phosphate-buffered saline (PBS)
Dissolve 8 g of NaCl, 0.2 g of KCL, 1.44 g of Na2HP04, and 0.24 g of KH2PO4 in 800 ml of 
distilled H2O. Adjust the pH to 7.4 with HCl. Add H2O to 1 litre. Dispense the solution into 
aliquots and sterilise them by autoclaving for 20 minutes at 15 Ib/sq.in. on liquid cycle. Store 
at room temperature.
Prehybridisation buffer
(For Southern blot, Dot blot and colony hybridisations)
Per 500 ml
Fonnamide 250 ml
20x SSC 125 ml
5 Ox Denhardt's 50 ml
0.5 M EDTA 1 ml
20% SDS 25 ml
1 M PBS (pH 7.0) 25 ml
10 mg/ml sheared salmon sperm DNA 10 ml
(Sigma Catalogue# D-1626, DNA sodium salt type III from salmon testes) 
Prehybridisation buffer contains 50% Fonnamide, 5x SSC, 5x Denhardt's, 0.1 M EDTA, 1% 
SDS, 50mM Sodium phosphate buffer (pH 7.0), 200 pg/ml Denatured, fragmented (sheared) 
salmon sperm DNA (SSS).
3M  Sodium acetate (pH 5.2 and p H  7.0)
Dissolve 408.1 g of sodium acetate.3H2O in 800 ml of H2O. Adjust the pH to 5.2 with glacial 
acetic acid or adjust the pH to 7.0 with dilute acetic acid. Adjust the volume to 1 litre with 
H2O. Dispense into aliquots. Sterilise by autoclaving.
2ÙXSSC
Dissolve 175.3 g of NaCl and 88.2 g of sodium citrate in 800 ml of H2O. Adjust the pH to 7.0 
with a few drops of a 10 N solution of NaOH. Adjust the volume to 1 litre with H2O. Dispense 
into aliquots. Sterilise by autoclaving.
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20XSSPE
Dissolve 175.3 g of NaCl, 27.6 g of NaH2P04.H20 and 7.4 g of EDTA in 800 ml of H2O. 
Adjust the pH to 7.4 with NaOH (~ 6.5 ml of a 10 N solution). Adjust the volume to 1 litre 
with H2O. Dispense into aliquots. Sterilise by autoclaving.
1X TAE buffer
Per 10 litres
48.4 g Tris
11.42 ml Glacial acetic acid
20 ml EDTA (0.5 M, pH 8.0)
Adjust the volume to 10 litres with H2O
7x TBE buffer
Per 10 litres
Tris
Boric acid
EDTA (0.5 M, pH 8.0) 
Adjust the volume to 10 litres with H2O
108 g55 g40 ml
TE buffer
PH 7.4:
10 mM Tris.Cl (pH 7.4) 
1 mM EDTA (pH 8.0) 
PH 7.6
10 mM Tris.Cl (pH 7.6) 
1 mM EDTA (pH 8.0)
Transfer buffer
(For transfer of DNA to nitrocellulose filters) 
lOx SSC 
10 SSPE
IM  Tris
Dissolve 121.1 g of Tris base in 800 ml of H20. Adjust the pH to the desired value by adding 
concentrated HCl.
pH HCl
7.4 70 ml
7.6 60 ml
8.0 42 ml
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Allow the solution to cool to room temperature before making final adjustments to the pH. 
Adjust the volume of the solution to 1 litre with H20. Dispense into aliquots and sterilise by 
autoclaving.
Terrific broth
(Tartof and Hobbs 1987)
Per liter:
To 900 ml of deionised H2O, add:
Bacto-tryptone 12 g
Bacto-yeast extract 24 g
Glycerol 4 ml
Shake until the solutes have dissolved and sterilise by autoclaving for 20 minutes at 15 Ib/sq. 
in. on liquid cycle. Allow the solution to cool to 60°C or less, and then add 100 ml of a sterile 
solution of 0.17 M KH2PO4, 0.72 M K2HPO4. (This solution is made by dissolving 2.31 g of 
KH2PO4 and 12.54 g of K2HPO4 in 90 ml of deionised H2O. After the salt have dissolved, 
adjust the volume of the solution to 100 ml with deionised H2O and sterilise by autoclaving for 
20 minutes at 15 Ib/sq. in. on liquid cycle.). In this study, to make 1000 ml temfic broth 
containing 50 pg/ml kanamycin (Sigma), 47 g terrific broth powder, 4ml glycerol (Sigma) and 
double distilled H2O were mixed to get a final volume of 1000ml. The broth was autoclaved at 
121°C for 20 minutes.
Tris-acetate (TAE)
Working solution (IxTAE): 0.04M Tris-acetate
O.OOIM EDTA
Concentrated stock solution (50xTAE) (per litre): 242 g Tris base
57.1 ml glacial acetic acid 
100 ml 0.5M EDTA (pH 8.0)
Tris-buffered saline (TBS) (pH 7.2)
150 mM NaCl 
20 mM Tris (pH 7.2)
Dissolve 8 g of NaCl, 0.2 g of KCl, and 3 g of Tris base in 800 ml of distilled H2O. Add 0.015 
g of phenol red and adjust the pH to 7.4 with HCl. Add distilled H2O to 1 litre. Dispense the 
solution into alliquots and sterilise them by autoclaving for 20 minutes at 15 Ib/sq. in. on 
liquid cycle. Store at room temperature.
Sequencing gel-loading buffer
98% deionised formamide 
10 mM EDTA (pH 8.0) 
0.025% xylene cyanol FF 
0.025% bromophenol blue
179
2 X SDS gel-loading buffer
100 mM Tris.Cl (pH 6.8)
200 mM dithiothreitol 
4% SDS (electrophoresis grade)
0.2% bromophenol blue 
20% glycerol
2x SDS gel-loading buffer lacking dithiothreitol can be stored at room temperature. 
Dithiothreitol should then be added, just before the buffer is used, from a 1 M stock.
Spectrophotometric Determination o f  the Amount o f  DNA or RNA
For quantitating the amout of DNA or RNA, readings should be taken at wavelengths of 260 
nm and 280 mn. The reading at 260 mn allows calculation of the concentration of nucleic acid 
in the sample. An OD of 1 corresponds to approximately 50 qg/ml for double-stranded DNA, 
40 pg/ml for single-stranded DNA and RNA, and ~ 20 pg/ml for single-stranded 
oligonucleotides. The ratio between the readings at 260 nm and 280 nm (OD260/OD280) 
provides an estimate of the purity of the nucleic acid. Pure preparations of DNA and RNA 
have OD260/OD280 values of 1.8 and 2.0, respectively. If there is contamination with protein or 
phenol, the OD260/OD280 will be significantly less than the values given above, and accurate 
quantitation of the amount of nucleic acid will not be possible.
Washing buffer A
(For nylon membrane washing following Southern blot/Dot blot/Colony blot hybridisations) 
1 mM EDTA 
0.1% LiDS
10 mM Tris-HCl, pH 7.5 
0.15 M LiCl
Washing buffer B
(For nylon membrane washing following Southern blot/Dot blot/Colony blot hybridisations) 
10 mM Tris-HCl, pH 7.5 
0.15 M LiCl 
1 mM EDTA
1 8 0
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